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Abstract 
Humans are approximately 99% similar with inter-individual differences caused in part by single-
nucleotide polymorphisms (SNPs), which poses a challenge for the effective treatment of disease. 
Bioinformatics resources can help to store and analyse gene and protein information to address this 
challenge, however these resources have limitations, so the collation and biocuration of gene and 
protein information is required. Using the large conductance calcium- and voltage-activated potassium 
channel, also known as the Big Potassium (BK) channel as an example, due to its ubiquitous expression 
and widespread varied role in human physiology, this study aimed to prioritise SNPs with the potential 
to affect the function of the channel. Using a BK channel resource created with bioinformatics tools 
and published literature, mSlo SNPs H55Q and G57A, located in the S0-S1 linker, were prioritised and 
selected for lab-based verification. These SNPs flank three cysteine residues proven to modulate 
channel cellular distribution via palmitoylation, a reversible process shown to increase protein 
association with the cell membrane. The SNPs alter the predicted palmitoylation status of C56, one of 
the cysteine residues located in the S0-S1 linker. The cellular distribution of BK channels incorporating 
the SNPs was assessed using confocal microscopy and revealed that the direction and magnitude of 
SNP mimetic cell membrane expression was closely related to the C56 predicted palmitoylation score; 
a 'C56 palmitoylation pattern' was observed. It was shown that exposure to metabolic substrates 
glucose, palmitate and oleate modulated SNP-mimetic cellular distribution and could invert the 'C56 
palmitoylation pattern', indicating that there is interplay between the metabolic status of the cell and 
the amino-acid composition of the channel via palmitoylation. The creation of a novel BK channel 
resource in this thesis highlighted the limitations, and inter-dependency of bioinformatics and lab 
based experimentation, whilst SNP verification experiments solidified the link between S0-S1 cysteine 
residues and BK cellular distribution. BK channel function is linked with a number of physiological 
processes; thus, the potential clinical consequences of the SNPs prioritised in this thesis require further 
research.  
 
Keywords: SNPs, BK channel, cell membrane expression, palmitoylation, glucose, palmitate, oleate, 
biocuration, cysteine, bioinformatics 
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1. General Introduction 
 
1.1 Introduction Synopsis 
Every human has a unique genetic composition, with DNA variations contributing to genotypic and 
phenotypic differences existing between individuals (Levy et al., 2007); in some cases DNA variations 
contribute to the development of disease (as reviewed by Goldstein, 2009; Hindorff et al., 2009; Albert 
and Kruglyak, 2015). These inter-individual variations pose a challenge for the effective treatment of 
disease, as any one therapy may not be equally effective for all. Personalised medicine aims to take 
into account these inter-individual variations, and seeks to determine the individual’s risk for disease 
and probable response to treatment (Guttmacher and Collins, 2003; Burke and Psaty, 2007). This 
process aims to target and optimise disease screening and treatment therapies at the individual level, 
rather than at the ‘average’ of the population, to increase treatment efficacy. Personalised medicine 
utilises bioinformatics resources to facilitate the storage and analysis of the vast amount of biological 
information produced with the aim of identifying new genetic targets in the treatment of disease 
(Fernald et al., 2011; Overby and Tarczy-Hornoch, 2013; Alyass et al., 2015). The number of genetic 
variations across the whole genome is too vast to assess as part of any one thesis. Consequently, for 
the purpose of this work, a single gene was selected to investigate the prioritisation of potentially 
harmful single nucleotide polymorphisms, on the basis of existing information available in 
bioinformatics resources. The BK channel, a potassium channel found ubiquitously in the human body, 
and involved in processes such as neuronal function and the regulation of smooth muscle tone was 
selected. Genetic variations occurring in the BK channel gene have been shown to result in disease (Du 
et al., 2005; Díez-Sampedro et al., 2006; Wang, Rothberg and Brenner, 2009; Plante, 2016); proving 
that mutations in the BK channel gene can affect normal physiology, making the channel a worthy 
protein for research.  
 
1.2 Genetic variation in humans 
Every human has a unique genetic code, comprised of approximately 3 billion base pairs, the building 
blocks of DNA (Lander et al., 2001; Venter et al., 2001). The first large scale multinational investigation 
into the base pair composition of the complete human genome was undertaken by the Human 
Genome Project. The consortium comprising 20 international research centres began the investigation 
in 1990 and concluded with the announcement of the near-complete (99%) human DNA sequence in 
2003 (Human Genome Sequencing Consortium, 2004). This created the first reference map of the 
2 
 
human genome, and facilitated research into the genetic differences between individuals not only by 
providing increased detail and understanding of genomic composition, but by releasing study findings 
to open access resources within 24 hours of discovery (Guyer and Guyer, 1998). Research has 
estimated that there is approximately 95% to 99.9% sequence homology between humans (Collins and 
Mansoura, 2001; Human Genome Sequencing Consortium, 2004; Levy et al., 2007), with the remaining 
percentage of mismatch associated with genetic variation. Genetic variation is responsible for the 
visible phenotypic differences observed between individuals, such as eye colour, height and the ability 
to roll the tongue, but also for genotype differences that are not immediately apparent, such as blood 
type and the shape of the red blood cells. Genetic variation is multi-level and serves to increase the 
diversity between individuals, such as during meiosis occurring in the process of normal human 
reproduction (as reviewed by Thompson, 2013).  
Human variation can occur out with the DNA, such as in the case of epigenetics, which involves the 
expression or silencing of genes without alterations to the DNA base pair sequence (as reviewed by 
Mazzio and Soliman, 2012). Epigenetics has been associated with many disease states, with evidence 
reviews conducted for diabetes (Sommese et al., 2017), cardiovascular disease (Muka et al., 2016), 
cancer (Biswas and Mallikarjuna Rao, 2017), autism (Grafodatskaya et al., 2010) and mental 
retardation (Nageshwaran and Festenstein, 2015). There is also evidence of variations in the number 
of copies and order of genes in the DNA, or alterations to large sections of DNA creating ‘copy number 
variations’ (CNVs) which add to inter-human variation (as reviewed by Zhang et al., 2009; Zarrei et al., 
2015). CNVs have been associated with diseases such as Crohn’s disease (Fellermann et al., 2006; 
McCarroll et al., 2008), psoriasis (Hollox et al., 2008) and Alzheimer disease (Rovelet-Lecrux et al., 
2006). Whilst variation occurs via a number of mechanisms, it is thought that the most frequent type 
of sequence variation is the single nucleotide polymorphism (SNP) (Human Genome Sequencing 
Consortium, 2004).  
 
Single nucleotide polymorphisms 
The human DNA sequence is composed of a chain of four nucleotide bases: Adenine (A), Thymine (T), 
Guanine (G) and Cytosine (C), structured in two complementary DNA strands within a chromosome. A 
single nucleotide polymorphism or a SNP is a variation or ‘point mutation’ of a single nucleotide within 
the DNA sequence. The convention is that the frequency of a DNA point mutation must be above 1% 
in the population to qualify as a SNP (Cavalli-Sforz and Bodmer, 1971; Arias, Jorge and Barrantes, 1991).    
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Figure 1.1- Illustration of the DNA sequence consequence of single nucleotide polymorphisms. 
Detailed in this figure are the four different categories of single nucleotide polymorphism consequence 
on the DNA base pair sequence. Illustrated is A) substitution, B) inversion, C) insertion and D) deletion. 
The top row of letters shows the original base pair sequence, whilst each of the quadrants illustrates 
the consequence of the DNA mutation. Adapted from Genome Research Limited, 2017.    
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However, DNA variations with a lower frequency have also been referred to as SNP (Wong et al., 2003; 
Bush and Moore, 2012; Yoo, Sun and Bull, 2013), and have been shown to have downstream effects. 
Consequently, revision of the criteria has been suggested (Karki et al., 2015). As shown in Figure 1.1, 
there are four types of DNA mutation: substitution, inversion, insertion and deletion. In addition, there 
is further categorisation of SNP depending on their location in the gene, and their downstream 
consequence. SNPs located within the exonic (protein coding) region of the DNA in which a base pair 
substitution results in a change in the translated amino acid sequence of the protein are called 
‘missense’ or non-synonymous SNP (nsSNP). Synonymous SNP (sSNP) cause a change in base pair 
sequence, however do not result in a change in amino acid.  
Non-protein coding areas of the DNA include 5’ and 3’ untranslated (UTR), intronic and regulatory 
regions. SNPs in the non-coding regions of DNA have no direct effect on the amino acid composition 
of a protein, but may augment the expression of proteins produced by affecting areas in the DNA 
associated with regulation of transcription and translation (as reviewed by Shastry, 2009; Zhang and 
Lupski, 2015). DNA mutations can change the amino acid sequence of a protein, or affect the amount 
of protein expressed, therefore having the potential to disrupt physiological processes and result in 
disease. As a result of this potential, the identification of the number, location and consequence of 
SNP has been the focus of large scale investigative projects. A selection of the projects most relevant 
to the thesis work are introduced below.  
 
1.3 Projects investigating human single nucleotide polymorphisms 
The ENCODE project 
The Encyclopaedia of DNA Elements (ENCODE) project was launched in 2003 by the US National Human 
Genome Research Institute (NHGRI) and aimed to develop and apply high-throughput approaches to 
detect DNA sequence elements that confer biological function (The ENCODE Project Consortium, 
2004). In several publications spanning over a decade, the ENCODE project determined that over 80% 
of the human genome was ‘active’ and associated with biological functions, such as controlling coding 
DNA (cDNA) levels, and thus protein expression levels (The ENCODE Project Consortium, 2004, 2007; 
Ecker et al., 2012; ENCODE Project Consortium and The ENCODE Project, 2012; Kellis et al., 2014). To 
encourage use of the ENCODE project outputs, rapid data release to the scientific community was 
agreed (The Wellcome Trust, 2003). The ENCODE project added to the reference genome mapped by 
the Human Genome Project, by taking steps towards the accurate annotation of the function of DNA 
elements in the genome; this facilitated the classification of SNP potential damage as more was known 
about the regions in which they occurred (Bryzgalov et al., 2013).  
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The 1000 genomes and the 100,000 genomes projects 
In 2001, the International SNP Map Working Group identified the location of 1.42 million SNPs 
(Sachidanandam et al., 2001), comprised of data from the Human Genome Project (Venter et al., 2001) 
and the SNP Consortium (Lander et al., 2000). As technology advanced and the number of genomes 
sequenced increased, the estimated number of SNPs also increased; the approximate value in a recent 
publication by the 1000 Genomes Project Consortium was 84.7 million (Auton et al., 2015). The 1000 
genomes project aimed to identify 95% of ‘common’ SNPs (those occurring above a frequency of 1%) 
in the genome. At the completion of the study in 2015, the project had successfully sequenced the 
genomes of 2,504 individuals from 26 populations (Auton et al., 2015; Sudmant et al., 2015). In 2012, 
the Genomics England initiative, the ‘100,000 genomes project’ was announced (Cameron, 2012; 
Torjesen, 2013). The project focuses on the identification of SNPs associated with rare disease and 
cancer by sequencing the genomes of individuals effected by disease, their family members and the 
genetic material contained within the tumours of those with cancer. The aim is to facilitate the 
identification and treatment of patients suffering from rare diseases and cancer by the creation of a 
comprehensive database of genomic material and SNPs, which can be used by clinicians to sub-group 
and stratify patients to the most effective treatments.  
 
The International HapMap Project 
The International HapMap Project commenced in 2002 and aimed to create a haplotype (group of 
genes inherited together) map (HapMap) of the human genome to facilitate the discovery of genes 
and genetic variations that affect health, disease and response to drug treatments (Goldstein and 
Weale, 2001; The International HapMap Consortium et al., 2003; Thorisson et al., 2005; International 
HapMap Consortium, 2007). A goal was that the resource would reduce the number of SNPs required 
to be investigated in order to establish association with a phenotype, and utilised linkage 
disequilibrium (the non-random association of alleles and thus SNP at different sites in the DNA) to 
achieve this goal. The project data release in 2007 provided the location and base pair consequence of 
approximately 3 million SNPs from the genome of 1400 individuals from 11 populations (International 
HapMap Consortium, 2007). This information was used to create technologies containing SNP 
information that could reduce the time required to conduct a basic screen of the genome, such as 
Chip-based genotyping assays (Edenberg and Liu, 2009). The popularity of The 1000 Genomes Project 
resulted in traffic to the HapMap website decreasing dramatically; this alongside issues with security 
resulted in it being closed down in June 2016 (Buchanan et al., 2012; National Center for Biotechnology 
Information, 2016). 
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Progress made by the international collaboration of large research organisations has enabled an 
exponential expansion in the understanding of the composition of the human genome, the role and 
location of genes, as well as a more accurate estimation of the number of single nucleotide 
polymorphisms. Investigations now focus on linking SNP with disease; these include global 
collaborations to complete genome wide association studies and large-scale exome screening. These 
genome investigation, SNP identification and SNP-disease association projects work alongside one and 
other and inform each other to advance upon current understanding.  
 
1.4 Linkage of single nucleotide polymorphisms with disease 
1.4.1 Exome screening and Genome Wide Association Studies (GWAS)  
SNPs occurring in non-coding DNA regions are associated with disease (Greenwood and Kelsoe, 2003; 
Yasuda et al., 2008; Nascimbeni et al., 2010; Castaman et al., 2011), however, nsSNP continue to be 
studied extensively due to their direct effect on the amino acids residues comprising proteins. It is 
proposed that 83% of disease-causing mutations affect the stability of proteins (Wang and Moult, 
2001). In addition, estimates suggest that nsSNP in exonic regions constitute approximately 80-90% of 
inherited-disease causing mutations (Cooper, Krawczak and Antonorakis, 1995), and approximately 
50% of the entries of disease causing genetic changes in the human gene mutation database (HGMD) 
(Stenson et al., 2014). Exome screening (also known as exome sequencing) is a method used to 
investigate the occurrence of SNP in the genome and link genetic variations with disease. Exome 
screening is efficient at detecting low frequency genomic differences resulting in rare disease, due to 
low cohort number requirements (Gilissen et al., 2011). Exome screening focuses on only the exonic 
regions of the DNA, which comprises less than 2% of the whole genome; although advances in 
technology are reducing the cost of whole genome screening, exome screening can produce outputs 
in a much shorter timeframe and a reduced cost in comparison to whole genome screening (Belkadi 
et al., 2015; Meienberg et al., 2016). As a result, exome screening is more commonly used in a clinical 
setting (as reviewed by Majewski et al., 2011; Retterer et al., 2016). 
A genome wide association study (GWAS) is the examination of thousands to millions of genetic 
variants in large cohorts of individuals to assess if a mutation is associated with a phenotype or disease 
trait, (as reviewed by Pearson and Manolio, 2008; Wang and Wang, 2009; Visscher et al., 2012). The 
principles of GWAS were first proposed in 1996 (Risch and Merikangas, 1996), and the first major 
analysis results by large research groups were published a decade later (Klein et al., 2005; DeWan et 
al., 2006; Wellcome Trust Case Control Consortium, 2007; Manolio and Collins, 2009). GWAS 
investigations are conducted across the whole genome and are hypothesis generating rather than 
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hypothesis driven, as a hypothesis is not formed in advance of undertaking the study (Hirschhorn and 
Daly, 2005). Variant association is determined by powered statistical analysis, which assesses the 
frequency of SNPs in participants sharing a phenotypic trait or disease straits; those SNPs are then 
taken forward for further analysis and verification. GWAS are well suited to associate genetic variations 
with disease in SNP with a relatively high frequency, above 1%. This guideline cut-off is because current 
technology limits the number of variant sites that can be incorporated into analysis arrays to 
approximately 5 million, and an ever increasing number of sample genomes will be required to provide 
statistical power to accurately detect associations with low frequency SNP (Lam et al., 2006; Tabangin, 
Woo and Martin, 2009; Corvin, Craddock and Sullivan, 2010).  
As described in the review articles, a challenge of GWAS is that the location of SNP in the genome of 
interest must have already been established to compare SNP frequency between subjects; there is also 
the requirement to have a large number of genome samples with detailed subject information, such 
as ancestry and phenotype description, from which to compare. Advantages of GWAS are that a) pre-
selection of target regions of the gene to be screened is not required, b) it is not necessary to have 
prior understanding of the function of genes in the genome to associate them with disease and c) a 
large number of SNPs, in the order of millions, can be investigated simultaneously. However, exome 
screening in contrast to GWAS, is not reliant on previous database of SNP, and can be used to identify 
undiscovered SNP in exome in regions of DNA (as reviewed by Lee et al. 2014).  
 
1.4.2 Diseases associated with SNP 
SNPs are being directly attributed to the causation and development of many diseases. GWAS in 
combination with exome screening have successfully led to the identification of genes previously 
unknown to be associated with disease, such as peroxisome proliferator-activated receptor gamma 
(PPARγ) in relation to type II diabetes (Yen et al., 1997; Ruchat et al., 2010) and hypothalamus located 
melanocortin 4 receptor (MC4R) associated with body mass index (Loos et al., 2008; Wang et al., 2011) 
to name a few. However, there are diseases, especially inherited diseases, where a causal link to 
genetic mutations, rather than an association, has been established. A well-known example is sickle-
cell anaemia, were a nsSNP substituting glutamic acid with valine in the β-globin gene coding for 
haemoglobin results in ‘sickle’ shaped red blood cells. These abnormally shaped blood cells are more 
likely to clump together and result in haemolytic anaemia (Herrick, 1910; Taliaferro and Huck, 1923; 
Ingram, 1959).  
Another example is Cystic Fibrosis, where multiple mutations on the CFTR gene cause Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR) protein malfunction, (as reviewed by Moskowitz et al. 
8 
 
2008). CFTR is a cAMP-dependent chloride channel located in epithelial cells which regulates salt 
transport and fluid flow; malfunction of the CFTR protein results in airway disease, pancreatic failure, 
meconium ileus and male infertility (as reviewed by Hull 2012). Phenylketonuria (PKU), where a series 
of damaging nsSNPs affecting the phenylalanine hydroxylase (PAH) gene results in impaired 
hydroxylation of phenylalanine to tyrosine, causing hyperphenylalaninemia and if untreated, 
intellectual disability and neurological abnormalities, (discussed by Gámez et al., 2000; Blau et al., 
2010). Further examples of mutations causative of disease are the BRCA1 and BRCA2 gene mutations, 
which are proposed to result in a 5 to 30-times increased risk of breast cancer and ovarian cancer; 
however the exact percentage of increased risk is yet to be determined (Antoniou et al., 2003; Pal et 
al., 2005; Chen and Parmigiani, 2007; Levy-Lahad and Friedman, 2007). Huntington's disease, identified 
in 1872 (Huntington, 1872) is caused by mutations in the HTT gene responsible for the production of 
the protein huntingtin. In patients suffering from Huntington’s disease, the CAG segment within the 
gene is repeated 36 to 120 times, rather than the 10 to 35 in people without the disease, as discussed 
by (The Huntington’s Disease Collaborative Research Group, 1993; Petersén A et al., 2001; Zheng and 
Diamond, 2012). The specific role of the huntingtin protein is not yet known, however base pair repeats 
in the HTT gene have been shown to cause chorea, dystonia, cognitive and psychological disorders.  
Thus far, global collaborative research efforts such as The Human Genome Project, HapMap and 1000 
genomes project have advanced knowledge of the composition of the human genome, the 
physiological role of genes, the location of SNPs, and the role of SNP in disease. Increasing knowledge, 
and the improvement of disease diagnosis and treatment were long-term goals of the global research 
projects. To realise these goals, a new field of medicine has emerged that seeks to make use of the 
huge volume of insights and data produced from these studies to better target disease therapies to 
individuals.  
 
1.5 SNPs in the context of disease treatment  
Each individual has a unique genetic composition; when treating complex diseases, unlike those 
affecting a single gene, inter-individual genetic variations pose a challenge for healthcare professionals 
as diseases with a similar phenotypic presentation may be of differing aetiology and thus no one 
treatment may be suitable for all. An example of this would be the case of diabetes type II (which 
presents as deranged glucose and lipid levels) as the disease is one of linked, however heterogeneous 
factors of aetiology and progression. Contributing factors include peripheral insulin resistance, 
reduced pancreatic beta-cell insulin secretion, increased secretion of glucagon consequently 
increasing hepatic gluconeogenesis, and enhanced glucose re-uptake in the kidneys (as reviewed in 
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Cerf 2013; Farber, Berger and Earle 1951; Moon and Won 2015; Taylor 2012). As a result, it is unlikely 
that a standard treatment would be sophisticated enough to account for the inter-individual 
differences.  
Personalised medicine (sometimes referred to as precision medicine, stratified medicine or 
individualised medicine) seeks to take into account inter-individual variations, and aims to determine 
the individual’s risk for disease and probable response to therapy in order to achieve optimum 
treatment outcomes (Guttmacher and Collins, 2003; Burke and Psaty, 2007). This is achieved by sub-
grouping individuals according to the biological or risk characteristics, also known as ‘stratifying’ 
individuals (Trusheim, Berndt and Douglas, 2007), which represents a paradigm shift in the thought 
process behind patient treatment, and is a step away from treating the ‘average’ patient.  
Personalised medicine has been implemented successfully in a number of cases; advance testing is 
with vemurafenib (brand name Zelboraf®), a drug used to treat advanced malignant melanoma 
(Chapman et al., 2011), which is only effective in those with a V600X mutation in the gene ‘BRAF’ which 
codes for the oncogenic protein kinase ‘B-Raf’. Vemurafenib is a potent inhibitor of mutated B-Raf and 
has marked anti-tumour effects against melanoma cells expressing the BRAF V600E mutation (Tsai et 
al., 2008). Another example of disease stratification in personalised medicine is in the prediction of 6-
mercaptopurine efficacy by assessment of gene deficiency and SNP occurring on the thiopurine 
methyltransferase (TPMT) gene (Karas-Kuzelicki and Mlinaric-Rascan, 2009). Treatment regimen and 
6-mercaptopurine dosage can then be amended to the individual patient.  
The field of personalised medicine seeks to utilise information regarding the molecular and genetic 
mechanisms of disease to improve treatment; therefore it is informed by genomics, proteomics, 
metabolomics and pharmacogenomics (Chen and Snyder, 2013; Glauber, Rishe and Karnieli, 2014). 
The volume of biological information associated with these ‘omics’ is vast and varied, therefore 
personalised medicine utilises bioinformatics to store, analyse and manipulate this data (Bao et al., 
2014). 
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1.6 Bioinformatics 
1.6.1 Bioinformatics Databases  
Bioinformatics is a combination of biology, informatics, computing and statistics and is used to store 
and perform powerful analysis of biological data (as reviewed by Luscombe, Greenbaum and Gerstein, 
2001; Pabinger et al., 2014). This storage and analysis of biological data is achieved through the 
utilisation of databases and software programs. The number and type of bioinformatics databases is 
vast and varied, comprising of primary databases that store basic, experimentally derived biological 
data such as nucleotide and protein sequences; whilst secondary databases summarise and further 
process the data from primary databases and data contained within the literature (Luscombe, 
Greenbaum and Gerstein, 2001; The European Bioinformatics Institute, 2017). A summary of the main 
aspects of primary and secondary bioinformatics databases, and examples of each are contained 
within Table 1.1.  
The latest release of the database issue of the journal Nucleic Acid Research (NAR), which is the key 
source for a comprehensive list of curated databases, states there are 1,685 live biological databases 
available online (Rigden, Fernández-Suárez and Galperin, 2016). The team at NAR ascertained the 
number of ‘live’ databases using measures such as the number of data downloads, literature citations 
and web links from outside sources (Cochrane and Galperin, 2010; Rigden, Fernández-Suárez and 
Galperin, 2016). The 1,685 databases are comprised of many broad categories, often developed to 
cater to a specific need. Examples include organism specific databases such as FlyBase and WormBase 
(Howe et al., 2016; Millburn et al., 2016), disease specific databases such as the cancer database 
COSMIC (Forbes et al., 2011), databases for protein families (Finn et al., 2010) and of protein 
nomenclature, such as ExPASy for enzymes (Gasteiger et al., 2003). There is evidence however that 
the databases are not accessed with equal frequency; a recent assessment of bioinformatics database 
and software usage discovered that 5% of resources accounted for 47% of total database usage (Duck 
et al., 2016). This implies that the vast majority of databases are not commonly frequented; this finding 
was in line with other articles that discussed the issues associated with unused databases, such as 
under-utilisation of relevant data and the waste of financial investment (Cannata et al., 2005; Wren 
and Bateman, 2008). Due to the overwhelming number and categories of databases available, only the 
databases used in the thesis will be introduced below.   
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Table 1.1- Summary of the main aspects of primary and secondary bioinformatics databases. 
Included in the table are the synonyms, source of data and examples of primary and secondary 
bioinformatics databases. Adapted from The European Bioinformatics Institute, 2017. 
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NCBI 
The National Center for Biotechnology Information (NCBI) was established in 1988 as a national 
resource for molecular biology information, which aimed to develop new technologies to facilitate 
understanding of the molecular and genetic origins of health and disease (Woodsmall and Benson, 
1993). This was achieved in the creation of automated systems for storing and analysing data produced 
by molecular biology, biochemistry and genetics, and is accessible from www.ncbi.nlm.nih.gov . NCBI 
is host to other established databases such as PubMed, the sequence alignment tool BLAST and the 
short genetic variations database dbSNP (Sherry et al., 2001).  
 
Ensembl 
The Ensembl Project is a collaboration between the European Bioinformatics Institute (EMBI-EBI) and 
the Wellcome Trust Sanger Institute (WTSI) and began in 1999 (Hubbard et al., 2002). The aim of the 
project was to automatically annotate the genome and integrate this annotation with biological data 
generated from data generation projects such as the Human Genome Project. In line with the Human 
Genome Project, another aim of Ensembl was to enable open access to the data produced via the web 
(Hubbard et al., 2002). To this end, the Ensembl database produced a free to access database in July 
2000 (The European Bioinformatics Institute, 2000) and is accessible from 
http://www.ensembl.org/index.html. Although categorised as a secondary database (see Table 1.1), 
the database includes primary data (nucleotide sequence), in addition to comparative genomics, 
variation data and regulatory data. 
 
UniProt 
The Universal Protein Resource (UniProt) is a collaboration between the European Bioinformatics 
Institute (EMBL-EBI), the SIB Swiss Institute of Bioinformatics and the Protein Information Resource 
(PIR) and is accessible from http://www.uniprot.org/. The UniProt Knowledgebase (UniProtKB) 
database (accessible from http://www.uniprot.org/uniprot/) is a secondary database and contains 
functional information on proteins with annotation conducted manually by Swiss-Prot (Bairoch and 
Boeckmann, 1991), and computationally by TrEMBL (Bairoch and Apweiler, 1996). Swiss-Prot entries 
are reviewed and manually annotated, integrating results from lab-based experimentation and 
scientific conclusions (Bairoch and Boeckmann, 1991; Boeckmann et al., 2003). However, as the 
number of sequence data submissions to the UniProt database for inclusion increased, the capacity 
for timely review was exceeded. Therefore TrEMBL (Translated EMBL Nucleotide Sequence Data 
Library) was created to annotate computationally and increase the speed of review. It is the aim of 
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UniProt to manually annotate all sequences; therefore, sequences annotated computationally by 
TrEMBL may later be reviewed Swiss-Prot. Although categorised as a secondary database (see Table 
1.1), the database includes primary data (nucleotide sequence), in addition to comparative genomics, 
regulatory data and variation data from sources such as dbSNP and the 1000 genomes project. 
 
1.6.2 Biocuration  
Biocuration is the processes of collecting, interpreting, organising and validating biological 
information. This process is used by individuals and large scale projects such as CCDS and Swiss-Prot 
and serves as a form of ‘quality control’ to improve the accuracy and quality of data, for instance the 
information held in bioinformatics databases (Boeckmann et al., 2005; Pruitt et al., 2009). Key to this 
process is the integration of information from multiple sources such as scientific literature and large 
datasets produced by next-generation sequencing, and the clarification of discrepancies in this 
information such as protein name, sequence, structure, function and interactions (Altman, 1998). The 
International Society for Biocuration (ISB) encourages the profession to facilitate the linking of 
researchers to biocurated data in an effort to ensure the data is in the ideal form to support further 
investigation and computational analysis (Bateman, 2010). As databases are increasingly becoming a 
mainstay in biological research, biocuration of the data has moved from a niche to something that is 
essential; however, the ‘gold standard’ of manual biocuration is ‘time-expensive’ and cannot match 
the speed of data generation. Automated methods such as TrEMBL aim to tackle this challenge 
(Boeckmann et al., 2003); however, often a large amount of information associated with a protein will 
remain un-curated and can result in protein records that are not comprehensive.  
 
Consensus CDS (CCDS)  
The annotation of genes is achieved by combining information from multiple sources (such as journal 
articles, raw data from high throughput screens and annotation via Ensembl and NCBI); this can result 
in information that is similar but not necessarily identical. Thus, the Consensus CDS (CCDS) project, a 
collaboration between projects such as NCBI, EBI WTSI and HUGO Gene Nomenclature Committee 
(HGNC), was established to provide consistent high-quality annotation. CCDS aimed to facilitate the 
creation of a ‘gold standard’ set of gene annotations for the murine and human genome , and define 
"Consensus" as “protein-coding regions that agree at the start codon, stop codon, and splice junctions, 
and for which the prediction meets quality assurance benchmarks” (Pruitt et al., 2009). This consensus 
is achieved by mandating agreement on annotation by multiple collaborators before changes can be 
made (Harte et al., 2012). In order to achieve the standard annotation across databases, the concept 
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of a ‘canonical’ transcript and protein was created, so that protein annotation could be uniform, 
independent of the website being used. Ensembl details the canonical transcript for a gene according 
to the following hierarchy: 1) Longest CCDS translation with no stop codons, 2) the longest 
Ensembl/Havana merged translation with no stop codons, 3) the longest translation with no stop 
codons or 4) the longest non-protein-coding transcript. 
 
1.6.3 Bioinformatics Prediction Software  
1.6.3.1 SNP damage prediction software  
SNP information is stored in a number of databases such as Ensembl and EBI, which collate SNP data 
from specialised SNP databases such as dbSNP (Sherry et al., 2001). These specialised SNP databases 
are populated with SNP information from high-throughput sequencing from projects such as The 
Human Genome Project and the 1000 genomes project. Due to the increased density and quality of 
genome annotation, and ever increasing richness SNP location and consequence data, computational 
methods of SNP damage prediction have been developed (as reviewed by Wu and Jiang, 2013). These 
software programs, with the aid of algorithms, aim to assess the likelihood that a SNP is damaging to 
function. It is important to note that ‘damaging’ is the terminology used in the field of bioinformatics 
to describe SNPs that have ‘an effect’ on protein function, rather than necessarily causing ‘damage’ to 
a protein or organism in actual terms. However, the term will be used in this thesis to maintain 
consistency of terminology with other publications in the field. Damaging potential is assessed based 
upon factors such as: a) the level of sequence conservation at the SNP location across orthologs, b) the 
functional role of the region (such as a splice site), c) alignment of orthologs to indicate if the SNP lies 
on a key domain such an enzyme binding site and d) ‘supervised machine learning’ of experimentally 
verified protein specific data (Tavtigian et al., 2008; Geurts et al., 2009; Dukka, 2013). Algorithms 
associated with damage scoring software use differing sources of information to compile algorithm 
training data sets (Frousios et al., 2013; Nan Zhao et al., 2014). Consequently, each has its own 
strengths and weaknesses and therefore it has been suggested that multiple software using different 
algorithms and training data are used to achieve a more accurate prediction of SNP damage (Frousios 
et al., 2013).  
The database issue of the journal Nucleic Acid Research (NAR) does not provide a comprehensive list 
of SNP prediction software, however it is estimated that there are approximately 90 tools available 
online (Martin, 2016). Commonly utilised are; SIFT, PolyPhen-2, MutationTaster, Mutation Assessor, 
PANTHER and FATHMM (Ng and Henikoff, 2001; Thomas et al., 2003; Reva, Antipin and Sander, 2007; 
Adzhubei et al., 2010; Schwarz et al., 2010; Adzhubei, Jordan and Sunyaev, 2013; Shihab et al., 2013). 
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However, SIFT and PolyPhen-2 are two of the most widely used because of their differing but 
complementary programming (Flanagan, Patch and Ellard, 2010) to this effect, they are imbedded into 
the Ensembl variation table output. 
 
SIFT 
The SIFT (Sorts Intolerant From Tolerant) software program is available from http://sift.jcvi.org/, and 
is a SNP damage prediction tool that aims to reduce the number of functional assays required to 
determine phenotypes affected by SNP (Ng and Henikoff, 2001). SIFT predicts whether an amino acid 
substitution is likely to affect protein function based purely on residue conservation score from 
multiple alignment sequence homology and the physicochemical similarity between the alternate 
amino acids. SIFT does not use supervised machine-learning methods and is therefore not continually 
trained using experimentally verified SNP consequence data. SIFT classifies the predicted damage into 
two categories; ‘tolerated’ and ‘deleterious’. The potential scores for SIFT outputs range from 1 to 0, 
with lower score indicative of a higher probability of damage. The thresholds for each of the damaging 
categories are 1 to 0.05 for tolerated and 0.05 to 0 for deleterious. SIFT has been utilised in a number 
of previous publications to prioritise damaging SNP (Stead et al., 2011; Teng et al., 2012; Alipoor et al., 
2016; Kalia et al., 2016). 
 
PolyPhen-2 
The PolyPhen-2 (Polymorphism Phenotyping v2) software program is available from 
http://genetics.bwh.harvard.edu/pph2/ and is a tool used for the classification of nsSNPs (Adzhubei et 
al., 2010). Unlike SIFT, the damage score can be calculated from the amino acid or nucleic acid 
sequence. Machine learning of PolyPhen-2 is based upon a set of eight sequence, and three structure-
based features (Adzhubei et al., 2010), that include multiple sequence alignment sequence 
conservation and Swiss-Prot annotation, taking into account any structural and functional annotation 
associated with the protein to predict nsSNP damage. The software can also use information from an 
available homologous protein 3D structure to assess the effect to protein stability (Adzhubei, Jordan 
and Sunyaev, 2013). If no 3D structure is available, the structural features are prediction based. 
PolyPhen-2 is trained using data sets with nsSNP of known consequence, and has been shown to be 
one of the most sensitive tools for the prediction of SNP functional consequence (Frousios et al., 2013). 
The potential scores for PolyPhen-2 outputs range from 0 to 1, with higher score indicative of a higher 
probability that the nsSNP is damaging to protein function. Poly-Phen-2 classifies predicted damage 
into three categories; ‘benign’, ’possibly damaging’ and ‘probably damaging, with thresholds cut-offs 
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at 0.15 and 0.85. PolyPhen-2 has been used in a number of previous publications to prioritise damaging 
SNP (Flanagan, Patch and Ellard, 2010; Hepp, Gonçalves and de Freitas, 2015; Kalia et al., 2016). 
It is not uncommon for the tools to be unable to classify certain variants if the information required to 
do so is unavailable, such as appropriate ortholog alignment for that amino acid location (Frousios et 
al., 2013); this is true for PolyPhen-2 where the outcome is reported as unknown if there is insufficient 
data. 
 
1.6.3.2 Post-Translational Modification Prediction Software 
The modification of a protein during or after translation (post-translational modification) includes 
processes such as phosphorylation (the addition of phosphate groups), N-glycosylation (the addition 
of carbohydrate moieties) and lipidic modifications such as palmitoylation and myristoylation. Post-
translational modifications (PTMs) play a crucial role in the regulation of protein function, stability and 
targeting (as reviewed by Walsh 2006). Additional detail regarding the process of PTMs and examples 
of their role in proteins will be provided later in the chapter.  
PTMs are crucial for the proper function and regulation of proteins and this has encouraged 
investigations to better understand their occurrence and location. PTM frequency and location 
information is also of value to determine potential protein function perturbation as a result of SNPs 
occurring on PTM sites. Lab-based experimentation to identify and verify sites of PTM are costly and 
time consuming, therefore PTM prediction software tools were developed to tackle this challenge. The 
software aims to reduce the number of functional assays required to determine the location of a PTM, 
and focus experimentation the amino acids most likely to undergo a PTM (Chen et al., 2016). PTM 
prediction tools work by utilising algorithms, much in the same way as nsSNP damage prediction 
software, and are trained using datasets containing the locations of experimentally verified sites of the 
respective PTM.  
The prediction of the location of PTMs that do not have a conserved motif is challenging and requires 
sophisticated algorithms. As a result, many PTM prediction software employ an ‘artificial neural-
network’ method which utilises a network of artificial neurons that function in a manner comparable 
to a biological brain. The principles and methods underpinning this process are complex; however, the 
aim of the neural network method in PTM prediction software is to improve the accuracy of 
predictions. This is achieved by allowing the algorithm to ‘learn’ from the training dataset, and 
establish the requirements for an amino acid residue to qualify as a PTM site. The software can then 
use these requirements to identify new potential PTM sites.  
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The score thresholds in PTM prediction software represent the cut-offs set based upon performance 
evaluation and are related to the accuracy and rate of false positive results from the training dataset 
of experimentally verified sites. The threshold value for each individual amino acid prediction indicates 
the minimum score required to provide confidence that the site is involved in a true PTM. This 
threshold value is informed by conservation at that site, as well as results from previous datasets. With 
this information, it confirms that the location of the amino acid is not the only determinant of the 
predicted PTM score. A wide variety of PTM predictive tools are available, however a brief introduction 
will be provided only for the predictive software utilised in this thesis, which includes NetPhos 2.0 for 
phosphorylation, CSS Palm for palmitoylation, GPS-SNO for S-Nitrosylation, GPS–SUMO for 
SUMOylation and NetNGlyc for N-glycosylation.  
 
NetPhos 2.0 and NetNGlyc 1.0 
NetPhos 2.0 (available from http://www.cbs.dtu.dk/services/NetPhos-2.0/) is provided by the Centre 
for Biological Sequence Analysis (CBS), and is an artificial neural-network based software package 
designed to predict sites of phosphorylation on serine (S), threonine (T) and tyrosine (Y) amino acid 
residues (Blom, Gammeltoft and Brunak, 1999). The NetPhos 2.0 neural-network was trained using a 
dataset of known phosphorylation sites (584 serine, 108 threonine and 210 tyrosine) and takes into 
account the tertiary structure of the protein, sourced from the structure database Protein Data Bank 
(Bernstein et al., 1977) where available. The NetPhos 2.0 output score ranges from 0 to 1, with higher 
values indicating greater confidence in the prediction and greater similarity to one or more of the 
phosphorylation sites in the training dataset. The NetPhos 2.0 prediction threshold score is 0.5. 
NetPhos software has been used in a number of publications to identify predicted sites of 
phosphorylation (Eklund and Edqvist, 2003; Savas and Ozcelik, 2005; Jianxi Liu et al., 2006; Chen et al., 
2009; Dos Santos, Nunez-Castilla and Siltberg-Liberles, 2016). NetNGlyc 1.0 (available from 
http://www.cbs.dtu.dk/services/NetNGlyc/) is provided by CBS and like NetPhos 2.0, and is an artificial 
neural-network based software package. NetNGlyc 1.0 is designed to predict sites of N-glycosylation 
on asparagine (N) amino acid residues (Gupta and Brunak 2002). Training dataset information was not 
available for this software. The NetNGlyc 1.0 prediction threshold score is 0.5. NetNGlyc 1.0 software 
has been used in other studies to identify predicted sites of N-glycosylation (Rafiee et al., 2012; Sheta 
et al., 2016). 
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CSS-Palm 4.0 
CSS-Palm 4.0 (available from http://csspalm.biocuckoo.org/online.php) is a software tool designed to 
predict sites of palmitoylation on cysteine (C) amino acid residues (Zhou et al., 2006; Ren et al., 2008). 
CSS-Palm 4.0 utilises a complex computational method called Group-based Prediction System (GPS) 
(Xue, Liu, Cao, et al., 2010), formally known as Group Based Phosphorylation Scoring, to increase the 
accuracy of palmitoylation site prediction and scoring (Zhou et al., 2004). In summary, GPS works by 
incorporating the biochemical characteristics of neighbouring amino acids and the predicted 3D 
structure conservation of the local amino acid environment, in addition to scoring based on verified 
palmitoylation sites to estimate the likelihood of palmitoylation. CSS-Palm 4.0 was developed by taking 
510 experimentally verified palmitoylation sites from 232 distinct proteins and using them as training 
data to improve the accuracy of prediction (Xue and Ren, 2013). Prediction threshold values of 95%, 
90% and 85% (high, medium and low), were set on the percentage specificity calculated after 
performance evaluation assessments. The prediction threshold for each cysteine residue is calculated 
individually, however details of the criteria for this are not detailed specifically. The CSS-Palm 4.0 
output score does not have a fixed range and is based upon the degree of conservation at each site, 
with a higher score indicating a greater likelihood of palmitoylation. Examples of threshold and scoring 
will be provided in chapter 3. CSS-Palm has been used in a number of publications to identify predicted 
sites of palmitoylation (Jeffries, 2010; Zoltewicz et al., 2012; Oku et al., 2013; Bi, 2014). 
 
GPS-SNO 1.0 and GPS–SUMO 
GPS-SNO 1.0 (available from http://sno.biocuckoo.org/index.php) is a software tool designed to 
predict sites of S-nitrosylation on cysteine (C) amino acid residues (Xue, Liu, Gao, et al., 2010). GPS–
SUMO (available from http://sumosp.biocuckoo.org/) is a tool designed to predict sites of 
SUMOylation on lysine (K) residues (Ren et al., 2009; Zhao et al., 2014). Both software tools utilise the 
same GPS method of PTM prediction scoring as previously described for CSS-Palm 4.0. However, GPS-
SNO 1.0 prediction threshold values of approximately 90%, 85% and 80% (high, medium and low) were 
set based on the percentage specificity calculated after performance evaluation assessments. GPS-
SNO 1.0 was developed using a training dataset comprising 504 experimentally verified S-nitrosylation 
sites from 327 unique proteins, whilst GPS-SUMO was developed using 983 SUMOylation sites from 
545 proteins. A number of studies have utilised GPS-SNO 1.0 (Gould et al., 2013; Chaki et al., 2014; 
Zahid et al., 2014; Kashyap, Sehrawat and Deswal, 2015) and GPS–SUMO (Aguilar-Martinez et al., 2015; 
Nepveu-Traversy et al., 2016) tools for PTM site identification.  
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The number of genetic variations and post-translational modification sites across the whole genome 
is too vast to assess as part of any one thesis. Consequently, for the purpose of this work, a single gene, 
KCNMA1 coding for the BK channel α-subunit, was selected to investigate the prioritisation of 
potentially harmful nsSNPs on the basis of existing information available in bioinformatics resources 
and the literature.  
 
1.7 A focus on the BK channel 
Ion channels are membrane spanning proteins that allow for the selective and rapid movement of ions 
through a pore, across an otherwise impermeable lipid membrane and are found in cells throughout 
the body. These membrane proteins are integral for homeostasis of intracellular ion concentrations 
within physiological limits and for the changes in concentration gradient associated with membrane 
depolarisation and repolarisation. They differ from many other proteins due to the presence of 
hydrophobic membrane-spanning domains, which allow insertion of the protein across lipidic 
membranes. There are many forms of ion channel family, including voltage-gated ion channels (Figure 
1.2), extracellular ligand-gated ion channels and intracellular ligand-gated ion channels. Ions such as 
sodium, calcium, magnesium, chloride and potassium have specialised channels that allow for their 
passage. 
The potassium channel family (Figure 1.3) is the largest and most diverse group of ion channels with 
over 70 loci found in the mammalian genome (Gutman, 2005). The DNA motifs that code for the 
protein that forms the potassium channel is highly conserved across species (Butler et al., 1993). 
Potassium channels allow the selective passage of potassium ions across lipidic membranes regulating 
membrane potential and cellular function. The resting membrane potential of many cells is related to 
the potassium channel equilibrium potential and contributes to charge regulation (Brayden and 
Nelson, 1992; Nelson and Quayle, 1995; Nelson et al., 1995; Salkoff et al., 2006). Potassium channels 
can be grouped into three main structural classes encoding 2 transmembrane (2 TMD), 4 
transmembrane (4 TMD) and 6 transmembrane (6 TMD) domains. Various subfamilies of potassium 
channels are known and generally correspond to the physiological signal by which pore opening is 
activated; for example, voltage-gated and calcium-gated (Miller, 2000). Potassium channels are also 
grouped based on their configuration and conductance, such as inward rectifying, outward rectifying, 
small conductance (SK), and big conductance (BK) (Köhler et al., 1996; Sah, 1996; Vergara et al., 1998; 
Peña and Rane, 1999; Shipston et al., 1999; Diness et al., 2010).  
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Figure 1.2- Representation of the voltage-gated ion channel superfamily. Phylogenetic tree 
illustrating the diversity of the voltage-gated ion channel superfamily comprising 143 members of 
related ion channel genes. The voltage-gated calcium (CaV) and sodium (NaV) channels are denoted 
by grey branches, cyclic nucleotide-gated channels (CNG) and hyperpolarization-activated cyclic 
nucleotide–gated (HCN) are denoted by orange branches, the large voltage-gated potassium (Kv) 
family is separated into two, with Kv1-9 denoted by red branches and Kv10-12 by brown branches. The 
two-pore potassium (K2P) channels are denoted by pink branches, the calcium activated potassium 
(KCa) channel family denoted by dark red branches, and the inward rectifier (Kir) channels denoted by 
black branches. Transient receptor potential (TRP) and two-pore channels (TPC) channels are denoted 
by purple branches. Figure adapted from (Yu et al., 2005).   
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Figure 1.3- The potassium channel family. A hierarchical classification of potassium channels. 
Potassium channels can be grouped into three main structural classes encoding 2 transmembrane (2 
TMD), 4 transmembrane (4 TMD) and 6 transmembrane (6 TMD) domains. Grouping is also based upon 
the physiological signal by which pore opening is activated; for example, voltage and calcium gated. 
Potassium channels are also grouped based upon their configuration and conductance, such as inward 
rectifying, small conductance (SK) and big conductance (BK). Adapted from Wei, 2005 and Zhong et al., 
2013. 
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Calcium- and Voltage-gated Potassium channels 
There are two groups of calcium-activated potassium channels providing 8 α-subunit types (Figure 1.3) 
(as reviewed by Wei 2005). The first group are voltage insensitive and are sensitive to calcium 
concentration via binding of the cation to calmodulin; members include KCa2.1-2.3 (the SK1-3 
channels) and the KCa3 (the IK channel). The second group are ‘Slo’ gene members and include KCa1.1 
(Slo, the BK channel), KCa4.1 and KCa4.2 (Slo2.2 Slack and Slo2.1 Slick) and KCa5 (Slo3). Each channel 
differs in conductance, with the BK channel having the largest at approximately 250pS in symmetrical 
150 mM KCl (Marty, 1981; Latorre, Vergara and Hidalgo, 1982; McManus and Magleby, 1991).  
 
1.7.1 BK Channels 
BK channels are large conductance calcium- and voltage-gated potassium channels also known as Slo 
or ‘MaxiK’ and are members of the voltage gated potassium channel family. Calcium- and Voltage-
gated Potassium channels can be activated by both depolarisation and a rise in intracellular calcium 
and therefore can integrate the response to intracellular calcium and cell membrane potential 
(Adelman et al., 1992; Cui, Cox and Aldrich, 1997; Horrigan, Cui and Aldrich, 1999). Calcium and voltage 
sensitivity of the channel are related (Schreiber and Salkoff, 1997) and this characteristic is vital for 
their role as a feedback mechanism to regulate the activity of voltage gated calcium channels (Sah and 
Louise Faber, 2002). BK channels, then known as ‘Gardos channels’, were first ‘described’ in 
erythrocytes in the late 1950’s when Hungarian haematologist George Gardos described a change in 
potassium permeability across the plasma membrane that responded to minor increases in 
intracellular calcium (Gardos, 1958). It was noted that when calcium was buffered using EDTA as a 
chelating agent, potassium movement across the membrane was substantially reduced. However, 
there was a substantial delay before an ionic current activated by a rise in cytosolic calcium was first 
identified (Meech, 1972). Studies conducted in 1981 and 1985 using cultured rat skeletal muscle served 
to prove the BK channel can be activated by calcium and membrane potential independently and 
enhance the channels opening probability (Pallotta, Magleby and Barrett, 1981; Pallotta, 1985).  
 
1.7.1.1 BK channel structure 
The BK channel is comprised of four pore-forming α-subunits assembled into a tetramer to form the 
channel pore; a recent publication details the full-length BK channel 3D structure as determined by 
cryo-electron microscopy at a resolution of 3.5 Å (Tao, Hite and MacKinnon, 2016). Each α-subunit 
within the tetramer is comprised of seven transmembrane domains (TMDs) spanning from S0 to S6, 
with an extracellular N-terminus (NH2) and an intracellular C-terminus (COOH) comprising 
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approximately two thirds of the channel length and containing four additional, but non-membrane 
inserted, hydrophobic domains (S7-S10) (Figure 1.4).  
The S0 TMD is unique to the BK channel and is not shared by members of the related voltage activated 
potassium channel family, who unlike the BK channel have six TMDs (S1-S6) (Wallner, Meera and Toro, 
1996; Meera et al., 1997). Consequences of this additional TMD are the relocation of the N-terminus 
to the extracellular space and the creation of an S0-S1 TMD linker region; these additions are highly 
conserved among vertebrates suggesting that they play an important role in the structure or function 
of the channel (Koval, Fan and Rothberg, 2007). Experimentation has provided further evidence of this 
crucial role; BK channels mutated to omit the S0 TMD were found not to be active, and were not 
expressed in the cell membrane (Wallner, Meera and Toro, 1996; Morrow et al., 2006; Guoxia Liu et 
al., 2008).  
The α-subunit contains key regions of functional importance, such as the voltage sensing domain (VSD) 
(spanning TMD S1-S4). This region is responsible for sensing changes in membrane potential and link 
depolarisation with opening of the channel pore. The channel is dually activated by calcium and 
depolarisation however activation can occur in the absence of calcium (Horrigan, Cui and Aldrich, 
1999). The VSD contains charged amino acid residues involved in voltage-dependent gating of the 
channel; three arginine residues (Ma, Lou and Horrigan, 2006; Sakai, Harvey and Sokolowski, 2011) 
within the S4 TMD are proposed to move up and out towards the extracellular space, ‘tightening’ the 
linker between S4 and the pore region, facilitating pore opening (Jensen et al., 2012). Charged residues 
in TMDs S2 and S3 (Ma, Lou and Horrigan, 2006) have also been shown to be involved in voltage 
activation of the channel. Mutations in the S0 TMD have been shown to alter activation curves and 
thus may be involved in voltage-gating (Koval, Fan and Rothberg, 2007). Site directed mutations of 
amino acids in this domain result in reduced coupling of calcium with channel opening (Díaz et al., 
1998). 
The pore-forming domain (PFD) of the channel is comprised of TMD S5, the P-loop and TMD S6, and 
forms the channel pore situated in the centre of the BK channel tetramer. Within the PFD is also the 
potassium selectivity filter containing the GYG sequence, which is conserved in potassium channels 
across species from Drosophila to humans (Heginbotham et al., 1994). Mutations to this sequence 
result in alterations to potassium channel ion selectivity (Yool and Schwarz, 1991; Chapman, Krovetz 
and VanDongen, 2001). The entrance to the intracellular vestibule (EIV) is located in the PFD and spans 
the entirety of the S6 TMD. The structure of the EIV is larger than other potassium channels and this is 
thought to allow for the large potassium conductance associated with the channel (Li and Aldrich, 
2004; Brelidze and Magleby, 2005). The EIV has a negatively charged ring structure, composed of eight 
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negatively charged glutamate residues. This structure creates an environment that facilitates the 
targeting of cations such as potassium from the intracellular domain to the selectivity filter (Brelidze 
and Magleby, 2005). Mutation to this region results in a 50% reduction in single channel conductance 
and conversion of the channel to inwardly rectifying, where potassium ions flow preferentially in the 
inward direction (into the cell) than in the outward direction (out of the cell) (Brelidze, Niu and 
Magleby, 2003). The intracellular C-terminal region comprises approximately two thirds of the total 
channel length and is involved in many aspects of channel function. The C-terminus is involved in α-
subunit tetramerization; mutation of an association domain in this region prevented the correct 
assembly of the channel (Quirk and Reinhart, 2001). Within the C-terminus are the regulators of 
potassium conductance (RCK) domains RCK1 and RCK2 (Jiang et al., 2001) comprised of S7-S8 and S9-
S10 respectively. These regions confer calcium sensitivity to the channel; the addition of calcium to the 
intracellular face of the channel results in a left-shift in activation voltage to a more physiological range. 
Within RCK2 is the calcium bowl (Schreiber and Salkoff, 1997) with a conserved sequence of aspartic 
acid residues (DQDDDDDPD), conserved from nematode to human (Wei, Jegla and Salkoff, 1996). 
Mutation of the calcium bowl has been shown to reduce calcium mediated channel activation 
(Schreiber and Salkoff, 1997). Two aspartic acid residues in the region have been shown to be essential 
for calcium sensing (Bao et al., 2002, 2004), however mutations to those residues did not completely 
abolish calcium sensitivity; therefore, the presence of additional calcium binding sites was postulated. 
A low affinity binding site for divalent cations in RCK1, that can bind with calcium and magnesium in 
millimolar concentrations was identified (Zhang, Solaro and Lingle, 2001). The calcium sensing ability 
means that the BK channel can act as a feedback mechanism for intracellular calcium concentration 
from local intracellular increases in calcium (calcium sparks) and to the activity of voltage gated calcium 
channels for example.  
 
1.7.1.2 Physiological role of BK channels 
BK channels are ubiquitously expressed in the body with the exception of the cell membrane of 
cardiomyocytes; however there is contrary evidence which supports their presence in rodent 
cardiomyocytes (Ko et al., 2009; Imlach et al., 2010). Functioning BK channels have also been identified 
in the inner mitochondrial membrane (as reviewed by Szabo and Zoratti, 2014), with the first discovery 
made in 1999 when a single channel current of 295pS was recorded from mitoplasts (mitochondrion 
with the outer membrane removed) of the human glioma cell line LN229 (Siemen et al., 1999).  
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Figure 1.4- Schematic of BK channel α-subunit. The schematic illustrates the BK channel α-subunit 
formed of seven transmembrane domains (S0-S6) in the core region (pink shading) and four 
hydrophobic domains (S7-S10) in the c-terminal tail region (green shading). The core region contains 
the voltage sensing domain spanning from (S1-S4) and the pore-forming domain and p-loop spanning 
from S5 to S6. The intracellular C-terminal tail region contains the regulators of the conductance of 
potassium (RCK1 and RCK2 in orange and green respectively). Schematic not drawn to scale. Adapted 
from Orio et al., 2002. 
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BK channels are implicated in a wide range of processes, many relating to their effect on smooth 
muscle contractility. An example is in the physiological regulation of vascular tone (Aldrich et al., 2000; 
Sausbier et al., 2005) where BK channel activation results in vascular smooth muscle cell relaxation, 
vasodilation and thus a reduction in blood pressure. BK channels have also been implicated in bladder 
control (Meredith et al., 2004); channel activation results in relaxation of urinary bladder smooth 
muscle cells and prevents incontinence as a result of an overactive bladder. BK channel function is 
linked to uterine contractility via myometrial smooth muscle (as reviewed by Khan et al., 2001), where 
channel activation supresses myometrial activity during pregnancy. This suppression is lost during 
labour due an uncoupling of calcium and BK channel activation.  
In the brain, BK channels are found on the plasma membrane and presynaptic terminals of neurons 
and are implicated in the regulation of neuronal cell function and neurotransmitter release. For 
example, presynaptic BK channels have been shown to serve as negative regulators of 
neurotransmitter release by indirectly regulating calcium entry and modulating cell repolarisation 
(Robitaille and Charlton, 1992; Raffaelli et al., 2004; Wang, 2008). The hyperpolarising effect of BK 
channels can either reduce neuronal activity or increase it and in cases is associated with autism, 
mental retardation and epilepsy (Hu et al., 2001; Sausbier et al., 2004; Du et al., 2005; Laumonnier et 
al., 2006; Ghezzi et al., 2010). BK channel activity also play a role in hearing (Rüttiger et al., 2004; Föller 
et al., 2012).  
Publications detailing the varied role of the BK channel on physiological processes led to speculation 
about the organism wide effect of the channel, and investigation into the effect a lack of BK channels 
on mammalian physiology in vivo was of interest. The development of a knockout model was 
accomplished in 2004 when BK channel α-subunit deficient mice (Kcnma1-/-) were created (Meredith 
et al., 2004; Sausbier et al., 2004). These mice were viable, however presented with minor 
abnormalities linked to BK channel roles, such as hypertension, over-active bladder, ataxia, abnormal 
gait, erectile dysfunction and hearing loss (Meredith et al., 2004; Rüttiger et al., 2004; Sausbier et al., 
2004; Werner et al., 2005; Pyott et al., 2007).  
 
1.7.2 Complexity of the BK channel 
1.7.2.1 Splicing 
The BK channel is coded for by a single gene (KCNMA1), however there is a high degree of diversity in 
channel function; this is in part because KCNMA1 displays extensive pre-mRNA splicing at multiple sites 
throughout the channel (Adelman et al., 1992; Butler et al., 1993; Xie and McCobb, 1998). These 
variants have been shown to influence the calcium and voltage sensitivity of the channel (Adelman et 
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al., 1992; Lagrutta et al., 1994; Tseng-Crank et al., 1994; Saito et al., 1997; Shipston et al., 1999), 
regulate phosphorylation (Tian, Duncan, et al., 2001; Tian et al., 2004) and control cell surface 
expression (Zarei et al., 2001, 2004; Kwon and Guggino, 2004; Chen et al., 2010). A number of inserts 
may be accomplished at each splice site. For example, there are five splice variants originating at the 
C2 site; e20, STress Regulated EXon (STREX) e21, e22(exon 22), Δe23 and ZERO (no insert) (Chen et al., 
2005). A study was conducted with the purpose of characterising C2 BK splice variants STREX, e22 and 
ZERO by their sensitivity to elevations in intracellular free calcium level mediated by inomycin and the 
extent of inhibition by BK channel blocker paxilline (Saleem, Rowe and Shipston, 2009). Results showed 
a calcium response potency in order STREX>e22>ZERO and relatively similar paxilline inhibition, 
proving that splicing at a single site can dramatically alter calcium sensitivity in this case.  
 
1.7.2.2 Auxiliary Subunits  
The BK channel is associated with two types of auxiliary unit; the β-subunit and γ-units (as reviewed 
by Li and Yan, 2016). The gating characteristics of the BK channel can be modulated by β-subunits, two 
TMD units which associate with the channel in a 1:1 ratio via the S0 TMD (Wallner, Meera and Toro, 
1996) and are coded for by genes KCNMB1-4. The β-subunits have wide ranging effects on the α-
subunit, including altering the calcium and voltage sensitivity of the channel, gating kinetics, and 
sensitivity to extracellular modulators, as comprehensively reviewed in a 2014 article (Torres, 
Granados and Latorre, 2014). There are four subtypes of the β-subunit and each confers differing 
properties to the channel (Petrik and Brenner 2007). The β1- subunit is primarily located in smooth 
muscle cells where it shifts BK activation to more negative voltages for a given calcium concentration 
and confers slower current activation and increased open probability to the channel (Dworetzky et al., 
1996); the β2-subunit is prominent in the kidney, brain, lung and heart and causes rapid channel 
inactivation. This effect is thought to be due to the ‘ball and chain’ NH2 region of the beta subunit 
blocking the channel opening (Xia, Ding and Lingle, 1999; Bentrop et al., 2001). The β3- subunit is found 
in organs such as the spleen, placenta, heart and liver and is shown to cause extremely rapid but 
incomplete inactivation of the BK channel, reducing, but not abolishing channel activity after initial 
opening (Xia et al., 2000; King et al., 2006). The β4 subunit is extremely prevalent in brain and neuronal 
tissue, as with β1, β4 increases calcium sensitivity and slows BK activation (Brenner et al., 2000; King et 
al., 2006).  β4 knockout mice have been shown to experience temporal lobe seizures indicating that the 
β4 subunit is necessary for control of neuronal firing rate (Brenner et al., 2005).  
The auxiliary γ-units were discovered comparatively recently in 2005 in BK channels with an 
uncharacteristically low half-activation voltage of approximately 30 mV in the absence of intracellular 
calcium (Gessner et al., 2005). Since then three additional subtypes have been identified (Yan and 
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Aldrich, 2010, 2012) found throughout the body and are implicated in the modulation of aspects such 
as vasodilation and male fertility (Yang et al., 2011; Evanson et al., 2014).  
 
1.7.2.3 PTM of the BK channel 
Post translational modification (PTM) is the chemical modification of a protein after translation; this 
process serves to increase the diversity and complexity of proteins that can be produced from a 
relatively basic set of genes (Burge at al 1999, Hastings and Krainer 2001, Shipston 2011) . There are a 
number of post translational modifications currently known; some involve the addition of 
hydrophobic/hydrophilic groups or modifications which change the nature of the amino acids within 
the proteins themselves (Walsh and Jefferis, 2006). The modifications that are relevant to this project 
are listed and explained below.  
 
Phosphorylation  
Phosphorylation is believed to be the most abundant form of PTM affecting a multitude of signalling 
pathways and is the addition of a phosphate chemical group to a serine, tyrosine, threonine or histidine 
amino acid residue of a protein or other organic molecule. Phosphorylation was first described in 1927 
(Rimington, 1927). Phosphate groups are large, negatively charged and bulky, thus the addition of a 
phosphate group may cause a conformational change potentially leading to alterations in binding 
affinity and thus changing the functional properties of the protein (Swope et al., 1992). The process of 
phosphorylation is reversible and is undertaken by protein kinase enzymes which add phosphate 
groups; phosphatase enzymes remove phosphate groups (Swope et al. 1992). The phosphorylation 
and de-phosphorylation of enzymes, receptors and ion channels are crucial for regulation of their 
activity and adds to functional diversity (Levitan, 1994; Tian et al., 2004). BK channels are regulated by 
a range of kinase enzymes (such as PKA, PKC and PKG) and phosphatases (such as PP1 and PP2A) (White 
et al., 2000; Tian, Duncan, et al., 2001; Widmer, Rowe and Shipston, 2003; Tian et al., 2004; Zhou et 
al., 2012). The kinase AMPK has been reported to increase BK channel trafficking to the cell membrane 
in Xenopus oocytes (Föller et al., 2012). The precise molecular mechanism of the effect has not yet 
been defined, and it is unclear whether direct phosphorylation of the BK channel or phosphorylation 
of another component involved in channel trafficking is required. Phosphorylation effect has been 
shown to be variable depending on splice variant; in the ZERO form of the channel PKA and PKG 
phosphorylation cause activation and PKC causes inhibition, however in STREX, PKA phosphorylation 
results in channel inhibition (Tian, Duncan, et al., 2001).   
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Lipidation  
Lipidation is defined as the covalent binding of a lipid group to a peptide chain; this may affect 
intracellular trafficking of the protein and therefore the cellular location, or alter its activity in the case 
of a channel or an enzyme (Resh 1999). Several categories of lipid are included in this process such as 
fatty acids, isoprenoids and cholesterol (Salaun, Greaves and Chamberlain 2010). Lipidation can be 
divided into two broad categories; those that occur in the cytoplasm or the cytoplasmic side of the 
plasma membrane and those that occur within the cell membrane (Nadolski and Linder 2007). 
Myristoylation and palmitoylation (the addition of a 14 and 16-carbon fatty acid respectively), are two 
of the most common forms of protein lipidation. The role of palmitoylation in BK channels will be 
briefly introduced below.  
 
Palmitoylation  
Palmitoylation is the addition of a 16-carbon saturated fatty acid molecule (palmitate) to a cysteine 
amino acid residue (Figure 1.5). The addition of palmitate increases the hydrophobicity of a protein, 
and facilitates protein biosynthesis, membrane trafficking and anchorage in the cell membrane (Linder 
and Deschenes, 2007). Investigation of palmitoylated proteins by mass-spectroscopy has shown that 
other long chain fatty acids such as stearate (C18:0), palmitoleate (C16:1) and oleate (C18:1) can be 
attached to cysteine residues in place of palmitate. This has been shown in a number of proteins such 
as Src family kinases (Liang et al., 2001, 2004), hemagglutinating glycoproteins of influenza viruses 
(Kordyukova et al., 2008), viral spike proteins (Kordyukova et al., 2010), human platelets (Muszbek et 
al., 1999), synaptosomal-associated protein 25 (SNAP-25) (Greaves et al., 2017), and the G-protein-
coupled receptor (GPCR) (O’Brien and Zatz, 1984).  
Two forms of palmitoylation have been identified; N-palmitoylation and S-palmitoylation that differ in 
their method of protein linkage and reversibility. N-palmitoylation is the attachment of palmitate to 
an N-terminal cysteine residue via amide linkage; this process is irreversible (Iwanaga et al., 2009). This 
form of palmitoylation offers a stable, permanent form of lipidation; a limited number of proteins such 
as the secreted morphogen ‘Hedgehog’ undergo this modification (Pepinsky et al., 1998; Buglino and 
Resh, 2008, 2012). S-palmitoylation is the reversible thioester linkage of palmitate to a cytoplasmic 
cysteine residue. The most commonly described function of palmitoylation is to increase the affinity 
of proteins to the cell membrane, which can affect its recognition and transport by the cell 
cytoskeleton or vesicular transport (Salaun, Greaves and Chamberlain 2010). The reversible nature of 
palmitoylation presents a dynamic regulatory mechanism for protein location and function (Mumby 
1997, Conibear and Davis 2010, Shipston 2011). It is speculated that palmitoylation serves to enable 
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clustering of the protein, binding to specific cytosolic lipid and protein domains, to encourage orderly 
folding and to prevent aggregation (Salaun, Greaves and Chamberlain, 2010). It is also speculated that 
initial protein palmitoylation is necessary for assembly of signalling complexes (Resh, 2006). 
The BK channel has been shown to be palmitoylated; palmitoylation can occur at specific cysteine 
residues in the S0-S1 linker (Jeffries, 2010; Jeffries et al., 2010) and STREX splice insert (Tian et al., 
2008; Jeffries, 2010), and this palmitoylation allows the protein to reversibly locate from the cytoplasm 
to the cell membrane, thus determining its overall function. Palmitoylation of STREX has been shown 
to abolish PKA mediated inhibition of the BK channel (Tian et al., 2008).  
 
Palmitoylation Enzymes  
As more is revealed about the role of palmitoylation and de-palmitoylation in cell mechanisms and 
pathways, it was of interest to investigate the enzymes that undertake the process of palmitoylation. 
There are 23 known palmitoylation enzymes all of which share a cysteine rich domain, a 51 amino acid 
sequence Asp-His-His-Cys (DHHC motif) with a CX2CX9HCX2CX2CH4DHHCCX5CX4NX3FX4 consensus 
sequence (Mitchell et al., 2006; Korycka et al., 2012), and thus are often referred to as DHHC palmitoyl 
acyl transferases (PATs) (Xie and McCobb, 1998; Tsutsumi, Fukata and Fukata, 2008; Tian et al., 2010). 
Many proteins share this specific motif, however not all have been shown to palmitoylate cysteine 
residues and therefore cannot be included as palmitoylation enzymes (Xie and McCobb 1998). The 
exact location of active palmitoylation enzymes within cells has not been fully elucidated; some 
theorise that they are situated in cell membranes such as the Golgi apparatus and endoplasmic 
reticulum whilst others suggest that they can be found in the cytosol. It is postulated that PATs are 
transmembrane proteins found in the plasma, Golgi and ER membranes (Baekkeskov and Kanaani, 
2009). In a study to test the localisation and distribution of human DHHC proteins in HEK293 cells, eight 
were restricted to the ER, six in the Golgi apparatus and four in both the ER and Golgi (Ohno et al., 
2006). The specific role that each of the palmitoylation enzymes has on protein trafficking/function 
has not been fully elucidated- though the importance of specific enzymes in the regulation of proteins 
involved in neuronal function and specific disease states has recently been reviewed (Salaun, Greaves 
and Chamberlain 2010). 
It would be expected due to the relatively large number of PATs in the mammalian genome, that there 
would be a similar number of enzymes that remove palmitate from cysteine residues; however, this 
seems not to be the case. To date two palmitoyl-protein thioesterases (PPTs) have been discovered in 
mammals. PPT1 has been shown to de-palmitoylate proteins undergoing degradation in lysosomes 
(Camp and Hofmann, 1993; Hellsten et al., 1996).  
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Figure 1.5- Reversible process of palmitoylation. Schematic illustrating the reversible addition to, and 
removal of, palmitate (C16) from a cysteine amino acid by protein acetyltransferases (PATs) and 
palmitoyl-protein thioesterases (PPT). A cysteine containing protein and a palmitate molecule 
esterified to Coenzyme A (Palmitoyl-CoA) are shown initially. A representation of a palmitoylated 
protein is also shown. Adapted from Christie, 2014. 
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PPT1 is also involved in the in the de-palmitoylation of H-Ras, N-Ras, GAD65 and endothelial nitric 
oxide synthase, and the trafficking of SNAP25 in neuronal synaptic vesicles (Duncan and Gilman, 1998; 
Baekkeskov and Kanaani, 2009). PPT2 shares 18% homology with PPT1 and is also found in lysosomes 
where it hydrolyses long-chain fatty acyl CoAs (Baekkeskov and Kanaani, 2009). Acyl-protein 
thioesterases (APTs) APT1 and APT2, have been identified as palmitoyl thioesterases that de-
palmitoylate cytosolic cysteine residues of the BK channel (Tian et al., 2012). An APT1 homolog, APT1-
like thioesterase, coded for by the gene LYPLAL1, has been identified that is involved in de-
palmitoylation of the BK channel (Tian et al., 2012). Interestingly however, the enzyme was shown to 
contain a narrow substrate-binding pocket unable to accommodate long-chain fatty acids (Bürger et 
al., 2012). It is worth noting that it can be challenging to differentiate between the de-palmitoylation 
enzymes in the literature, as publications use the terms APT and PPT inconsistently, possibly due to 
the lack of an identifying motif and increasing understanding of the proteins function over time 
(Dunphy and Linder, 1998; Munday and López, 2007; Tsutsumi, Fukata and Fukata, 2008; Iwanaga et 
al., 2009; Edmonds and Morgan, 2014). 
 
Additional PTMs of interest 
Additional PTMs have been linked with the BK channel, such as S-nitrosylation, N-glycosylation and 
SUMOylation. S-nitrosylation is the covalent modification of a cysteine amino acid residue by a nitrous 
oxide group to generate S-nitrosocysteine (CySNO), which facilitates regulation of protein function, as 
reviewed in 2013 (Gould et al., 2013). It is generally accepted that the BK channel activating effects of 
nitric oxide can be mediated via elevation of intracellular cGMP (Feil, 2003; Kyle, Mishra and Braun, 
2017), however nitric oxide can exert BK activating effects independent of cGMP for instance via S-
nitrosylation (Ahern, 2002; Tjong et al., 2008).  
N-glycosylation is the addition of a carbohydrate moiety to the amino acid residue asparagine (N) and 
is implicated in the control of ion channel folding, stability, trafficking and function (Schwarz and Aebi, 
2011; Moharir et al., 2013). An N-glycosylation site has been detected in the N-terminal of Drosophila 
BK channels, however this site is not conserved in mammalian BK channels (Meera et al., 1997). 
Mutation of an N-glycosylation site identified in the human BK channel had no effect on cell membrane 
expression but resulted in a significant left-shift in voltage for half-maximal activation (Bravo-Zehnder 
et al., 2000).  
SUMOylation is the addition of SUMOs (small ubiquitin-like modifiers) to proteins via the lysine (K) 
amino acid residue, and is categorised as a post-translational modification that tags proteins for 
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ubiquitin-dependent degradation (as reviewed by Geoffroy and Hay, 2009; Wang and Prelich, 2009; 
Miteva et al., 2010). C-terminal ubiquitination of BK channels in rodent brain has been shown to cause 
channel retention in the ER, and inhibition of channel surface expression (Liu et al., 2014).  
 
1.7.3 External Environment and the BK channel  
There are a number of metabolic factors that influence BK channel function and distribution, such as 
oxygen concentration (Liu, Moczydlowski and Haddad, 1999; Williams et al., 2004; McCartney et al., 
2005; Cheng et al., 2008), pH levels (Avdonin, Tang and Hoshi, 2003) and exposure to compounds such 
as alcohol (Dopico, Lemos and Treistman, 1996; Jakab, Weiger and Hermann, 1997). However, the 
external factors most relevant to the thesis will be briefly introduced below. 
 
Glucose 
Glucose is a tightly regulated energy substrate required for metabolic homeostasis and plays a role in 
a plethora of cellular processes. Alteration of cell glucose concentration has been shown to affect the 
BK channel and its associated auxiliary subunits. Exposure of murine podocytes to high glucose at 
36.1mM reduced BK channel steady-state plasma membrane expression by 70% (Kim and Dryer, 2011). 
The hyperglycaemia associated with diabetes type 2 has been shown to down-regulate β1 subunit 
expression in retinal arterial smooth muscle of rats (McGahon et al., 2007). A review article written in 
2011 describes impaired vascular BK channel function associated with type 2 diabetes (Lu and Lee, 
2010) and highlights that studies collectively show a down regulation of vascular BK channel β1 subunit 
expression (McGahon et al., 2007; Zhang et al., 2010). The β1 subunit of the BK channel is responsible 
for the modulation of calcium and voltage activation, it is speculated that that is a mechanism by which 
high glucose causes channel deregulation. High glucose concentration has also been shown to increase 
BK channel activity in retinal pericytes (Berweck et al., 1994). In human podocytes, high glucose causes 
an increase in BK channels at the plasma membrane and increased channel activity; this was 
hypothesised to be due to increased oxidative stress, increasing intracellular calcium and leading to BK 
channel activation (Huang and Ma, 2010). The relationship between oxidative stress, intracellular 
calcium and the BK channel is varied and complex, and is described in a comprehensive 2015 review 
article (Hermann, Sitdikova and Weiger, 2015).  
Although low glucose concentration causes cell death, as comprehensively reviewed in 2008 (Zhao et 
al., 2008), exposure of cells to high glucose concentrations can result in apoptosis (Ho et al., 2000; 
Maedler et al., 2003; Samikkannu et al., 2006; Jiaqi Liu et al., 2016). It has been proposed that, in some 
cases, BK channel activation and up-regulation can play a role in cell apoptosis, such as was shown 
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when HEK293 cells were exposed to high (25mM) glucose concentrations (Chang et al. 2011). The 
increased cell apoptosis was thought to be caused by increased potassium loss (due to BK channel 
activation), which is associated with apoptotic cell shrinkage (Dallaporta et al., 1998), and activation 
of apoptotic pathways involving protease enzyme caspases family and members of the apoptosis 
regulator Bcl-2 family amongst others (Elmore, 2007). 
 
Lipids 
The effects of lipid on BK channel activity has been discussed in a review by Dopico and Bukiya (2014). 
Cholesterol is one of the most widely studied lipids and there is mounting evidence that cholesterol 
has direct effects on BK channel function (Lam, Shaw and Duszyk, 2004; Bukiya et al., 2011). There are 
a number of potential mechanisms to explain the effects; for example, the incorporation of cholesterol 
into the plasma membrane increases the lateral steric pressure on the channel, increasing the 
mechanical energy required to overcome this and open the channel, reducing the open probability 
(Po) of the channel (Lam, Shaw and Duszyk, 2004). Cholesterol is reported to cause destabilisation of 
the BK channel open state via steric bilayer lateral stress, decreasing open probability in rat cerebral 
artery myocytes (Bukiya et al. 2011). BK channels may be involved in the secretion of trans-epithelial 
anions through a cholesterol-dependant mechanism in colonic epithelial cells of mice (Lam, Shaw and 
Duszyk 2004). Another hypothesis is that when a cell is loaded with cholesterol, that this altered 
protein:lipid ratio causes a change in the formation of lipid rafts and altered translocation of the 
channel into the cell membrane. This may be seen as a change in the number of channels in the cell 
membrane, or altered cycling of the channel.  
Several studies have shown that an increased extracellular concentration of palmitate elicits a change 
in cellular processes. Such examples include altered autophagy regulation in human aortic endothelial 
cells mediated by diminished AMPK activity, and increased phosphorylation of previously inactive 
kinase enzymes (Weikel et al., 2014), induction of apoptosis in hepatocytes via activation of protein 
kinase C (Cai et al., 2014), increased expression of interleukin-6, a cytokine with an inflammation 
modulating role, in human myotubules (Staiger et al., 2004; Weigert et al., 2004) and to increase the 
protein expression of the pseudo-kinase Tribbles homolog 3 (TRB3) (Morse et al., 2010; Yan et al., 
2014). Palmitate has also been shown to affect the cell membrane expression of proteins; when THP-
1 cells were exposed to palmitate at 0.3mM, the cell membrane expression of the integrins CD11b and 
CD36 was increased by over 60% (Pararasa, 2013). Palmitate also increased by more than 2-fold, tumor 
necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor 5 (DR5) cell surface 
expression in hepatocarcinoma (Huh-7) cells exposed to 0.4mM palmitate for 8 hours (Cazanave et al., 
2011). There is limited evidence of a direct effect of palmitate on BK channels (Pipili, 2012), however 
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there has been extensive investigation of the effects of palmitoylation on BK channel function (as 
reviewed by Shipston 2011).  
Oleate (18:1) has been used in laboratory experiments as a fatty acid control for saturated lipids such 
as palmitate, to determine if any of the measured variables are affected by the degree of fatty acid 
saturation (Yuzefovych, Wilson and Rachek, 2010). Experiments frequently compare and contrast the 
effects of the lipids on mitochondrial function, markers of ER stress, apoptosis, insulin signalling, insulin 
resistance and inflammation (Gaster, Rustan and Beck-Nielsen, 2005; Coll et al., 2008; Yuzefovych, 
Wilson and Rachek, 2010; Kwon, Lee and Querfurth, 2014; Hetherington et al., 2016). The majority of 
studies demonstrate that oleate has no significant effect on study endpoints in comparison to control, 
normally culture medium supplemented with bovine serum albumin (BSA). However, a small number 
of studies have shown that excess oleate can influence cellular processes. For example, incubation of 
the neural cell culture line N2a with 0.3mM oleate decreased mitochondrial superoxide levels, which 
are associated with oxidative damage and inflammation (Kwon, Lee and Querfurth, 2014), exposure to 
oleate at 1mM for 48 hours resulted in cell death of hepatic stellate cells (Hetherington et al., 2016) 
and oleate exposure at 0.1mM increased the phosphorylation of Akt protein kinase (Hardy et al., 2005). 
No literature describing the effect of oleate on BK channel or ion channel cellular distribution was 
found, however there are publications describing the activating effects of oleate on BK channel activity 
(Denson et al., 2000; Clarke et al., 2002; Sun et al., 2007).  
 
Hypoxia  
Chronic hypoxia has been shown to cause increased production of calcium transport systems 
(Jurkovicova et al. 2008) and inhibition of BK channel opening (Hartness et al. 2003). In a study 
conducted in 2005, the STREX splice variant was used to demonstrate that splice variants exhibit 
differing sensitivities to oxygen tension (McCartney et al., 2005). In this case, hypoxia caused the BK 
channel with STREX insert to be inhibited, with the inhibition being calcium sensitive and reversible 
and not mediated by redox regulation. Hypoxia also increases the expression of the β1 regulatory 
subunit (Ahn et al., 2012) and through monitoring of KCNMB1 and hypoxia inducible factor 1 a (HIF-
1a) expression it was discovered that HIF-1a is responsible for the increased expression of the β1 
subunit through binding to the KCNMB1 promoter. Hypoxia causes a 300% increase in BK a-subunit 
mRNA expression and a 200% increase in β1 subunit expression in both cultured ovine pulmonary 
smooth muscle cells (PSMC) and Sprague-Dawley rats (Resnik et al., 2006). Williams et al provide 
evidence that the BK channel complex contains the enzyme hemoxygenase-2, and that this, through 
the production of carbon monoxide (CO) enhances channel activity in normoxia and causes channel 
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inhibition in hypoxia (Williams et al., 2004). Native BK channel responses to hypoxia are extremely 
variable depending on the tissue they are expressed in (Park et al., 1995). The general consensus is 
that hypoxia causes BK channel inhibition through direct mechanisms such as oxygen and carbon 
monoxide binding, indirect mechanisms such as changes in splice variant and auxiliary β-subunit 
expression and via secondary signalling such as changes in calcium, haemoxygenase or AMPK (Tang et 
al., 2003; Laderoute et al., 2006; Hou et al., 2008; Yi, Morgan and Ragsdale, 2010). 
 
REDOX 
REDOX is the term for reversible oxidation and reduction reactions. The sulphur containing amino acids 
cysteine and methionine are sensitive to REDOX reactions due to the presence of highly reactive 
disulphide bonds. Cysteine residues can be oxidized at their thiol groups where two cysteine molecules 
link to form disulfide bonds internally within the protein or with other proteins. Disulfide bonds can be 
readily reduced by agents such as dithiothretiol (DTT), and oxidised by agents such as dithiodipyridine 
(DTDP) and hydrogen peroxide. A 2015 review comprehensively details the effect of REDOX on BK 
channels (Hermann, Sitdikova and Weiger, 2015). As an example, DTT shifted the voltage activation of 
the channels to more negative potentials and increased current activation as well as channel open 
probability human BK channels expressed in HEK293 cells, whilst oxidation using hydrogen peroxide 
had the opposite effect (DiChiara and Reinhart, 1997).  
 
1.7.4 Cell membrane expression of BK channel trafficking 
The BK channel must be inserted into a membrane to function; therefore, the channel needs to be 
transported from the location of synthesis in the endoplasmic reticulum (ER) -via its processing site 
the Golgi apparatus-, to the cell membrane. The cell must also have the ability to rapidly alter the 
number and location of BK channels; therefore, transport vesicles, endosomes and lysosomes are 
important parts of the cell machinery. Figure 1.6 shows a schematic of the current understanding of 
BK channel trafficking within the cell, highlighting the main steps in channel movement from creation 
in the ER to degradation in the lysosome. Many factors have been shown to modulate BK channel 
trafficking and enable the fine-tuning of channel location and distribution in the cell; however, 
relatively little is known about the specific spatiotemporal dynamics of BK channel control (Shipston, 
2014; Shipston and Tian, 2016).  
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Palmitoylation 
Palmitoylation has been shown to occur in a wide range of proteins (Yang et al., 2009), however 
evidence that palmitoylation plays a role in protein trafficking in each case is lacking. Notwithstanding, 
a relationship between palmitoylation and protein trafficking is increasingly being shown. For example, 
evidence suggests that the small GTPase enzymes H-Ras and N-Ras cycle between the cell membrane 
and the Golgi apparatus, regulated by palmitoylation (Goodwin et al., 2005; Rocks et al., 2005; Iwanaga 
et al., 2009; Lynch et al., 2015). The post-synaptic molecular scaffold protein PSD-95 has been shown 
to undergo dual palmitoylation on cysteine residues adjacent to the N-terminus which aid association 
with synaptic AMPA receptors at the synaptic membrane (Craven, El-Husseini and Bredt, 1999; El-
Husseini et al., 2002; Elias and Nicoll, 2007). Palmitoylation can also modulate the trafficking of BK 
channels; the cysteine residues of the S0-S1 TMD linker (mSlo C53, C56 and C56) have been shown to 
modulate channel localisation to the cell membrane via palmitoylation. This relationship was 
demonstrated in work published in 2010 (Jeffries, 2010; Jeffries et al., 2010), in 2012 (Tian et al., 2012) 
and in 2014 (Bi, 2014; Kim et al., 2014); here de-palmitoylation of the S0-S1 cysteine residues 
suppresses BK channel cell membrane expression by approximately 50%.  
Fundamental to the process of BK channel palmitoylation are the palmitoylation and de-palmitoylation 
enzymes. PATs zDHHC22 and zDHHC23 have been identified as primarily responsible for the 
palmitoylation of the cysteine residues of the S0-S1 linker (Tian et al., 2012); knockdown of the PATs 
resulted in trapping of the channel in trafficking vesicles, recycling endosomes or lysosomes. The 
cellular location of zDHHC22 was not determined, as overexpression of the PAT was not tolerated by 
the HEK293 cells. However, it was determined that zDHHC23 was located in the Golgi network and is 
facilitates BK channel exit from the ER. There is evidence of compensatory feedback between the PAT 
enzymes; knockdown of zDHHC5, zDHHC7, and zDHHC17 resulted in a paradoxical increase in BK 
channel membrane expression (Tian et al., 2012), however, this occurred alongside a significant up-
regulation of zDHHC22 and zDHHC23 expression. APT 1 is located in the Golgi apparatus; activity is 
associated with trapping of the channel in the GA. Overexpression of de-palmitoylation enzymes APT1 
and APTL1 reduced surface expression of ZERO channels (Tian et al., 2012). 
 
Splice Variants 
The addition or removal of coding exons (resulting in splice variants) add to the diversity of the BK 
channel and have been shown to modulate the channel trafficking pathway. Splice variant SV1, found 
in the S0-S1 linker, creates an ER retention signal that prevents efficient export of the channel from 
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the ER (Zarei et al., 2004), whilst splice variant mk44, also found in the S0-S1 linker, results in N-
terminal endoproteolytic cleaving and trapping of the remainder of the channel in the ER (Korovkina 
et al., 2001). Cysteine residues located in the STREX splice insert in the C-terminus (Tian et al., 2008; 
Jeffries, 2010) have been linked with increased cell membrane localisation. In addition, an acidic 
cluster-like motif upstream of the STREX splice insert site was found to be essential for channel exit 
from the endoplasmic reticulum and subsequent cell surface expression (Chen et al., 2010). However, 
differences in splice variant cell membrane expression have also been noted. Splice variant Δe23 in the 
C-terminus, located at the same site of splicing as STREX, results in a frameshift, and introduction of a 
premature stop codon (Chen et al., 2005) and produces channels lacking a C-terminus past RCK1 which 
act as a dominant negative of cell membrane expression.  
 
β -subunits  
Interaction of auxiliary subunits with the BK channel further increases the functional diversity of the 
channel and have been shown to modulate BK channel trafficking. For example, the β4-subunit may 
play an important role in trafficking of the BK channel to the cell membrane; it has been shown that 
assembly of β4-subunits with α-subunits reduces the surface expression of the channel complex in 
HEK293 cells (Shruti et al., 2012). Interestingly, the effect of β4-subunit and α-unit co-expression on 
channel surface expression is splice variant dependent; the surface expression of α-subunits containing 
the REVEDEC motif (normally associated with reduced membrane expression (Kim et al., 2007) is 
upregulated by β4-subunit co-expression (Chiu et al., 2010; Chen et al., 2013). 
 
Phosphorylation 
A level of cross-talk between ion channel palmitoylation and phosphorylation has been demonstrated. 
PKC has been shown to inhibit the BK ZERO channel by approximately 50%, however, inclusion of a 
palmitoylated STREX insert prevents PKC inhibition by preventing the phosphorylation of serine 695, 
which is required for PKC inhibition (Zhou et al., 2012); in the same study, removal of STREX 
palmitoylation at C645 and C646 restored PKC inhibition. However, palmitoylation of the STREX insert 
is required for BK channel inhibition by PKA (Tian et al., 2008). There have been few publications to 
date detailing a direct role of phosphorylation on BK channel membrane expression. However, in a 
2012 study, overexpression of 5' AMP-activated protein kinase (AMPK) was shown to increase the 
surface expression of BK channels expressed in Xenopus oocytes (Föller et al., 2012). The study also 
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showed that AMPK deficient mice had reduced BK-channel expression in the inner ear in comparison 
to wild-type.  
 
Cytoskeleton 
Cytoskeletal networks and the trafficking machinery controlling movement of the BK channel within 
the cell are integral to the positioning of the BK channel within the cell membrane(Kim and Oh, 2016). 
For example, an actin-binding domain situated in the C-terminus of the BK channel was shown to 
promote trafficking of the channel to the plasma membrane in HEK293 cells (Zou et al., 2008); a point 
mutation of this domain at L1020, reduced membrane association by 75%. The cell cytoskeleton has 
also been implicated in the control of rat BK channels in the cell membrane; lateral movement of BK 
channels in COS-7 cells was increased by point mutagenesis of the actin-binding domain (Won, Lee and 
Park, 2011). Overexpression of synaptopodin, an actin-associated protein with a role in actin-based 
cell shape and motility regulation, with the BK channel resulted in increased channel surface 
expression in the HEK293T cell line of approximately 100% (Won, Lee and Park, 2011). Filamin A, an 
actin-binding protein that forms perpendicular actin cross-links to modulate cell shape, is required for 
BK channel membrane expression in M2 melanoma cells (Kim, Ridgway and Dryer, 2007). Contrary to 
actin and filamin-A, co-expression of membrane-associated guanylate kinase with inverted orientation 
protein-1 (MAGI-1), a cell scaffolding protein, with the BK channel inhibits channel membrane 
expression by approximately 50% in HEK293T cells (Ridgway, Kim and Dryer, 2009). Cereblon, a protein 
which forms part of the E3 ubiquitin ligase complex, suppresses the surface expression of rat BK 
channels (Jo et al., 2005) and reduces trafficking of the BK channel from the ER.  
Other cytoskeleton proteins such as microtubule-associated protein 1A (MAP1A) (Park et al., 2004) 
have been shown to bind to the BK channel, however there has been limited evidence of their role in 
membrane trafficking.   
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Figure 1.6- BK channel trafficking pathway. A) BK channel protein synthesis in the endoplasmic 
reticulum (ER). B) BK channel processing in the Golgi apparatus (GA). C) BK channel sorting and 
trafficking to target membranes via transport and secretory vesicles. D) Localisation of BK channels to 
specific cell membrane microdomains. E) BK channel recycling between the cytosol and the cell 
membrane via endosomes. F) BK channel degradation via lysosomes. Figure adapted from (Jeffries, 
2010; Shipston, 2014). 
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1.8 BK channel as a personalised medicine target 
1.8.1 Pharmacological agents targeting BK channels 
Due to the wide and varied effects of the BK channel in physiology, it has been investigated as a 
pharmacological target (Gribkoff, Starrett and Dworetzky, 2001). Agents have been formulated to 
tackle pathophysiologies associated with channel dysfunction or take advantage of the hyperpolarising 
effect of the channel. An example of this is in the treatment of urinary incontinence; the BK channel 
activating agent NS11021 was designed to inhibit bladder spasms whilst leaving voluntary bladder 
contraction intact (Layne et al., 2010). Compounds NS-8, TA-1702 and NS19504 have also been 
investigated as BK channel targets for overactive bladder, however efficacy in patients has not yet 
been conclusively established (Tanaka et al., 2003; Tanabe, 2007; Nausch et al., 2014).  
BK channel opener BMS-204352 was designed to prevent the toxic increase in intracellular calcium 
concentration observed in neurones during ischaemic stroke (Jensen, 2002). Whilst initial phase I and 
phase II clinical trial results were positive, a phase III trial found no significant difference in stroke 
outcomes compared to placebo and so the agent was not developed further (Jensen, 2006). The lack 
of effect is proposed to be due to delay in administration of the compound to patients due to logistical 
issues (Wulff and Zhorov, 2008). The BK channel blocker GAL-021 was developed to treat respiratory 
insufficiency in an acute care setting; GAL-021 increased respiratory drive and stimulated ventilation 
by blocking BK channels in the hypoxia sensitive carotid body (McLeod et al., 2014). BK channels are 
also a target of interest for asthma with several agents in development (as reviewed by Rusiecka and 
Kocic, 2012). 
However, due to the lack of widespread therapeutic success of compounds targeting BK channels to 
date (Wulff and Zhorov, 2008; dela Peña and Cheong, 2011), another approach may be warranted. This 
approach would be to look for inter-individual difference in the BK channel gene, and investigate the 
potential effects this could have on channel function and thus disease. This would enable the 
stratification of patients for more precise treatment targeting with existing therapies. To this end, SNP 
occurring on the BK channel are of interest.  
 
1.8.2 Disease causing SNP in BK channels 
Genome wide association (GWA) studies have provided evidence that DNA mutations occurring in the 
intronic regions of the BK channel gene are associated phenotypic traits related to diseases. The BK 
channel gene (KCNMA1) was identified as an obesity suceptability gene; in a GWAS using a morbidly 
obese case group (n=4214) and control cohort (n=5417) a significant association between SNP 
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rs2116830 and obesity was identified (Jiao et al., 2011). Further investigation uncovered increased 
KCNMA1 mRNA expression in adipose tissue and fat cells. As stimulation of BK channels in fat cells has 
led to pre-adipocyte proliferation (Hu et al., 2009), the study proposed that changes in BK channel 
expression levels could result in obesity by increasing the number of adipocytes. Further evidence to 
support this theory was provided in a 2016 study where it was shown that BK channel knockout mice 
had reduced body weight and overall fat mass in comparison to wild-type (Illison et al., 2016).  
The BK channel gene has also been associated with all cause mortality in those with heart failure 
(Morrison et al., 2010). In this 2010 GWAS, the genomes of 2,992 individuals who suffered a heart 
failure event were screened and the SNP rs4979906 was found to be associated with increased all 
cause mortality. Whole exome sequencing identified KCNMA1 SNP rs16934182 and rs1131824 
associated with severe hypertension and myocardial infarction (Tomás et al., 2008). SNP rs7071206 
was identified during a meta-analysis of GWAS that assessed SNP occurring in the genome of 133,460 
individuals; rs7071206 is associated with risk of low-trauma fracture, however the nature of the 
realtionship between fractures and the BK channel has not yet been established (Estrada et al., 2012). 
The nsSNP D434G (rs137853333), characterised in both the human and murine form of the channel 
(Du et al., 2005; Wang, Rothberg and Brenner, 2009; Yang et al., 2010) is responsible for the genetic 
disorder Generalized Epilepsy and Paroxysmal Dyskinesia (GEPD). GEPD occurs as a result of the 
substitution of an aspartic acid amino acid residue for a glycine residue in the conserved cytosolic linker 
region in the C-terminus, downstream from the S6 transmembrane domain (Yang et al., 2010). The 
mutation results in reduced activation time and enhanced channel calcium sensitivity as a result of 
increased calcium affinity (Du et al., 2005; Díez-Sampedro et al., 2006; Lee and Cui, 2009; N’Gouemo, 
2014). The mechanism behind this increased calcium sensitivity is proposed to be reduced flexibility of 
the AC region in the RCK1 domain (Yang et al., 2010).  
The BK channel nsSNP A138V (rs144215383) is located in the intracellular S0-S1 linker has been 
associated with a loss of function of the channel; in this case, the substitution of valine for alanine is 
associated with autism and mental retardation (Laumonnier et al., 2006). The biomolecular cause of 
the effect has yet to be elucidated, however it is postulated that the mutation creates a ‘cryptic’ splice 
site, a disadvantageous splice site that is dormant or used only at low levels unless activated by 
mutation, that results in impaired channel expression (Guglielmi et al., 2015).  
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Disease causing nsSNP in ion channels 
Disease causing SNPs have been identified in other ion channels. The voltage-gated sodium channel 
Nav1.7 plays a role in the generation of action potentials in peripheral neurons and thus is an important 
step in the pathway for the generation of pain signals. This channel is coded for by the SCN9A gene 
and variations in this channel that cause either gain or loss of function mutations (Drenth and Waxman, 
2007). Gain of function mutations in this channel, such as L858H, I848T (Yang et al., 2004), L858F (Han 
et al., 2006) and N395K (Drenth et al., 2005), are responsible for the disease Primary Erythermalgia, a 
rare, hereditary syndrome of hyperaemic and inflamed extremities, which in all cases has been 
attributed to mutations in the highly-conserved regions of the channel. The majority of perturbing 
mutations are located in the cytoplasmic transmembrane domain linkers, and cause a hyperpolarizing 
shift in the voltage dependence of channel activation. This allows the channel to be activated by 
smaller than normal depolarizations whilst also slowing the deactivation of the channel, resulting in 
the open-state being present for longer. Loss of function mutations of the Nav1.7 channel are causative 
of Channelopathy-associated Insensitivity to Pain (CIP); nsSNP S459X, I767X and W897X (Cox et al., 
2006) result in nonsense mutations that code for a triplet sequence that does not code for an amino 
acid residue, resulting in a truncated, non-functioning ion channel protein.  
The voltage-gated calcium channel, CaV3.2, coded for by the CACNA1H gene, is present in the adrenal 
glomerulosa. Gain of function mutations in this channel, result in early-onset hypertension as a result 
of primary aldosteronism (Scholl et al., 2015). Exome sequencing was conducted for 40 subjects 
suffering from the condition and the root cause identified as nsSNP M1549V. This mutation occurring 
in a highly-conserved domain causes channel activation at more hyperpolarised membrane potentials 
and impaired channel inactivation. This results in a significant and chronic increase in intracellular 
calcium concentrations, leading to increased aldosterone production. As aldosterone is responsible for 
increasing the retention of sodium, which is coupled with water, an increase in this hormone lead to 
an inappropriate increase in blood volume and thus blood pressure. 
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1.9 Thesis Aims 
1.9.1 Rationale for Study 
Bioinformatics informs personalised medicine and facilitates the discovery of SNPs with the potential 
to cause disease. Due to the volume of SNPs associated with the human genome (over 84 million 
(Auton et al., 2015)), it is not practical in any one thesis to assess those most likely to cause harm across 
the whole genome using a protein map; thus, the selection of a single gene would allow a more in-
depth study and enable the prioritisation of those SNP likely to alter BK channel function. The BK 
channel was selected as the model gene of investigation due to its ubiquitous nature and role in a 
diverse range of physiological processes. The SNP D434G is causative of generalised epilepsy and 
paroxysmal dyskinesia (GEPD) (Du et al., 2005); this provided evidence that genetic mutations of that 
gene can result in disease. Before the prioritisation of SNP can commence, biocuration of BK channel 
data contained in bioinformatics databases will be undertaken. Due to the inherent limitations of 
bioinformatics, the SNPs categorised as having a high potential to cause a change in BK channel 
function would need to be validated experimentally to confirm effect. Thus, the SNP will be taken to 
the lab for verification.  
 
1.9.2 Aims 
To capture and curate the key aspects of data relating to the human BK channel (such as the 
locations of structural, functional, PTM, site-directed mutagenesis sites and single-nucleotide 
polymorphisms (SNPs)) stored within bioinformatics databases. This will be undertaken in 
steps 1-4 of the thesis workflow, shown in Figure 1.7.  
• To use the collated and curated BK channel information to create a novel ‘at a glance’ resource 
for the BK channel with the synthesised information. This will be undertaken in step 5 of the 
thesis workflow.  
• To use the BK channel resource to facilitate the prioritisation of SNPs predicted to affect BK 
channel function. This will be undertaken in step 6 of the thesis workflow. 
• To assess the effect of prioritised S0-S1 linker SNPs (hSlo H120Q and G122A) on the cellular 
distribution of BK channels expressed in HEK293 cells cultured in combinations of the 
metabolic substrates glucose, palmitate and oleate. This will be undertaken in step 7 of the 
thesis workflow. 
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Figure 1.7- Schematic of proposed thesis workflow. Described are the steps to be undertaken in this 
thesis work to identify new potential genetic targets for personalised medicine. Step 1: the BK channel 
gene has been selected for investigation as it is coded for by a single gene, plays a diverse role in 
physiology and has prior evidence of SNP mediated dysfunction. Steps 2-6 will be undertaken in 
chapter 3, whilst step 7 will be addressed in chapter 4.  
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2 General Methods 
 
2.1 Bioinformatics  
2.1.1 Identification of the Human KCNMA1 Gene and Transcripts 
BK channel genomic information contained in bioinformatics databases was investigated for the 
human form of the KCNMA1 gene using a range of databases and software tools including Ensembl 
(release 72, accessible via www.ensembl.org/index.html). Some of the key steps and procedures have 
been captured in Figure 2.1. For example, the first steps in procedure for accessing the appropriate 
gene are shown in Figure 2.1. The molecular location for the BK channel gene, as well as the transcript 
data was accessed by selecting the ‘Result in Detail’ option and the ‘Gene:KCNMA1’ tab respectively 
(see Figure 2.2). The cytogenic location of the BK channel gene was also accessed via the Ensembl 
database.  
Selection of the associated ‘Transcript ID’ link for a specific transcript in the ‘transcript ID’ column 
presents additional transcript information, including the number of exons associated with each 
transcript and identifiers from other databases as can be seen in Figure 2.3A. This option must be 
selected before searching for information for differing transcripts to ensure that splice variant specific 
information is gathered. Ensembl contains amino acid sequence information for all transcript entries 
in FASTA format; this can be accessed by selection of the ‘Protein’ tab in ‘Transcript-based displays’. A 
sample FASTA output for one of the KCNMA1 transcripts can be seen in Figure 2.3B.  
In addition to Ensembl, data held on the UniProt bioinformatics database (available from 
www.uniprot.com) was used to determine the canonical transcript for the KCNMA1 gene and retrieve 
additional protein information. Figure 2.4 shows the steps taken to retrieve BK channel transcript 
information using UniProt. After selection of the KCMA1_HUMAN protein family, a large amount of 
information becomes available on a single page including an ‘Alternative Products’ section near to the 
bottom of the page. This section provides details of transcripts (here identified as isoforms) associated 
with the KCNMA1 gene. Selection of a transcript from the ‘Alternative products’ page produces an 
output as shown in Figure 2.5. ‘Isoform 1’ in the list is the canonical transcript of the BK channel. In 
order to illustrate the nature of the process, data from the canonical transcript is shown in Figure 2.5B, 
which displays the amino acid sequence for the canonical protein and the link to the amino acid 
sequence in the FASTA format. The rational for selection of the canonical protein will be examined and 
discussed in the following chapters.  
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Figure 2.1-Locating the BK channel gene on the Ensembl database. A) Ensemble gene search from 
release 72. Search boxes containing search terms highlighted in red. The human genome was selected 
from the species dropdown menu and ‘KCNMA1’ was entered into the search box. After pressing enter 
the search result page is produced. B) Ensembl search result for Human KCNMA1 gene. This shows the 
total number of entries for the gene and a breakdown of entry category. The human form of the gene 
was selected from the menu as highlighted in blue.     
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Figure 2.2- Selection of BK channel transcripts on the Ensembl database. A) Expanded Ensembl search 
result for Human KCNMA1 Gene. Selection of the ‘variation table’ link under the ‘variations’ 
subheading and opening up the ‘show transcript table’ produces a list of all transcripts associated with 
the KCNMA1 gene. In this section gene description and links to the gene ID, location, variation and 
source are included. B) Ensembl summary of all KCNMA1 associated transcripts. The chromosome 
location and number of splice variants are included in this output, as well as splice variant name, 
Ensembl ID, length in base pairs (bp), the ID of the resulting protein, the protein length in amino acids 
(AA) and the biotype of the splice variant. Highlighted in red to the left is the ‘Variation Table’ option 
which is selected to view SNPs associated with each transcript.  
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Figure 2.3- Transcript Summary and Protein Amino Acid Sequence output in Ensembl. A) Ensembl 
transcript summary output. Presented here is a schematic highlighting the number of exons that make 
up the selected transcript; exons are represented by vertical red bars, separated by introns 
represented by horizontal red lines. The direction in which the chromosome strand is read is shown at 
the bottom of the schematic, with additional information about the protein such as transcript length 
in base pairs (bps) and in amino acid residues and its identifier in other databases. B) Ensembl amino 
acid sequence output for exemplar transcript. After selection of the ‘protein’ link circled in red, the 
amino acid (AA) sequence for the protein is displayed. Alternate exons are differentiated by alternating 
blue and black segments; red letters indicate residue overlap splice sites.  
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Figure 2.4- Locating KCNMA1 protein information using the UniProt database. A) UniProt Protein 
Search from Homepage. KCNMA1 was entered into the ‘query’; search bar on the UniProt homepage 
and the search option selected. B) Selection of the human KCNMA1 protein family from the UniProt 
database. This option displays results of the search query; in this output all entries containing KCNMA1 
as a keyword have been shown. Highlighted in red is the human canonical KCNMA1 protein, which is 
listed on UniProt as KCMA1_HUMAN.  
51 
 
 
 
Figure 2.5- UniProt Summary of human KCNMA1 protein isoforms. A) UniProt Summary of all human 
KCNMA1 protein isoforms held on the UniProtKB database. In this output, a comprehensive list of 
documented transcripts is displayed with a brief annotation on how each isoform deviates from the 
canonical isoform. B) UniProt transcript-amino acid sequence output. Amino acid sequences are listed 
in groups of ten. The link that leads to the amino acid sequence in FASTA format is highlighted in red. 
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2.1.2 Identification of the amino acid locations of KCNMA1 protein structural and functional sites 
UniProt and Ensembl databases were used to identify the amino acid location of structural and 
functional areas on the KCNMA1 canonical transcript. In the UniProt database, the name of the 
structural and functional sites or ‘Regions’ on the channel were listed alongside the position of the site 
on the channel, and the site length in amino acid residues. A simplified schematic indicating where 
these sites are located on the channel is displayed in Figure 2.6A. UniProt gives users the option to 
view areas of the protein involved in secondary structure, illustrated in Figure 2.6B. The secondary 
structure information can be used in conjunction with the ‘Regions’ subsection to locate areas involved 
in protein folding. The Ensembl outputs for BK channel structure and functional regions are accessed 
by selecting the ‘Domains and features section’ tab on the left-hand side of the page as indicated in 
Figure 2.7; here the functional regions are described.  
 
2.1.3 Identification of nsSNPs on KCNMA1 transcripts 
Collation of the location and nature of single nucleotide polymorphisms (SNP) on the BK channel was 
undertaken prior to the implementation of a bioinformatics methodology to allow for prioritisation of 
damaging SNP. Therefore, SNP data for the BK channel was accessed using the Ensembl database. 
Upon selection of a transcript from the ‘variation table’ option shown in Figure 2.3B, a table containing 
a summary of variants, their nature and description could be obtained (Figure 2.8). This option enables 
the user to retrieve variation information associated with the gene as a whole or for a particular 
transcript. Such variations include ‘in-frame insertions’, ‘intron variants’ and ‘synonymous variants’. 
The number of variations of each type is included in the output, alongside a brief description of the 
type and the nature of variations that are included in the category. Selection of a category of variants 
provides comprehensive information about the nature of each variant within that category. In Figure 
2.8B, a sample of information contained in the database for ‘missense’ (non-synonymous) variations 
of the BK channel are listed. This section is used to find specific information about a variation such as 
its amino acid location within the protein, the specifics of the amino acid substitution (such as the base 
pair alteration) or its molecular location in the gene.  
By selecting the ‘Variation Image’ option either in Gene view or after selecting a specific transcript, an 
image with SNP data is produced with locations in respect to the associated transcript and its 
composite exons (Figure 2.9).  
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Figure 2.6- Uniprot output: Protein Regions and Secondary Structure. A) Uniprot ‘Regions’ subsection 
output. Shows the amino acid locations of structural and functional regions of the canonical KCNMA1 
protein. This output details the region type, location in terms of amino acids and a basic graphic 
denoting rough location and proportion of the total protein that the region occupies. B) UniProt Output 
for KCNMA1 Protein Secondary Structure. Colour coded as per the key, the bar above is a 
representation of the areas within the protein that are involved in the formation of secondary 
structure. 
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Figure 2.7- Ensembl Domains and Features output. Detailing the domains associated with the 
KCNMA1 protein, with location listed in amino acid residues via numbering the start and end of the 
domain. Also included is a brief description of the domain.  
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This output aids SNP location visualisation and complements the information presented in the 
‘variation table’ output. More detailed information on each variation can be accessed by clicking on a 
filled box; a pop-up will be created containing the same information, found in the ‘variation table’. An 
alternative method of viewing the SNPs associated with a protein coding transcript is to select the 
‘Protein summary’ option. This option, like the ‘variation image’, allows SNPs to be presented as colour 
coded boxes and in relative position to the protein and its functional regions. As with the ‘variation 
image’, clicking on one of the coloured boxes presents the user with expanded variation information.  
BK channel variation information is also contained in the UniProt database and can be found under the 
‘Natural Variations’ subheading on the KCNMA1 protein family homepage (Figure 2.10A). Here, 
naturally occurring variations are compared with the canonical transcript of the gene. A key to the 
right of the page indicates the location of the variation on the transcript, whilst another column 
explains the nature of the variation.  
 
2.1.4 The predicted damaging potential of BK channels nsSNP calculated by SIFT and PolyPhen-2  
Damage prediction software outputs were used to facilitate the prioritisation of nsSNP on the BK 
channel. The predicted damage score of BK channel nsSNPs was calculated by SIFT and PolyPhen-2 
software. The Ensembl variation output includes the predicted damage category and score for nsSNPs 
which is integrated into the output, therefore a query sequence does not need to be separately 
submitted manually for each variation. SIFT and PolyPhen-2 software can be accessed via 
http://sift.jcvi.org/ and http://genetics.bwh.harvard.edu/pph2/ respectively.  
 
2.1.5 Assessment of previous site directed mutagenesis studies of the BK channel  
Site directed mutagenesis studies are useful for studying the functional effects of nsSNPs, and facilitate 
the prioritisation of BK channel nsSNPs, as they can indicate the role that a region plays in the structure 
and function of the channel. As a result, the occurrence of SNP at those same sites could predict the 
consequence; thus, knowledge of the locations of site directed mutagenesis on the channel is 
desirable. The UniProt database holds information on mutagenesis studies, an example of which is 
shown in Figure 2.10B. This section combines the results of studies where the effects of KCNMA1 
mutations have been tested. The list of mutagenesis sites in the UniProt database was not extensive, 
therefore a literature search was also conducted to establish the location, nature and consequence of 
mutagenesis sites of the BK channel.   
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Figure 2.8- Ensemble Variation Table and sample ‘Missense Variant’ output. A) Truncated sample of 
Ensembl ‘Variation Table’ output for protein of transcript KCNMA1-009. Selection of the ‘variation 
table’ option results in all recorded variants for the selected transcript (in this case KCNMA1-009) to 
be displayed. Variations are categorised by the location of the variant on the transcript, for example 5 
prime UTR .... or intron variant …. or on the resulting alteration to normal translation such as in-frame 
deletion .… or missense variant ….. The number of variants in each category is displayed on the left of 
each category, and a description of each variant consequence is included in the right-hand column. B) 
Sample ‘Missense Variant’ output for KCNMA1 transcript. Details of variant ID, molecular location, 
alleles involved in the variation, class of change, the source of information, type of variation and amino 
acid coordinates provided in this output.  
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Figure 2.9- Ensembl KCNMA1 protein Variation Image Output. A copy of a page for a specific 
transcript, its composite introns and exons, notable functional regions in the protein, and variations. 
These variations are colour coded into categories as seen in the key at the bottom of the figure. The 
transcript is at the top of the figure in brown; exons are represented as filled boxed with the thinner 
lines on either side representing introns. The hollow box to the left of the first exon represents the 
three prime untranslated region (3’ UTR region). Boxes below the transcript help to decipher the 
position and category of variants; the letters contained within the boxes inform of any change in amino 
acid residue as a result of the variation in question. A colour key for the category of variations is 
included at the bottom of the figure.  
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Figure 2.10- UniProt KCNMA1 Natural variations and Experimental Information output. A) UniProt 
Natural variations output. Natural variations in transcript composition are compared with the 
canonical transcript for the gene. The amino acid location of the variation is shown in the second 
column, then the length and nature of the variation. B) UniProt experimental information output. 
Results from mutagenesis studies are presented; with columns stating the amino acid location, length, 
nature and position of the mutation in the transcript. 
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2.1.6 Identification of PTM sites on the KCNMA1 canonical transcript 
A range of software tools were utilised to identify predicted sites of post translational modification on 
the human KCNMA1 transcript. Post-translational modification is important for the function of the BK 
channel, as reviewed by (Shipston and Tian, 2016). Identifying the location of post-translational 
modification sites on the BK channel will aid prioritisation of potentially damaging nsSNP; as nsSNP co-
localised with post-translational sites may perturb channel function.  
Phosphorylation prediction software site, NetPhos 2.0 is (available at 
(http://www.cbs.dtu.dk/services/NetPhos/), was used to determine serine (S), tyrosine (Y) and 
threonine (T) phosphorylation sites on the BK channel (Figure 2.11A). The FASTA sequence of the BK 
channel was entered; and the resultant serine, tyrosine and threonine sites were selected for 
investigation. A table and a graphic of the predicted phosphorylated amino acids, the threshold and 
the predicted score is produced as an output of the software.  
Palmitoylation prediction software site CSS-Palm 4.0 (available at http://csspalm.biocuckoo.org/) 
pinpoints the location of potentially palmitoylated cysteine residues in the amino acid sequence 
entered. To determine the number of cysteine residues on the BK channel that were predicted to be 
palmitoylated, the FASTA sequence was entered, as shown in Figure 2.11B, producing a list of cysteine 
residues predicated to be palmitoylated, along with the threshold for each residue and the predicted 
score. A high threshold for detection was selected as supported by previous publications utilising the 
software (Jeffries, 2010; Shipston, 2011; Feng et al., 2013; Aguilar-Martinez et al., 2015). 
Using a link on the left-hand side of the CSS-Palm 4.0 website, the online server homepage for S-
nitrosylation (http://sno.biocuckoo.org/online.php), and SUMOylation 
(http://sumosp.biocuckoo.org/) were accessed. The predictive software packages for S-nitrosylation 
and SUMOylation have the same controls as CSS-Palm 4.0, and thus predicted sites were accessed 
using the same procedure.  
Predicted sites of N-glycosylation on the BK channel were predicted using NetNGlyc 1.0, accessible via 
http://www.cbs.dtu.dk/services/NetNGlyc/. The BK channel FASTA sequence was entered into the 
software at default detection threshold. The output produces an amino acid sequence with N-
glycosylated sights highlighted, as well as a table listing the amino acid location of the predicted site, 
as well as the predicted score.  
Sites of verified post-translational modification of the BK channel were identified using a literature 
search.   
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Figure 2.11- Post-translational modification predictive software. A) NetPhos 2.0 homepage. The FASTA 
sequence of the particular transcript is entered into the search box and the appropriate phosphorylated amino 
acid type (tyrosine, serine or threonine) is selected via tick box. The default setting is to predict  for all three 
possible phosphorylated amino acid residues. B) CSS-Palm 3.0 online server homepage. The FASTA sequence of 
the transcript in question is entered into the search box and the threshold of the results is selected at the bottom 
of the webpage. Homepage accessible via http://csspalm.biocuckoo.org/online.php. The links to access the 
online server homepages to predict sumoylation and S-nitrosylation sites within the transcript are highlighted in 
red. Predictive software for N-glycosylation (NetNGlyc) is available via 
http://www.cbs.dtu.dk/services/NetNGlyc/.   
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2.1.7 Assessment of BK channel nsSNP and Key site co-localisation  
The co-localisation of nsSNP and key sites on the BK channel was assessed by cross-referencing the 
amino acid locations. Key sites include, structural, functional, post-translational modification and those 
previously examined by site-directed mutagenesis. For the initial assessment, only sites with a direct 
match (occurring at the same amino acid location) were included; during nsSNP prioritisation, sites 
that lay within 3 amino acid residues of a nsSNP were included.  
 
2.1.8 Prioritisation of BK channel nsSNP  
SNPs predicted to result in alterations in protein function and possibly cause disease have been 
prioritised in previous studies with the aid of algorithms (Lee, 2009; Stead et al., 2011; Teng et al., 
2012; Ryan et al., 2014). In the studies referenced above, this method has been proven to be effective, 
resulting in a reduction in the number of nsSNPs in comparison to the original number, based upon 
the criteria set in each study. However, algorithms rely exclusively on previous machine learning of key 
sites on the channel, which is often not comprehensive and can contain ambiguous labelling, creating 
challenges for accuracy (Huang et al., 2017). In this study, nsSNP prioritisation was conducted manually 
by the investigator. Priority was given to those SNPs that were; a) co-localised with, or were less than 
four amino acids away from a crucial functional site, such as the voltage sensor, b) proximal to crucial 
sites demonstrated by previous site-directed mutagenesis experiments to have a profound effect on 
channel function, such as mutations of the potassium selectivity motif, c) nsSNP with a significant 
effect on the local post-translational modification environment, for example a SNP that results in the 
creation or removal of a cysteine rich domain or d) proximal to another nsSNP shown to have 
physiological effects, such as D434G (Díez-Sampedro et al., 2006; Yang et al., 2010). The detail of this 
process is shown in the results section with a range of individual examples that help illustrate the key 
aspects of this process. 
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2.2 Lab Based Methods 
Functional assessment of the nsSNP prioritised following the procedure detailed in the bioinformatics 
section will be investigated in vitro. This lab based approach involves the production of appropriate BK 
channel constructs via site directed mutagenesis, their expression in HEK293 cells and assessment via 
confocal microscopy. The lab-based methods used in previous studies (Chen et al., 2005; Jeffries, 2010; 
Bi, 2014), for the investigation of the cell membrane expression of BK channels in HEK293 cells have 
served as a basis of the method selection for the lab based experiments.  
 
2.2.1 Addition of FLAG and HA antigen tags to the BK channel protein  
To assess the proportion of BK channels in the membrane, both membrane-bound and cytosolic 
channels must be tagged in a manner that allows for quantitative analysis. This study utilises confocal 
microscopy and thus a method producing fluorescently tagged channels was employed. FLAG and 
hemagglutinin (HA) tagging allows for the attachment of antibodies with fluorescent moieties to the 
BK channel. Expression of full length murine BK ZERO channel constructs with N-Terminal FLAG and C-
terminal HA epitope tags were created as previously described using pcDNA 3.1 vectors (Chen et al., 
2005). Briefly, synthetic double-stranded FLAG and HA- oligonucleotides were blunt end ligated in 
frame with the initiator methionine (DYKDDDDKDALI…) codon for the FLAG tag and C-terminal cysteine 
(...REVEDECYPYDVPDYA) HA tag using forward and reverse oligonucleotides (Figure 2.12). 
 
2.2.2 Site Directed Mutagenesis to create BK channel mutants 
To determine whether amino acid mutation occurring in the S0-S1 linker of the BK channel affects cell 
membrane distribution in HEK293 cells, BK channels containing the cysteine mutants (C53:C54A and 
C53:54:56A) and the SNP mimetic mutants (H55Q, G57A and H55Q:G57A) first needed to be created. 
This was achieved using site directed mutagenesis using the QuickChange II site-directed mutagenesis 
kit. An overview of the QuickChange II site-directed mutagenesis process is illustrated in Figure 2.13. 
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Design of oligonucleotides for site directed mutagenesis  
Normally, when designing primers for site directed mutagenesis, a 20-30 base oligonucleotide with the 
mismatch located in the centre is sufficient for a single base mutation and 40-45 bases for a double 
mutation. However due to the high G/C content of the primer sequences, extended sequences were 
required to allow for additional perfectly matched nucleotides on either side of the mismatch. 
Oligonucleotides were ordered from Eurofins MWG Operon, (Ebersberg, Germany). The final primer 
design for each mutant is detailed in Table 2.1. The DNA template used for amplification was the 
murine ZERO form of the BK channel with Flag and HA epitope tags as described previously (Chen et 
al., 2005).  
Codon oligonucleotide substitution for the H55Q mutation on the forward strand was ‘CAC’ (H) to 
‘CAG’ (Q) and for the G57A mutation was ‘GGG’ (G) to ‘GCG’ (A); the substitution of a cysteine amino 
acid residue to an alanine residue, as was conducted for the C53:54A mutant and C53:54:56A mutant, 
the codon sequence was changed from ’TGC’ (C) to ‘GCC’ (A). The C53:54:56A mutant was made using 
a 2-step process; initially the cysteine residues at amino acid locations 53 and 54 were mutated to 
alanine residues, then this transcript was further mutated at cysteine 56 to produce the final product. 
A schematic of the amino acid sequence of mutant proteins is displayed in Figure 2.14. 
 
Site Directed Mutagenesis 
Site directed mutagenesis of amino acid residues was carried out using PCR in 50μl reactions with the 
QuikChange II XL Site-directed Mutagenesis Kit (Stratagene #200522). Each reaction mixture 
contained, 1μl Pfu turbo polymerase, 5µl of 10x reaction buffer, 3μl Quiksolution (Stratagene), 1μl of 
dNTP mix (NE BioLabs), 125ng of oligonucleotide sense primer, 125ng of antisense primer, 1.5µl of 
MgCl2 (50 mM), 50ng template DNA, and DEPC water to make up to a 50μl final volume. Samples were 
heated to 95OC for 1 minute to denature template DNA. Reactions were generally run for 18 cycles 
with 50 seconds at 95OC, annealing temperature was set at 60 OC. Extension phases were conducted 
at 68 OC with times set at 1 minute per kb of plasmid length. This was followed by 10 minutes at 68OC 
after the final cycle for the final extension. The PCR product then underwent Dpn I (10U/μl) digestion 
for 1 hour at 37 OC to eliminate any parental methylated DNA template. 
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Figure 2.12- Schematic of FLAG and HA tagging of BK channel constructs. FLAG and HA tag amino acid 
sequence shown alongside N-terminal and C-terminal BK channel amino acid sequence. The initiator 
methionine is removed to allow ligation of the FLAG antigen, and moved to the front of the FLAG tag 
giving sequence MDYK. 
 
 
 
 
 
Equation 2.1-A) Stratagene Primer Melting Temperature Formulas. N= Primer length in base pairs B) 
Stratagene Primer Melting Temperature Calculation for Insertions and Deletions. N=Primer length in 
base pairs, excluding bases being inserted or deleted.  
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Transformation of Chemically Competent E. coli 
Transformation of newly synthesized plasmid DNA was carried out using chemically competent XL10-
Gold® ultra-competent E. coli cells (Stratagene). The process of transformation was undertaken to 
cause the uptake of the plasmid vector containing the DNA mutations into the competent cells, with 
the aim of sealing up the nicks in the backbone from the overlapping primer PCR method and generate 
more copies of the plasmid containing the mutated sequence. 100μl aliquots were stored at -80OC and 
subsequently thawed on ice. They were then split into 50μl aliquots. 10ng of plasmid DNA was added 
and the mixture was incubated on ice for 20 minutes. Subsequently, cells were heat-shocked at 42OC 
for 45 seconds and 500μl of Luria Broth (LB) medium was added. The mixture was incubated for 30 
minutes to 1 hour at 37OC in a shaking incubator, at 200 rpm and then 200μl of cells were plated onto 
selective agar with ampicillin at a working concentration of 100ug/ml and incubated overnight at 37OC. 
 
PCR Screening of Bacterial Colonies 
PCR screening of bacterial colonies was undertaken to confirm the successful incorporation of DNA 
within the plasmid vector. Individual colonies grown on selective agar plates were selected using a 
sterile pipette tip, then transferred into a 50μl PCR reaction tube containing primers specific to the 
region of interest. A standard PCR reaction amplified the region of interest (Figure 2.15), which could 
then be run out on a 1% (w/v) agarose gel. Those colonies shown by PCR screening to be the correct 
size (or if using double digest plasmid DNA, those that contained the correct size of insert), were again 
picked from the same plate using a sterile pipette tip and inoculated into either 5ml or 250 ml of LB 
medium with 100µg/ml ampicillin. This was incubated overnight at 37OC in a shaking incubator, at 200 
rpm, in order to set up either a mini- or maxi- prep culture. 
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Figure 2.13- QuickChange II Site-Directed mutagenesis overview. An overview of the procedure to 
conduct site directed mutagenesis of the BK channel using QuickChange II is illustrated. The green and 
yellow strands denote template DNA strands, whilst pink and blue strands denote the newly 
synthesised DNA strands incorporating base pair substitutions, denoted by the purple X. After 
sufficient replication of the DNA strands incorporating the base pair substitutions, template DNA is 
removed by Dpn I digestion. Figure was adapted from QuickChange II Site-Directed mutagenesis 
protocol.  
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Table 2.1- BK Channel Site Directed Mutagenesis Primer Sequences. Mutagenesis primer sequences 
for the SNP mimetic mutants (H55Q, G57A and H55Q:G57A) and the cysteine mutant channels 
(C53:54A and C53:54:56A) are detailed. Numbering starts from initiator methionine MDALI.. in the 
murine BK channel (accession number NM_010610). 
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Figure 2.14- Amino acid sequence for mutated BK channel proteins. The mutant name in the format 
FLAG-BK(X)-HA is annotated alongside the amino acid sequence of interest, with numbering, starting 
from the initiator methionine, detailed below the sequence. Sequence 1 is the ZERO channel with the 
original amino acid sequence; amino acid mutations are indicated by a box, as per the key. Details of 
the codon alterations for each of the mutated amino acids is detailed in the section ‘Design of 
oligonucleotides for site directed mutagenesis’ earlier in this chapter.   
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Figure 2.15- Schematic of DNA replication by PCR. 1) The target DNA sequence is first heated to 95ºC 
to melt double stranded DNA to single strands. 2) The temperature is lowered to allow primers to 
anneal to the newly exposed single stranded DNA. Typically, the annealing temperature is about 3–5 
°C below the Tm of the primers, to allow for greatest binding and alignment accuracy 3) Temperature 
is increased to 72°C and DNA polymerase synthesizes a new DNA strand complementary to the DNA 
template strand by adding dNTPs that are complementary to the template in 5' to 3' direction. 
Modified from (Lawley, 2009).  
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Sub cloning 
Double Restriction Digest 
Sequencing of the BK channel oligonucleotide sequence over the mutated region was conducted by 
Eurofins MWG Operon, Germany, to confirm incorporation of point mutations into the DNA sequence. 
On confirmation of the incorporation of the desired mutations, double restriction digestion was used 
to isolate the sequenced region and to then insert it into a new vector to assure a clean vector 
backbone without possible additional erroneous mutations in regions not submitted for sequence 
screening. Double restriction digests were prepared in 20μl reactions, each containing 2-10 U of 
restriction enzyme in the appropriate buffer diluted to 1x with DEPC water and 0.2-1μg of DNA sample. 
These reaction mixtures were then incubated at 37 OC for 1 hour.  
 
DNA Agarose Gel Electrophoresis and Gel Purification 
Gel Electrophoresis, to separate the DNA by molecular weight to confirm sizes of digested fragments, 
was carried out using a 1% agarose (w/v) gel prepared in 50ml or 100ml of 1xTBE buffer (45 mM Tris-
base, 45 mM Boric acid, 2 mM EDTA, pH 8.0), depending on the number of samples, and heated to 
allow dissolution. If the expected size of the DNA fragment was less than 300 base pairs, the 
percentage of agarose was increased up to 2% to increase band definition when imaging under UV 
transillumination. SYBR Safe DNA gel stain (Invitrogen Molecular Probes) was added at a 1x final 
concentration and mixed by swirling. The gel was then poured onto a plate to set. DNA samples were 
mixed with 5μl of loading dye (10x formula for 100 ml: 60% glycerol (v/v), 0.25% bromophenol blue 
(w/v), 33% 150 mM Tris (pH7.6) (v/v) in H20), loaded and run for 20-30 minutes at 130 V using a Bio-
Rad model 200/2.0 power supply and Bio-Rad wide min-sub cell GT gel electrophoresis apparatus. The 
appropriate DNA fragments could then be cut out and purified from the agarose gel.  
 
Ligation of Plasmid Vector and Insert DNA 
Ligation of the vector backbone and newly generated site directed mutant insert was undertaken using 
T4 DNA ligase (Fermentas), which catalyses the formation of covalent phosphodiester linkages 
between the free 5’ phosphate and 3’ hydroxyl ends of opposing double stranded DNA. DNA ligase 
joins blunt end and sticky end termini as well as repairing single gaps in double stranded DNA. 
Transformation of newly ligated DNA was carried out using chemically competent E. coli cells as 
described previously.  
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Standard PCR Conditions 
In order to create a sufficient amount and concentration of DNA to enable successful HEK293 cell 
transfection, PCR was used to amplify selected regions of DNA. The PCR was carried out in 50μl 
reactions containing 0.25µl of Taq DNA polymerase (Fermentas), 5µl of 10x reaction buffer 
(Fermentas), 1µl of 10mM dNTPs at (NE BioLabs), 1.25µl each of forward and reverse primers (10uM), 
1.5µl of MgCl2 (50 mM), 5µl of DNA solution at 10ng/ µl and DEPC water to make a final volume of 
50µl. Reactions were then run for 1 minute at 95 OC as a DNA denaturing step, followed by 25 cycles 
using annealing temperatures appropriate for the primers. The Tm was calculated using the Stratagene 
formula (Hogrefe et al., 2002) (Equation 2.1) and 72 OC extension phases according to the length of the 
amplicon, approximately 1 minute per kb, followed by 7 minutes at 72 OC after the final cycle. 
 
2.3 Cell Lines 
2.3.1 Standard Cell Culture Passage Protocol 
The HEK293 cell line was maintained in Dulbecco’s Modified Eagle Medium (DMEM) high (25mM) 
glucose (GIBCO®, Invitrogen, 41965-039) + L-glutamine and Phenol Red supplemented with 10% (v/v) 
foetal calf serum (FCS) (GIBCO®, Invitrogen, 16000). Cells were maintained in 25 cm2 flasks, at 37 0C 
and passaged every 3-4 days at 70-90% confluency. All cell incubation at 370C was undertaken in 95% 
(v/v) air, 5% (v/v) CO2 unless otherwise stated. When deemed ready for passage, the medium was 
removed and discarded. Cells were then washed with 5ml of Hanks Balanced Salt Solution (HBSS) 
(GIBCO®, Invitrogen, 14175) and 0.5 ml of Trypsin-EDTA x1 (GIBCO®, Invitrogen, 25300) was added and 
cells incubated at 37 OC for 1-2 minutes. Cells detached when gently tapped and were re-suspended in 
1 ml of DMEM + 10% FCS by trituration using a sterile p1000 pipette. Once cells were re-suspended, 
150µl of cell suspension was added to 5mls of fresh DMEM + 10% FCS and transferred to a new 25 cm2 
flask. HEK293 cells were utilised between passage 1 and 30 to conserve native phenotype and 
transfection efficiency (Thomas & Smart, 2005). The HEK293 cell line was cultured in growth medium 
without the addition of antibiotics. 
 
2.3.2 Transfection of Cells using Lipofectamine2000 
Briefly, transfection is the process of incorporating exogenous nucleic acids containing genes into cells 
to enable the study of the effect of that gene or the product of the gene, which in many cases is a 
protein. Transfection of the HEK293 cell line with DNA coding for the BK channel constructs was 
undertaken to investigate the effects of amino acid mutation on channel function, as transfection 
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would result in the over-expression of the transfected BK channel construct. Cells were cultured on 
glass coverslips (Warner Instruments, No 1 Glass Coverslips, 15mm, round, 0.15mm ± 0.02mm 
thickness. CS-15R, 64-0703) in sterile 6 well tissue culture plates with 2 ml DMEM + L-glutamine with 
10% (v/v) FCS at 37OC until 40% confluent. For each transfection, 2μg of DNA and 5μl LipofectamineTM 
2000 (Invitrogen, 11668-019) were diluted separately in 50μl DMEM + L-glutamine without serum per 
well, and incubated for 5 minutes at room temperature. The DNA and Lipofectamine2000 reactions 
were then combined to create 100μl of DNA-Lipofectamine mix per well, with a final concentration of 
1μg/ml cDNA and 2.5μl/ml of Lipofectamine2000 and incubated for 20 minutes. 100μl of the DNA-
lipofectamine2000 complex in DMEM was added directly into the culture medium in each well. Cells 
were subsequently incubated for 24-48 hours at 37OC in preparation for experimental study. This 
protocol is in line with manufacturer recommendation (Ciccarone 1999; Invitrogen Life Technologies 
2014) and previous work on BK channel expression in HEK cells (Tian, Duncan, et al., 2001; Chen et al., 
2005; Tian et al., 2006). 
 
2.3.3 HEK293 Cell Treatments 
Cells were maintained in 25mM glucose growth medium; 24 hours after transfection, cell medium was 
replaced as necessary to achieve treatment conditions. For glucose concentration experiments, cell 
medium was removed and replaced with fresh 25mM glucose or changed to 5mM glucose growth 
medium (Figure 2.16). For alteration of fatty acid content, 641mg palmitic acid (Sigma, P0500) was 
added to 10ml of 100% (v/v) ethanol to create a 250mM stock solution; 200μl of this solution was then 
added to 10ml growth medium (no BSA) heated to 37OC being vigorously swirled, thus creating a 5mM 
solution. Subsequently, 80μl of solution was added per ml of media to give a final concentration of 
0.4mM and 0.16% ethanol content. During dissolution, growth medium was maintained at 37 OC to 
avoid palmitate precipitation. Oleate treatment was conducted in the same manner as for palmitate; 
however, for creation of the 250mM stock solution, 793µL (0.706g) of oleic acid (Sigma-Aldrich, O1008) 
was added to 10mls of 100% (v/v) ethanol. It has been shown in the literature that HEK 293 cells can 
be exposed to ethanol at concentrations of up to 0.2% (v/v) without detriment (Hannah et al., 2001; 
Hallak and Rubin, 2004; Diaz et al., 2011). Comparison of BK channel expressing HEK293 cells, cultured 
in a) 25mM glucose growth medium and b) 25mM glucose growth medium containing ethanol at 0.16% 
(v/v) within this study did not result in a significant difference in channel cell membrane expression.  
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Figure 2.16- Schematic of Cell Culture and Treatment Protocol. 1). Cells cultured in 25mM glucose are 
seeded onto coverslips in 6 well plates and incubated for 24 hours. 2) Cells were transfected in 25mM 
glucose and incubated for a further 24 hours. 3) Cells were split into two groups, 25mM glucose and 
5mM glucose, with one third of each group being supplemented with palmitate, or oleate, to a final 
concentration of 0.4mM. Cells were incubated for a further 24 hours. 4) Cells were then fixed and 
immunofluorescently labelled. 
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2.4 Immunofluorescent Protein Labelling in HEK 293 cells transfected with BK channel 
constructs 
Transfected HEK293 cells were prepared for immuno-fluorescent protein labelling 48 hours after 
transfection; the major steps in the procedure are highlighted in figure 2.17. In order to label BK 
channel constructs that were at cell surface and those located in the intracellular compartments, the 
following procedure was undertaken.  
Labelling of BK channels located at cell membrane of HEK 293 cells. Existing medium was removed 
from each well of a 6-well plate and HEK 293 cells washed with fresh DMEM L-glutamine + 10% (v/v) 
FCS to remove any remaining transfection mixture. The primary antibody, (Monoclonal ANTI-FLAG® 
M2 antibody produced in mouse, Sigma, F1804) was diluted 1:100 in DMEM + L-glutamine + 10% (v/v) 
FCS and 1ml was added to each well. Cells were then incubated for 120 minutes at 4ºC to label the 
FLAG antigen and to inhibit protein recycling at the cell membrane. This step resulted in the binding of 
the anti-FLAG antibody to the FLAG antigen tag on the N-terminal of BK channels located at the cell 
membrane, as is shown in Figure 2.17 step 3. The medium was then removed and cells were washed 
once again with fresh DMEM L-glutamine + 10% (v/v) FCS.  
The secondary antibody, Alexa Fluor® 546 (red) conjugated donkey, anti-mouse IgG antibody 
(Invitrogen / Molecular Probes A11036) was diluted 1:1000 in DMEM + L-glutamine + 10% (v/v) FCS 
and 1ml added to each well, this was then incubated at 4°C for a further 60 minutes in the dark, in 
order to add the fluorophore to the BK channels at the cell membrane. This step resulted in the binding 
of the secondary antibody (Alexa Fluor® 546) to the anti-FLAG primary antibody, located at the N-
terminus of BK channels located at the cell membrane, as is shown in Figure 2.17 step 4. Successfully 
labelled channels emit red fluorescence when imaged using confocal microscopy, and are 
representative of membrane bound BK channels.  
Labelling of BK channels located intracellularly in HEK 293 cells. Cells were then washed, gently, 3 
times with 1ml of PBS to remove any remaining antibody, in preparation for fixing with 4% (w/v) 
paraformaldehyde in PBS solution with 2ml added to each well; this was left for 30 minutes in the dark, 
at room temperature to fix the cells, before cells were washed with 1x PBS buffer. Cell membrane 
permeabilisation was accomplished by treating cells with 0.3% (v/v) Triton X-100 (Sigma-Aldrich, X100) 
in PBS at room temperature for 10 minutes (Figure 2.17 step 5). The reaction was blocked with 1x PBS 
buffer, then 3% (w/v) Bovine Serum Albumin (BSA) (Sigma-Aldrich, 05470) in 1x PBS buffer and 0.05% 
(v/v) Triton X-100 for 60 minutes. The cells were then rinsed with PBS. For the double FLAG tag 
methodology, cells were then incubated either overnight at 4ºC, or for 1 hour at room temperature 
with 1ml of primary antibody, diluted 1:100 in DMEM + L-glutamine + 10% (v/v) FCS. As the cell 
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membrane of the HEK 293 cells had been permeabilised in the previous step, this allowed access of 
larger molecules, in this case antibodies, into the intracellular space. Therefore, exposure of the cells 
to the anti-FLAG antibody post-permeabilisation resulted in the binding of the antibody to the FLAG 
antigen tag on the N-terminus of BK channels located within the cells, as is shown in Figure 2.17 step 
6. The BK channels located intracellularly were not tagged during initial exposure to the anti-FLAG 
antibody (step 3) as the cell membrane was not permeable to the antibody.  
Cells were then washed once again with 1 ml PBS and incubated with an alternate secondary antibody, 
Alexa Fluor® 488 (green) Goat Anti-Mouse IgG (H+L) Antibody (Invitrogen / Molecular Probes A11017) 
in a 1:000 dilution for 60 minutes, in the dark, at room temperature. This step resulted in the binding 
of the secondary antibody (Alexa Fluor® 488) to the anti-FLAG primary antibody, located at the N-
terminus of BK channels located intracellularly, as is shown in Figure 2.17 step 7. Successfully labelled 
channels emit green fluorescence when imaged using confocal microscopy, and are representative of 
intracellular BK channels. Figure 2.17 step 8 provides an illustration of a HEK 293 cell with a labelled 
and fluorescing BK channel located at the cell membrane (red) and a BK channel located within the 
intracellular space (green). Although the BK channels expressed contain a C-terminal HA antigen tag, 
this wa not utilised as a tagging site; a double FLAG tagging method is utilised. 
The coverslips were then washed with 1x PBS buffer, followed by distilled water to prevent crystal 
formation, and two coverslips mounted onto one labelled 26mmx76mmx1mm glass slide (Thermo 
Scientific, MNJ-150-030U) with ProLong Gold Antifade Mountant (Invitrogen / Molecular Probes, 
P36930). Slides were stored in the dark to minimise fade. 
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Figure 2.17- Schematic of double FLAG fluorescent tagging methodology using primary and 
secondary antibodies. 1) Diagram of an idealised HEK 293cell showing membrane bound and 
intracellular BK channels 2) FLAG and HA antigen tags highlighted 3) Mouse Anti-FLAG primary 
antibody binds to extracellular FLAG antigen. 4) Anti-mouse secondary antibody with attached Alexa 
Fluor 546 (red) binds to the mouse primary antibody. 5) Cells are fixed using 4% paraformaldehyde, 
cell membrane permeabilized using 0.3% (v/v) Triton X. 6) Cells are re-incubated with Mouse Anti-
FLAG primary antibody which now can access intracellular FLAG antigen. 7)Anti-mouse secondary 
antibody with attached Alexa Fluor 488 (green) binds to the mouse primary antibody attached to 
intracellular BK channels 8) Overview of cell showing permeabilized cell membrane and fluorescently 
tagged membrane bound and cytoplasmic BK channels. Concept adapted from (Mattanovich and 
Borth, 2006).  
77 
 
2.5 Imaging Protocols 
2.5.1 Confirmation of Fluorescence-Labelling of HEK Cells 
HEK293 cells transiently expressing BK channel constructs due to successful transfection, can be traced 
as a result of fluorescent labelling of FLAG antigen tags. Therefore, to confirm the presence of cells 
labelled with fluorescent probes a preliminary screen was undertaken using a standard epifluorescent 
Nikon ECLIPSE TE200 microscope. Coverslips were viewed under white light to detect areas with 
adherent cells.  These cells were then examined for fluorescence under a 100x/1.3 Planar Fluor lens at 
excitation wavelengths 488 and 532 nm; coverslips containing fluorescent cells were marked and 
retained for confocal imaging.  
 
2.5.2 Confocal Imaging of fluorescently-labelled cells 
Once cells had been shown to be fluorescently labelled, indicating that they were successfully 
expressing tagged BK channels, images were acquired using a Zeiss Axiovert confocal laser scanning 
microscope (LSM510) operating with a 25mW argon laser tuned to 488 and 532 nm. Coverslips were 
examined initially under 20x magnification to locate fluorescing cells, then a Zeiss plan-apochromat 
1.4 NA x63 oil immersion objective lens was used to obtain confocal images. In order to obtain images 
that would allow for analysis of labelled BK channel distribution, Z-stacks comprising z-sections 
collected at 0.34-0.5μm intervals were acquired (Figure 2.18). HEK cells with intact membranes within 
a particular FOV were imaged in multi-tracking mode as has been used commonly in other studies 
(Barden et al., 2003; Ishiwata et al., 2004; Sun et al., 2010; Sheng and Acquaah-Mensah, 2011; Li et al., 
2013). Areas with pixel saturation were avoided by using the ‘range indicator’ function of the LSM510 
software package. Saturated areas in the FOV identified during image analysis were excluded using the 
‘region of interest’ (ROI) function available in the ImageJ software package. Gain and offset settings 
were optimised to the first sample of the control group as to utilise as much of the detector dynamic 
range as possible; these settings were constant and were used to image the remainder of the control 
group samples and treatment group samples from the same experiment set.  
An exemplar single slice confocal image of HEK293 cells transiently expressing the BK channel ZERO 
construct, fluorescently tagged via double FLAG tagging with Alexa Fluor 546 (red) indicating BK 
channels at the cell membrane and Alexa Fluor 488 (green) indicating BK channels intracellularly is 
shown in Figure 2.19.   
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Figure 2.18- Schematic of Confocal Z-Stack Image Acquisition. 1) Cell/cells in the FOV with prospective 
locations of optical slices. 2) Cross section of cell/cells, indicating that there is a tangible distance 
between slices and that each slice has a thickness. 3) The slice highlighted in red has been removed 
and presents a cross section of the cell/cells.  
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Figure 2.19- Single slice confocal image of HEK293 cells transiently expressing the BK channel ZERO 
construct. BK channels were fluorescently tagged via double FLAG tagging with Alexa Fluor 546 (red) 
indicating BK channels at the cell membrane and Alexa Fluor 488 (green) indicating BK channels 
intracellularly. Image corresponds to the schematic in (Figure 2.17, 8) and in (Figure 2.18, 3).  
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2.6 Quantification of Immunofluorescent labelling 
Quantification of FLAG surface expression was undertaken using a double FLAG  tagging methodology. 
As demonstrated in Figure 2.17, the exposed FLAG-tagged N-terminus of the BK channel, situated 
outside the cell membrane was tagged with Alexa Fluor® 546 red fluorophores. Red fluorescence was 
taken as representative of all of the BK channels located in the membrane at the time prior to 
permeabilization. After fixing, the cell membrane was permeabilized allowing previously inaccessible 
intracellular Flag tags to be tagged with Alexa Fluor® 488; as a result, green fluorescence was therefore 
attributed to BK channels located intracellularly.  
Confocal images were stored as LSM files which were then exported to the image processing software 
ImageJ for analysis (Abràmoff, Magalhães and Ram, 2004; Rasband, 2012; Schindelin et al., 2012) 
where the signal was converted to a 16-bit data file (8- bit image for red and green channels). The red 
and green channels were split, a region of interest (ROI) selected and background fluorescence 
removed using the ‘Remove Background’ function inbuilt into the software. Using ‘Stack Interlever’ 
and ‘Multi-Measure’ functions, the average red and green fluorescence for each confocal slice was 
calculated.  
To determine the proportion of BK channel located in the membrane in comparison to the total 
amount of BK channel produced, the ‘Raw Ratio’ (RR), which represents the cell membrane expression 
of the BK channel, was calculated. This was achieved by dividing the fluorescence from the red channel 
by the total of the red plus green channel. Results were also normalised to those of a selected group, 
resulting in that group being represented as 100% or 1, and the test group being expressed as plus or 
minus that value (Equation 2.2).  
 
 
Equation 2.2- Formula to Calculate Raw Ratio and Normalised Raw Ratio for the BK channel.  
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Normalisation of CSS-Palm 4.0 score for BK channel cysteine residues  
To enable comparison of the pattern of cell membrane expression of the SNP-mimetic mutants H55Q, 
G57A and H55Q:G57A to the pattern of C56 predicted palmitoylation for each of the mutants, the CSS-
Palm 4.0 scores were normalised. This was achieved by dividing the predicted C56 palmitoylation score 
for each of the mutants by the C56 palmitoylation detection threshold. The value for each was then 
normalised to the value of the wild type channel (ZERO), to a value of 1, representing 100%.  
 
Statistical Analysis 
Statistical analysis was performed using the GraphPad Prism® software package. All results are 
expressed as mean values ± standard deviation (SD). Experiments containing two groups were assessed 
using a Students T-Test with Welch’s correction to account for the possibility that groups have unequal 
variances. Experiments containing three or more groups were assessed using one-way ANOVA, 
assuming Gaussian distribution of sample data. Tukey’s post-hoc analysis was undertaken to compare 
the means of each test group. P-values equal to or below 0.05 were considered significant (P≤0.05).   
To measure the strength of the association between the cell membrane expression of BK channel 
constructs ZERO and the SNP-mimetic mutant channels (expressed as normalised raw ratio) and the 
corresponding normalised CSS-Palm 4.0 score for the constructs, the Pearson’s correlation coefficient 
(PCC) was calculated. This was achieved by analysing the values using the ‘Correlation’ function 
contained within the ‘analyse’ option within the GraphPad Prism® software package. The Pearson’s 
correlation coefficient was also calculated to assess the extent of co-localisation between red and 
green fluorescence emitted from HEK293 cells expressing FLAG tagged BK channels (red fluorescence 
is representative of cell membrane located BK channels and green representative of intracellular BK 
channels). This was achieved by utilising the ‘Colocalization’ plugin contained within the ImageJ 
software package to analyse confocal images of the transfected HEK293 cells. Coefficient values for 
PCC range from 1 to -1. A value of 1 indicates a complete positive correlation between the two channels 
(as red increases, green increases), whereas -1 indicates a negative correlation (as one increases, the 
other decreases). A score of 0 indicates no correlation.  
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2.7 Critical appraisal of key methodologies  
Selection of bioinformatics methodology  
There are a number of studies in the literature that support the utilisation of a bioinformatics 
methodology to prioritise SNPs (Lee, 2009; George Priya Doss et al., 2010; Cline and Karchin, 2011; Liu, 
Jian and Boerwinkle, 2011; Teng et al., 2012; Bryzgalov et al., 2013; Ghaedi et al., 2015; Hepp, 
Gonçalves and de Freitas, 2015; Alipoor et al., 2016; Kalia et al., 2016). Significantly less investigation 
has focussed on SNP prioritisation in potassium channels; however, an interesting example is a 2011 
publication that aimed to prioritise SNP occurring on the Kv channel (Stead et al., 2011), due to the 
occurrence of clinically significant nsSNP occurring on the channel that cause cardiac 
arrhythmogenesis, sudden cardiac death, Long QT Syndrome, and finally epilepsy, which is also linked 
with BK channel nsSNP (Du et al., 2005).  
Stead et al utilised a machine learning bioinformatics methodology with a training dataset that 
assessed 14 factors to prioritise SNPs, and focussed on the 5 most accurate of the 14 which were; a) 
amino acid conservation score, b) change in hydrophobicity, c) change in structural stability, d) change 
in Hidden Markov Models (HMM) score (the probability that the amino acid sequence is a member of 
the protein family) and e) subfamily membership. As part of this current investigation, 4 different 
parameters were investigated in the process of SNP prioritisation that focus on functional and 
experimental data specific to the BK channel; a) site directed mutagenesis (SDM) data, b) the functional 
role of the SNP site, c) PTM data and d) SNP sites with clinical evidence. Selection of the most optimal 
parameters to predict the effect of a SNP is challenging; the majority of tools utilise assessment 
parameters based solely upon ortholog sequence and structure (Sim et al., 2012; Martin, 2016); 
however the inclusion of additional protein specific information has been shown to increase SNP 
damage prediction accuracy (Stead et al., 2011; Teng et al., 2012). This supports the use of BK channel 
specific information to improve the accuracy of SNP prioritisation, as was conducted in this 
investigation.  
The machine learning method is argued to be an advancement on manual methods due to an increase 
in the number of sites that can be analysed, a reduction in analysis time, and increased complexity of 
parameters tested (Huang et al., 2017). However, there are limitations as an automated method relies 
on algorithms developed with training data produced by lab-based experimentation; these datasets 
may be incomplete or not be up to date, potentially resulting in inaccurate results. Thus, a method 
that includes the use of machine learning bioinformatics tools, such as CSS-Palm 4.0 and NetPhos 2.0, 
alongside manual annotation with data extracted from the literature, and lab-based verification of 
prioritised SNPs serves to minimise inaccurate results.  
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Selection of a suitable mammalian expression system for BK channel expression 
For ion channel research, a recombinant expression method that allows for the study of the structure, 
function, localisation and interactions of channels in mammalian cells that construct, process and fold 
proteins using their endogenous machinery is the most appropriate approach. The Human Embryonic 
Kidney 293 (HEK 293) cell line was used as it expresses the biochemical machinery to conduct the post-
translational folding and processing required to produce functional proteins from a wide range of 
mammalian nucleic acids (Hames and Higgins, 1999; Thomas and Smart, 2005; European Molecular 
Biology Laboratory, 2014; Thermo Scientific, 2014). HEK293 cells do not endogenously express BK 
channels (Tian, Hammond, et al., 2001), therefore only the BK channel constructs introduced via 
transfection will be manufactured by the cells and thus will be the only BK channels involved in analysis. 
In addition, expression systems provide an environment where assessing the effects of amino-acid 
substitution in proteins via site-directed mutagenesis is possible (Braun and Sy, 2001; McCartney et 
al., 2005; Jianxi Liu et al., 2008; Jeffries et al., 2010; Bi, 2014). 
Although there is value in conducting investigations in cells that endogenously express the BK channel 
such as smooth muscle cells (Brayden and Nelson, 1992) or neuronal cells (Knaus et al., 1996), HEK293 
cells are ideal cell candidates to achieve the thesis research objectives as BK channel DNA mutation 
was required. HEK293 cells have been successfully utilised as an expression system for the BK channel 
for over a decade (Ahring et al., 1997; Shipston et al., 1999; Shipston, 2001; McCartney et al., 2005; 
Jeffries, 2010; Bi, 2014); however, other mammalian expression systems have been used for 
experiments using the BK channel, such as the ‘COS’ cell line, a fibroblast-like cell line derived from 
monkey kidney tissue (Won et al., 2010; Won, Lee and Park, 2011; Kim et al., 2014).  
 
Selection of a suitable BK channel cellular distribution assessment method  
The BK channel has been investigated extensively using patch-clamp electrophysiology (Berweck et al., 
1994; Ahring et al., 1997; Raffaelli et al., 2004; Pyott et al., 2007; Naruse, Tang and Sokabe, 2009; 
Jeffries, 2010; Kim et al., 2014); this has been essential for characterisation of the channel and 
understanding the effects of different environments, exposure to ion channel modulators and the role 
of conserved regions of the channel. Whilst an electrophysiology approach can provide details of BK 
channel function and kinetics, it cannot provide information on the location and proportional 
distribution of total BK channels inside the cell and in the cell membrane, which are the objectives of 
the study. For proper function, the BK channel must insert into the membrane; therefore, factors that 
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affect this are worthy of investigation. Therefore, this study utilised an imaging based screen in 
preference to electrophysiology.  
Confocal microscopy in combination with immunofluorescent protein labelling; used to determine the 
location of BK channels in HEK293 cells (as either in the cell membrane or in the intracellular space) 
and to quantify the ratio of BK channels in the cell membrane in comparison to total. This method has 
been utilised successfully to investigate BK channel cellular expression (Williams et al., 2004; Rüttiger 
et al., 2004; Samaranayake et al., 2004; Chen et al., 2005, 2010, Tian et al., 2006, 2008, 2010; Pyott et 
al., 2007; Kim, Alvarez-Baron and Dryer, 2009; Ridgway, Kim and Dryer, 2009; Chiu et al., 2010; Jeffries 
et al., 2010; Tajima et al., 2011; Föller et al., 2012). 
To successfully use confocal microscopy the protein of interest must be fluorescently tagged. As shown 
in Figure 2.17, the BK channels used in this study were N-terminally tagged with the FLAG antigen tag, 
and C-terminally tagged with the HA tag. To attach fluorophores to the BK channel, a FLAG-FLAG 
antibody tagging methodology in combination with secondary tagging with Alexa Fluor®  fluorophores 
was utilised, where fluorophores were attached to N-terminal the FLAG tag only, on both membrane 
bound and cytosolic BK channels using surface and permeabilised labelling, as was undertaken in a 
2013 study (Chen et al., 2013). Use of the same antibody removes the potential challenge of differing 
antibody sensitivities affecting results, however FLAG-HA tagging has been used in other BK 
investigations (Erxleben et al., 2002; Tian et al., 2006; Tong et al., 2006; Huang and Ma, 2010; Jeffries, 
2010; Jeffries et al., 2010; Chang et al., 2011; Kim and Dryer, 2011). There was a theoretical possibility 
that surface BK channels could be tagged during the permeabilised tagging steps, leading to an 
overassessment of the number of cytosolic channels; therefore, a co-localisation assessment was 
undertaken. Other fluorophores have been used in BK channel investigations, such as yellow 
fluorescent protein (YFP) and green fluorescent protein (GFP) (Chen et al., 2005; Kim, Choi and Dryer, 
2008; Tian et al., 2008, 2010; Li et al., 2009; Jeffries et al., 2010).  
Another method of assessing the cellular distribution of BK channels in would be to grow, transfect 
and fluorescently tag the HEK293 cells on a 96- well plate, with fluorescence intensity measured using 
a micro plate reader (Chiu et al., 2010; Hei et al., 2016). This would dramatically reduce the time taken 
to capture BK channel membrane expression in comparison to confocal microscopy, and enable the 
capture of fluorescence from the total sample, completely removing any selection bias. In addition, 
thousands of cells could be analysed per experiment, however less detailed information would be 
collected in comparison to confocal microscopy, and the location of BK channels within the cell could 
not be assessed with the same accuracy.  
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Flow cytometry can be used for cell counting and to measure multiple physical characteristics of a 
single cell such as size, granularity and biomarker detection simultaneously as the cell flows in 
suspension (Adan et al., 2016). Like confocal microscopy, flow cytometry utilises lasers to detect 
fluorescently tagged proteins within or on the surface of a cell. As cells are in a flow, reducing the time 
in contact with the laser in comparison to confocal microscopy, fluorophores with the same excitation 
wavelength, but different emission wavelength are desired, such as. Alexa 488 and R-PE. Flow 
cytometry has been used to quantify BK channel expression (Ge et al., 2012; Tao et al., 2015; Warsi et 
al., 2015), and an advantage of flow cytometry is it can achieve multi-factorial analysis, however it 
cannot provide visualisation of the location of the BK channel in HEK293 cells, as required to fulfil the 
objectives of the study.  
Western blotting has been used to quantify the absolute amount of BK channel protein in the cell (Ling 
et al., 2000; Meredith et al., 2004; Chen et al., 2005, 2010; Tong et al., 2006; Naruse, Tang and Sokabe, 
2009; Jeffries et al., 2010; Tajima et al., 2011; Föller et al., 2012); this function is an advantage in 
comparison to confocal microscopy. Like confocal microscopy, Western blotting can determine the 
ratio of BK channels in the membrane in comparison to total, and uses of antibodies to isolate the 
channel from other proteins. This technique was used in a 2011 study (Kim and Dryer, 2011), where 
immunoblot cell surface labelling was utilised prior to cell lysing and anti-Slo tagging. Despite the many 
positives of Western blotting for protein quantification, it was not the optimum method to achieve the 
objectives of the thesis, because the location of the BK channel within the cell cannot be visualised in 
situ. 
 
Selection of HEK293 cell treatment conditions  
A reduction in extracellular glucose from 25mM to 5mM was chosen to assess the effect of glucose on 
BK channel membrane expression; this choice was driven by; a) 5mM being within the normal blood 
glucose range for humans (4mM to 6mM), and b) the fact that a considerable number of studies have 
used this concentration to test the effect glucose on different processes (Nutt and O’Neil, 2000; Moritz 
et al., 2001; Lin et al., 2005; Smith et al., 2006; Daoyan Liu et al., 2008; Chang et al., 2011; Sun et al., 
2013; Viskupicova et al., 2015), thus making the data outputs from this study comparable. 
Initially, the glucose concentration of the HEK293 cells was reduced from 25mM to 5mM at the seeding 
stage (Figure 2.16), however, the cells would tend to lift off the glass coverslips 48 hours later, during 
the process of immunofluorescent tagging (due to frequent coverslip washing steps), thus preventing 
further cell analysis. To combat this, the coverslips were coated in poly-L-lysine (Sigma-Aldrich P9155) 
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in an attempt to increase cell adhesion; this was however unsuccessful. The method was then 
optimised for a glucose concentration change at transfection stage which was also unsuccessful. 
Finally, the glucose concentration was altered at the cell treatment stage, which dramatically improved 
cell adhesion during cell washing, allowing immunofluorescent tagging and completion of cell analysis 
via confocal microscopy. 
The concentration of palmitate to be used in the investigation was 0.4mM as it is within the range 
found endogenously in human plasma (0.3mM to 4.1mM) (Abdelmagid et al., 2015), and is within the 
palmitate concentration range commonly used in research publications (0.2mM to 0.5mM) (Luiken et 
al., 1997; Staiger et al., 2004; Weigert et al., 2004; Bunn et al., 2010; Oberbach et al., 2012; Schilling et 
al., 2013; Weikel et al., 2014). The endogenous human plasma concentration of oleate is in the range 
of 0.03mM and 3.2mM (Abdelmagid et al., 2015). In addition, it was important that the concentration 
of palmitate was the same as oleate, to remove fatty acid concentration as a potential cause of 
membrane expression differences. Therefore, it was decided that a concentration of 0.4mM oleate 
would be used to investigate the impact of an unsaturated fatty acid on BK channel construct cellular 
distribution. 
There were initially some challenges in the production of growth media containing 0.4mM palmitate, 
as the fatty acid would precipitate out when added to the media from the ethanol stock solution. In 
order to combat this, the creation of BSA conjugated-palmitate was attempted, as has been used in 
publications (Haim et al., 2010; Lee et al., 2013; Weikel et al., 2014). Unfortunately, the protocol was 
not successful due to denaturing of the BSA during the conjugation process. A palmitate-BSA conjugate 
formulation was available for purchase (Agilent 102720-100), however it was not economically feasible 
to use this product for the study. Therefore, another method of palmitate dissolution was attempted, 
where the concentration gradients between dissolution steps were halved and the temperature of the 
growth medium was increased from room temperature to 37 OC to aid palmitate dissolution; this 
method was successful. The duration of metabolic substrate treatment was set at 24 hours, this time-
scale is in line with a number of publications that demonstrated a substrate mediated effect (Peiró et 
al., 2001; Chang et al., 2011; Kim and Dryer, 2011; Su et al., 2013).  
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3 Bioinformatics  
3.1 Introduction 
In this chapter, the focus is twofold: to capture key aspects of data relating to BK channels held on 
bioinformatics databases, and to use this information to prioritise potentially damaging single-
nucleotide polymorphisms (SNPs) for lab-based experimentation. 
SNPs have a proven effect on BK channel function; current evidence shows that BK channel SNPs 
associated with disease cause either a gain or loss of function and are found within the exonic, protein 
coding region of the gene. An example of a gain of function mutation of the BK channel is the non-
synonymous SNP (nsSNP) D434G, characterised in both the human and murine form of the channel 
(Du et al., 2005; Wang, Rothberg and Brenner, 2009; Yang et al., 2010). This mutation is responsible 
for the genetic disorder Generalized Epilepsy and Paroxysmal Dyskinesia (GEPD), and arises as a result 
of the substitution of an aspartic acid amino acid residue for a glycine residue in the conserved cytosolic 
linker region in the C-terminus, downstream from the S6 transmembrane domain (Yang et al., 2010). 
The mutation results in reduced activation time and enhanced channel calcium sensitivity as a result 
of increased calcium affinity (Du et al., 2005; Díez-Sampedro et al., 2006; Lee and Cui, 2009; N’Gouemo, 
2014). The mechanism behind this increased calcium sensitivity is proposed to be reduced flexibility of 
the AC region in the RCK1 domain (Yang et al., 2010). Conversely, the BK channel nsSNP A138V located 
in the intracellular S0-S1 linker has been associated with a loss of function of the channel; in this case, 
the substitution of valine for alanine is associated with autism and mental retardation (Laumonnier et 
al., 2006). The biomolecular activity that is associated with this change in channel sequence is yet to 
be elucidated, however it is postulated that the mutation creates a ‘cryptic’ splice site, a 
disadvantageous splice site that is dormant or used only at low levels unless activated by mutation, 
that results in impaired channel expression (Guglielmi et al., 2015).  
Genome wide association (GWA) studies have provided evidence that DNA mutations occurring 
outside of  exonic regions, in the intronic regions of the BK channel gene are associated with diseases 
such as diabetes, obesity and increased blood pressure (Tomás et al., 2008; Jiao et al., 2011). However, 
unlike mutations D434G and A138V, there is no published evidence of direct effects of these intronic 
region mutations on BK channel function. However, obesity was linked to increased RNA expression of 
the BK channel in adipose tissue (Jiao et al., 2011). 
Some gene mutations associated with or proven to cause disease, such as D434G, have been identified 
by exome screening patients presenting with the signs and symptoms of disease, and determining the 
common genetic variations in those patients. This method, whilst informative and effective, is costly 
and time consuming (Sastre, 2014). In addition, the challenge with the method is that the number of 
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SNPs occurring across even single genes, such as the BK channel, is overwhelming (in the region of tens 
of thousands), making it difficult to identify common genetic variations or patterns of genetic variation 
between the subjects with the disease (Schrijver et al., 2012; Bertier, Joly and Hétu, 2016; Petersen et 
al., 2017). Thus, a screen of genetic information associated with the BK channel gene, incorporating a 
prioritisation system ‘in silico’, to focus on the variations with a high probability of affecting channel 
function, may help overcome these time and cost barriers. This would involve the analysis of available 
free to access information as an alternative to the costly collection of additional data. This approach 
has been utilised in other studies, for example for the prioritisation of a) SNPs perturbing microRNA 
regulation (Ghaedi et al., 2015), b) SNPs occurring in Toll-like receptors (Alipoor et al., 2016), and c) 
SNPs involved in gene regulation (Teng et al., 2012).  
To effectively prioritise BK channel SNPs, there are key aspects of the channel that need to be mapped, 
as SNP proximity to key structural and functional regions may be an indicator of potential effect. The 
amino acid composition and amino acid location of the foundation structural units and functional 
domains of the human BK channel have previously been established (Adelman et al., 1992; Dworetzky, 
Trojnacki and Gribkoff, 1994; Pallanck and Ganetzky, 1994; Tseng-Crank et al., 1994; McCobb et al., 
1995; Meera et al., 1997). However, this information is yet to be collated into a resource where the 
relative locations of the regions can be easily cross referenced. Therefore, one aim of this chapter is to 
synthesise and present structural and functional information in a format that allows the locations of 
regions to be compared at a glance. This is particularly important for the bioinformatics approach to 
SNP prioritisation as it enables SNP proximity to functional and modulatory motifs, and the potential 
impact of this proximity on BK channel function to be established. The 3D structure of the BK channel 
has been resolved at 3.5 angstrom using crystallography and cryo-electron microscopy (Jiang et al., 
2002; Wang and Sigworth, 2009; Yuan et al., 2010; Hite, Tao and MacKinnon, 2016; Tao, Hite and 
MacKinnon, 2016). Whilst the 3D structure of the BK channel is important for understanding the spatial 
interactions between amino acids and chemical groups, the effect of mutagenesis and SNPs on the 3D 
structure of the BK channel will not be included in this thesis work.  
Post translational modifications (PTMs) have been established as having regulatory and modulatory 
effects on BK channel function (see reviews by Kyle & Braun 2014; Shipston & Tian 2016). Identifying 
the location of sites of PTM on the BK channel is important for interpreting the possible effects of SNPs. 
The proximity of SNPs to key PTM sites of channel activity or cell membrane translocation (Tian et al., 
2004; Jeffries et al., 2010) may disrupt these functions. Sites of PTM can be predicted using 
bioinformatics software (Blom, Gammeltoft and Brunak, 1999; Gupta, Jung and Brunak, 2002; Ren et 
al., 2008; Xue, Liu, Gao, et al., 2010; Q. Zhao et al., 2014) or verified experimentally using techniques 
such as mass spectroscopy or site directed mutagenesis. 
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Site directed mutagenesis (SDM) is a synthetically mediated change in the amino acid composition of 
a protein at a specific location, which can affect single or multiple amino acid residues. The mutated 
protein is then assessed for effect on a single function (such as membrane translocation) or multiple 
factors (such as membrane translocation and ion channel activity). The results of SDM are published 
in peer reviewed articles and held on databases containing secondary protein information, such as 
UniProt. The software to compile and classify the results of SDM and add them to bioinformatics 
databases exists, however have not been widely applied.  
Several nsSNPs have been proven to cause perturbations to BK channel function (Du et al., 2005; Díez-
Sampedro et al., 2006; Wang, Rothberg and Brenner, 2009; Yang et al., 2010; N’Gouemo, 2014) and it 
is plausible that there are other function-altering nsSNPs on the channel that have not yet been 
identified or associated with a functional change or disease. Therefore, in an effort to identify 
potentially damaging nsSNPs, this work will collate the predicted damage score for each SNP using SIFT 
and PolyPhen-2 predictive software programs (Kumar, Henikoff and Ng, 2009; Adzhubei et al., 2010) 
and this information will then be added to the annotated BK channel amino acid sequence.  
 
Chapter Aims 
The aims in this chapter will be achieved by completing the following objectives; 
1. Map the locations of structural and functional sites on the BK channel amino acid sequence 
2. Identify the amino acid locations of predicted and verified post-translational modification sites 
and map them on the BK channel sequence  
3. Identify the locations and consequences of site-directed mutagenesis investigations of the BK 
channel 
4. Identify the number and locations of non-synonymous SNPs, and map them on to the BK 
channel amino acid sequence.  
5. Establish the extent of co-localisation between nsSNP and of structure, function, PTM and SDM 
sites on the BK channel 
6. Prioritise BK channel nsSNP for further in-depth bioinformatics analysis, by investigating 
aspects such as nsSNP frequency, background information of the individual/s and effect on 
local PTM environment   
7. Select SNPs for lab based investigation as part of this thesis.  
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3.2 Results 
3.2.1 The location of the human BK channel gene 
A database search was undertaken to determine the molecular location and cytogenic location of the 
human KCNMA1 gene. The ‘molecular location’ refers to a gene in terms of the chromosome and base 
pair number; in this format, the initial number is the chromosome number and the succeeding number 
is the location given as a base pair coordinate. The Ensembl database listed the human KCNMA1 gene 
to be 768,994 base pairs in length, spanning from 10: 78,629,359 to 10: 79,398,353 on the reverse 
strand (Figure 3.1A). The cytogenic reference for the human KCNMA1 gene (which is based upon the 
gene location on the chromosome relative to the chromosome structure and banded regions that 
appear on the chromosome after staining) was found to be 10q22.3; the initial number refers to the 
chromosome number (10q22.3), whilst the letter indicates on which arm of a chromosome the gene 
is found, using the centromere as a reference point (p=short or q=long). A distinctive set of bands 
appear when the chromosome is Giemsa stained (Seabright, 1971) and the final set of numbers 
(10q22.3) denote in which band the gene is located. Once the location of the gene was established, a 
database search was conducted to determine the number and nature of transcripts associated with 
the gene. 
 
3.2.2 BK channel transcripts 
The process of transcription and translation of a single gene can lead to the production of multiple 
forms of a protein, referred to (often ambiguously) as transcripts, protein isoforms or splice variants. 
For this reason, a search of Ensembl and UniProtKB databases was undertaken to determine to what 
extent alternative splicing occurs with the human KCNMA1 gene. There were 23 transcripts identified; 
19 of these transcripts code for a protein and are successfully translated into a BK α-subunit (protein 
coding) and 4 of these are processed transcripts that form a long, non-coding RNA sequence not 
translated into an α-subunit protein (Figure 3.1B). The 19 BK α-subunit transcripts, coded for by the 
KCNMA1 gene, varied greatly in length, ranging from 128 amino acids (ENSP00000475086) to 1288 
amino acids (ENSP00000385717). Of the 19 protein coding isoforms for the KCNMA1 gene, 5 were 
members of the human consensus coding sequence CCDS (Pruitt et al., 2009); (ENSP00000385806, 
ENSP00000286628, ENSP00000474686, ENSP00000475086 and ENSP00000286627).  
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Figure 3.1- Schematic of BK Channel Gene Location and Transcript Overview. A) A schematic of 
human chromosome 10 is shown annotated at position 10q22.3 with the location of the BK channel α-
subunit gene, KCNMA1, highlighted with a pink box. The molecular location of KCNMA1 is 
10:78,629,359 to 10:79,398,353 and is 768,994 base pairs in length. Data was extracted from Ensembl 
Database webpage as a result of a search for the human BK channel gene, KCNMA1. Figure adapted 
from 'Region in detail' tab of gene ENSG00000156113 on the Ensembl database. B) Summary of 
KCNMA1 transcripts. There were 23 BK channel transcripts identified in total, 19 of which are protein 
coding and 4 of which are processed transcripts. Nonsense mediated decay (NMD) and retained intron 
transcripts were not identified as a product of the KCNMA1 gene. Transcripts are represented by the 
turquoise grid boxes. Data was extracted from 'transcript summary table' of the Ensembl database. 
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The ‘canonical’ protein isoform of the KCNMA1 gene 
Given the variety of pore-forming α-subunit isoforms available, it was necessary to choose a form that 
would serve as the reference protein isoform for the study. The protein chosen was the CCDS protein 
with the longest amino acid sequence, which is accepted to be ‘canonical’. This protein was identified 
by the UniProtKB database as being 1,236 amino acids in length, with the identifiers ENSP00000286628 
and Q12791-1. The equivalent transcript is named as ENST00000286628 in the Ensembl database. This 
transcript includes the STREX splice insert, a 58 amino acid insert at the C2 splice site, responsible for 
stretch sensitivity and enhanced calcium sensitivity (Saito et al., 1997; Xie and McCobb, 1998; Chen et 
al., 2005; Naruse, Tang and Sokabe, 2009; Saleem, Rowe and Shipston, 2009; Jeffries, 2010), hypoxia 
sensitivity (McCartney et al., 2005) and increased cell membrane affinity (Jeffries, 2010). Details of the 
canonical BK channel protein isoform are listed in Table 3.1. 
 
 
Table 3.1- Details of the reference KCNMA1 transcript (canonical transcript). The table contains 
details the BK channel canonical transcript, including its transcript identifier in bioinformatics 
databases Ensembl, UniProt and Havana, the protein coding transcript length in base pairs (BP), the 
protein length in amino acids (AA), protein mass in Daltons (Da) and the number of coding exons in the 
transcript.  
 
3.2.3 The amino acid composition of the BK channel structural and functional regions 
Mapping the structural and functional domains of the BK channel onto its amino acid sequence was a 
necessary initial step, as a compilation of this information did not already exist in the desired format 
and detail required for the aims of this thesis. A single figure, where the functional and structural 
domains of the BK channel are overlaid onto the amino acid sequence was produced to provide a visual 
summary of the location and amino acid composition of essential elements of the BK channel. 
Identification of the amino acid location of BK channel structural and functional domains was 
undertaken using the UniProt and Ensembl databases. A schematic of the canonical BK channel protein 
and the amino acid FASTA sequence, annotated with structural domains, is shown in Figure 3.2. 
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Figure 3.2- BK channel canonical protein structure.  
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Figure 3.2- BK channel canonical protein structure. A) Schematic of the BK channel α-subunit 
canonical protein, annotated with structures of: transmembrane domains (TMD) S0-S6 (pink blocks), 
linker region, the pore region and the C-terminus beginning at the end of the S6 TMD, containing the 
regulator of the conductance of potassium (RCK) domains (RCK1 in orange and RCK2 in green blocks). 
Schematic not drawn to scale.  
B) The amino acid sequence of the BK channel α-subunit canonical protein annotated with structural 
domains and regions, colour coded to correspond with the locations in Figure 3.2A. The total length of 
the channel is 1,236 amino acids. Domain amino acids locations extracted from UniProt database 
(identifier Q12791-1). 
 
  
 95 
 
The BK channel is shown to be formed of 7 transmembrane domains, named S0-S6. The length of the 
transmembrane domains was consistent at 20 to 21 amino acids, whilst the length of the linker regions 
varied greatly from 4 amino acids between S2-S3 and S3-S4, to 72 amino acids between S0 and S1. The 
cytoplasmic (C-terminus) end of the channel contains the regulators of the conductance of potassium 
(RCK) domains, RCK1 and RCK2. These, alongside the associated linker regions comprise approximately 
two thirds of the channel sequence. The search of the UniProt and Ensembl databases also identified 
the amino acid location of 14 domains of functional importance, including the potassium selectivity 
filter, the voltage sensing domain and calcium binding sites that are central to the definition of a BK 
channel (Figure 3.3). Other key components that alter or modify channel function, such as the haeme 
binding site, the STREX insert, and poly serine and glycine sites are identified. These domains have 
been chosen for inclusion based on their crucial impact on BK channel activity, thus allowing the 
identification of key functional and structural components and the proximity of SNPs at a later stage 
in the investigation.  
 
3.2.4 Identification of post-translational modification sites on the BK channel 
The data on the structural and functional domains within the BK α-subunit provides a backbone on 
which to build further layers of complexity. For example, the functional domains identified key 
regulatory features that influence channel activity in isolation, such as the intrinsic voltage and calcium 
sensitivity of the channel, and the STREX insert further modifies these properties. However, this does 
not capture a further layer of control and modulation that can occur with BK channels, namely that of 
post-translational modification.  
 
Phosphorylation 
Protein phosphorylation is the reversible addition of a phosphate group to an amino acid residue, a 
process of considerable importance in mammals where the regulated addition and removal of 
phosphate to serine, threonine and tyrosine residues can lead to changes in protein function (as 
reviewed by Nishi, Hashimoto & Panchenko 2011). More recently, studies have established that the 
phosphorylation of histidine residues can occur in mammals (Besant, Tan and Attwood, 2003; Zu, 
Besant and Attwood, 2008; Wieland et al., 2010; Wieland and Attwood, 2015). In an earlier publication, 
histidine phosphorylation was hypothesised to account for approximately 6% of total phosphorylation 
in eukaryotes (Matthews, 1995). 
 96 
 
 
Figure 3.3- BK channel functional domains. 
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Figure 3.3- BK channel functional domains. A) BK channel structure schematic annotated with 
functional domains identified using bioinformatics databases. The structural domains (from Figure 3.2) 
are shown as grey blocks and 11 different domains of functional importance numbered and coloured 
as listed in the figure key (B).  
B) Figure Key: provides the name of the functional domain, location in terms of the amino acid number 
and the length of the domain in amino acids. C) BK channel amino acid sequence annotated with the 
structural components in grey blocks and the various coloured functional motifs corresponding to the 
schematic (A) and figure key (B). Additional functional sites not annotated on the amino acid sequence 
are the hypoxia motif (C721-C723), REDOX sensitive cysteine residues (C495, C680, C1034) and carbon 
monoxide sensitive amino acids (H430, H459, D432). 
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To identify the potential phosphorylation sites on the BK channel, the KCNMA1 protein FASTA 
sequence was exported from UniProt and submitted to the phosphorylation prediction software 
NetPhos 2.0, which uses a neural-network based assessment method. The output showed that 87 
amino acid residues were predicted to be phosphorylated; 63 serines (S), 11 threonines (T) and 13 
tyrosines (Y). Figure 3.4 shows the location of these residues on the BK channel structural schematic 
and on the BK channel amino acid sequence.  
The investigation revealed a density of predicted serine phosphorylation sites at both the N- and C-
termini. In the extracellular portion of the channel (at the N-terminus), 22 of 28 serine residues were 
predicted to be phosphorylated. At the C-terminus, 15 of the 20 serine residues in the terminal region 
were predicted to be phosphorylated. There was a secondary area of increased predicted 
phosphorylation of amino acids in the region linking transmembrane domains S0 and S1 (S0-S1 loop), 
where 4 of the 7 threonine residues in the linker were predicted to be phosphorylated. As there were 
only 11 threonine residues predicted to be phosphorylated across the whole channel, the 4 predicted 
phosphorylation sites in the S0-S1 loop accounts for a large proportion of the total number of predicted 
threonine phosphorylation sites. In addition, there were two predicted sites of serine phosphorylation 
in the S0-S1 loop (S136 and S161), identifying this region as one of high potential regulation by 
phosphorylation. This region has already been associated with membrane translocation (Jeffries, 2010; 
Jeffries et al., 2010), and thus a high density of potential phosphorylation may be an indicator of a 
further level of regulation of membrane translocation. There are two predicted tyrosine 
phosphorylation sites in the pore-forming domain between S5 and S6 (Y355 and Y359); this region has 
been shown to be important for channel function as discussed by (MacKinnon, 2003; Hoshi, Pantazis 
and Olcese, 2013; Kuang, Purhonen and Hebert, 2015). Further downstream in the amino acid 
sequence, phosphorylation was less commonly predicted in the transmembrane and RCK domains, 
with 3 predicted phosphorylation sites in total (S248, T617 and S1041). There was also serine residue 
predicted to be phosphorylated within the hypoxic sensing region of the channel (S722), and a 
threonine residue predicted to be phosphorylated next to a magnesium binding site (T461).  
Figure 3.5 illustrates the percentage of total serine, threonine and tyrosine residues that were 
predicted to be phosphorylated per transmembrane domain and linker region. As existing evidence 
links phosphorylation to key mechanisms, such as BK channel activation or inhibition (Schubert and 
Nelson, 2001; Tian, Duncan, et al., 2001; Widmer, Rowe and Shipston, 2003; Jianxi Liu et al., 2006; 
Zhou et al., 2010), the existence of regions of high predicted phosphorylation of the BK channel 
signpost areas of interest to look for potential SNP co-localisation.  
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Figure 3.4- Phosphorylation Sites on the BK Channel 
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Figure 3.4- Phosphorylation Sites on the BK Channel A) BK channel schematic annotated with the 
locations of predicted and experimentally verified sites of phosphorylation on serine (S), threonine (T) 
and tyrosine (Y) amino acid residues. Sites of predicted phosphorylation were identified using the 
NetPhos-2 algorithm, available as online software at http://www.cbs.dtu.dk/services/NetPhos/. In 
total 87 predicted sites of phosphorylation were identified; 63 (S), 11 (T) and 13 (Y). Of these, 13 sites 
of phosphorylation have been verified experimentally and were identified via literature and database 
search.  
B) BK channel amino acid sequence annotated with the locations of predicted and verified sites of 
phosphorylation. The figure key provides the symbol for serine, threonine and tyrosine predicted and 
verified phosphorylation in the schematic and amino acid sequence. There are instances of threonine 
and tyrosine residues that are verified but were NOT predicted (T763, Y885 and T970). 
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Figure 3.5- Percentage of total potential BK channel phosphorylation sites predicted to be 
phosphorylated per region (schematic view). A schematic annotated with the percentage of total A) 
serine (S), B) tyrosine (Y) and C) threonine (T) amino acid residues predicted to be phosphorylated per 
region of the BK channel. The percentages highlighted in the schematics show that predicted 
phosphorylation most commonly occurred in the linker regions of the channel.   
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The STREX splice insert, spanning from K699 to F756, has been shown to be a region where 
phosphorylation is important for channel function (Tian, Duncan, et al., 2001; Tian et al., 2004). The 
bioinformatics search identified 7 predicted sites of phosphorylation on the STREX splice insert, 5 of 
which were associated with serine amino acids, 1 with tyrosine and 1 with threonine: S701, Y703, S717, 
S722, T734, S745 and S752. The predicted phosphorylation rate of linker regions from S1 to S6 plus the 
C-terminal linker regions was approximately 1 in 3, with 10 of 31 and 29 of 89 total serine, threonine 
and tyrosine sites predicted to be phosphorylated. In contrast, the predicted phosphorylation for the 
whole channel sequence was much lower at approximately 1 in 14 amino acids.  
 
Verified sites of BK channel phosphorylation 
A search of the literature, combined with the data held on the UniProt database identified 13 sites of 
experimentally verified phosphorylation of the BK channel, which are listed in Table 3.2 and plotted in 
Figure 3.4. The verified sites were located in the cytosolic C-terminus downstream of the RCK1 domain; 
10 were associated with serine residues (S701, S765, S778, S782, S978, S982, S992, S1204, S1221 and 
S1224), 2 with threonine residues (T763 and T970) and 1 with tyrosine (Y885). Of these 13 verified sites 
of phosphorylation, 10 serine residues were predicted to be phosphorylated by NetPhos 2.0. 
Only experimental results detailing the specific amino acid residue proven to be phosphorylated by 
means such as mutation or phosphorylation assay, were considered when listing verified sites. 
Furthermore, to be considered, the results had to provide an identifier for the transcript used in the 
experiments or provide sufficient flanking amino acid sequence to ensure accurate identification of 
the residue in question; this enabled the specific amino acid to be accurately plotted onto the BK 
channel amino acid sequence ‘map’. In instances where the amino acid verified to undergo 
phosphorylation was not conserved in the human BK channel sequence, the residue could not be 
included in the list of verified sites. For example, the threonine phosphorylation site T107 on bovine 
BK channels was not included (Jianxi Liu et al., 2006), as the site is not conserved in the human form 
of the channel, and therefore could not be plotted on the human BK channel amino acid sequence. 
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Table 3.2- Experimentally verified phosphorylation sites on the BK channel. This table lists the details 
for experimentally verified phosphorylation sites, including the species of BK channel construct that 
was used for verification, the amino acid location in that species of BK channel, the equivalent amino 
acid reference on the canonical human BK channel and the reference for the publication that the data 
was documented in. The majority of (8 of the 13) verified phosphorylation sites listed in the table were 
first characterised in the murine form of the BK channel. Threonine phosphorylation site T107 on the 
bovine BK channel was not included (Jianxi Liu et al., 2006), as the site is not conserved in the human 
form of the channel.  
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Palmitoylation 
Palmitoylation, a form of s-acylation, is the reversible addition of a palmitate moiety to an amino acid 
residue, via a thioester bond, resulting in a wide range of actions in the BK channel, such as protein-
membrane targeting and modulation of other post-translational modifications, such as 
phosphorylation (Widmer, Rowe and Shipston, 2003; Tian et al., 2008; Jeffries, 2010; Jeffries et al., 
2010; Bi, 2014). To ascertain the number of predicted palmitoylated amino acid residues for the BK 
channel, the FASTA amino acid sequence for the KCNMA1 canonical protein transcript was exported 
from the UniProt bioinformatics database and submitted to the CSS-Palm 4.0 palmitoylation prediction 
software. In total, 8 sites of palmitoylation were predicted with C118, C119 and C121 located in the 
S0-S1 linker, C206 in the S1-S2 linker, C710 and C711 in the STREX splice insert located between RCK1 
and RCK2, and C1124 and C1134 at the extreme C-terminal end of the channel. The amino acid location 
of the identified sites as well as the scores from the predictive software are detailed in Figure 3.6 and 
Figure 3.7.  
 
 
 
Figure 3.6- BK Channel palmitoylation scores for cysteine residues calculated by CSS-Palm 4.0 
predictive software. Figure displaying palmitoylation scores for cysteine residues predicted to be 
palmitoylated; included is the CSS-Palm 4.0 calculated palmitoylation prediction threshold indicated 
by the grey section of each column.  The prediction score for each of the cysteine residues indicated 
by the purple section of each column. 
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All the predicted palmitoylation sites are located in intracellular linker regions, with the exception of 
C206 which is located in an extracellular linker region. In comparison to protein phosphorylation, 
predicted palmitoylation has a much lower occurrence. Phosphorylation is predicted to occur at a rate 
of 1 in 14 of the total channel amino acid residues, whilst palmitoylation is predicted to occur at a rate 
of 1 in 155 of the total amino acids residues. When considering only serine, threonine and tyrosine 
amino acid residues for phosphorylation and only cysteine residues for palmitoylation, the rates 
become similar due to the lower number of cysteine residues (35 in total) in the BK channel, with 
approximately 1 in 3 serine/threonine/tyrosine residues and 1 in 4 cysteine residues predicted to be 
phosphorylated and palmitoylated respectively. 
As has been shown previously with cysteine residues involved in post-translational modification, there 
was grouping of the residues into ‘cysteine rich domains’ (McCartney et al., 2005; Jeffries, 2010; 
Jeffries et al., 2010; Zhou et al., 2012). For example, all 3 of the available cysteine residues in the S0-
S1 linker are predicted to be palmitoylated, the same is true for the S1-S2 linker where the only 
cysteine in that sequence is predicted to be palmitoylated. Therefore, those domains had a predicted 
palmitoylation frequency of 100% (1 in 1) of cysteine residues. In other regions, the density of 
palmitoylation was lower; for example, the S8-S9 linker, containing the STREX insert, had a predicted 
palmitoylation rate of 1 per 6 cysteine residues.  
 
Verification of palmitoylation sites on the human BK channel. 
To ascertain the extent of established palmitoylation of the BK channel, a literature and database 
search was conducted to identify the locations of cysteine residues that had been verified to undergo 
palmitoylation by lab- based experimentation. This search identified 5 verified sites, all of which were 
predicted by CSS-Palm 4.0 software. C118, C119 and C121 are located in the S0-S1 loop and have been 
linked with channel-membrane targeting (Jeffries, 2010; Jeffries et al., 2010), whilst C710 and C711 are 
located in the C-terminal STREX splice insert are associated with cell-membrane targeting as well as 
regulating the effect of phosphorylation on BK channel activity (Tian et al., 2008; Jeffries, 2010). All of 
the sites listed in Table 3.3 were verified in the murine form of the BK channel, however the cysteine 
residues are conserved in the human form of the channel and therefore could be included.  
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Table 3.3- Experimentally verified palmitoylation sites on the BK channel. This table lists the details 
for experimentally verified palmitoylation sites, including the species of BK channel construct that was 
used for verification, the amino acid location in that species of BK channel, the equivalent amino acid 
reference on the canonical human BK channel and the reference for the publication that the data. All 
experimentally verified publication sites were identified in the murine form of BK channel. 
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Figure 3.7- Palmitoylation sites on the BK Channel 
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Figure 3.7- Palmitoylation sites on the BK Channel A) The BK channel α-subunit schematic annotated 
with verified and predicted sites of palmitoylation; 8 cysteine amino acid residues (C) were predicted 
to be palmitoylated, 5 of which have been verified experimentally (C118, C118, C121, C710 and C711). 
Cysteine residues annotated as predicted were identified using CSS-Palm 4.0 software. The FASTA 
amino acid sequence for the BK channel canonical protein isoform was entered. Verified sites were 
identified by literature search.  
B) BK channel amino acid sequence annotated with predicted and verified palmitoylated cysteine 
residues, as plotted in Figure 3.7A. The figure key provides the symbols for cysteine predicted and 
verified palmitoylation in the schematic and amino acid sequence. 
 
  
 109 
 
S-Nitrosylation 
S-nitrosylation is the covalent modification of a cysteine amino acid residue by a nitrous oxide group 
to generate S-nitrosocysteine (CySNO), which facilitates REDOX-dependent signalling and regulation 
of protein function (as reviewed by Gould et al., 2013). The extent of S-nitrosylation of the BK channel 
was assessed using the predictive software GPS-SNO 1.0; the amino acid sequence for the canonical 
BK channel protein isoform was submitted to the software, this resulted in the identification of 5 
predicted sites of S-nitrosylation. The amino acid location of the identified sites as well as the scores 
from the predictive software are detailed in Figure 3.8. The 5 predicted sites, C487, C680, C845, C943 
and C1098, are located in the cytosolic C-terminus of the channel (Figure 3.11). Only C845 is located 
within a hydrophobic domain (S9), whilst the remainder lie within the intracellular linker regions. There 
is a predicted site of S-nitrosylation at cysteine C680, which is part of the haeme binding motif and a 
REDOX sensitive site, spanning from C677 to H681. There is no overlap between the cysteine residues 
predicted to undergo palmitoylation and those predicted to undergo S-nitrosylation. Experimentally 
verified S-nitrosylation sites on the BK channel were not identified during a literature search. The 
overall incidence of predicted S-nitrosylation is 1 per 247 total amino acid residues, and 1 in 7 based 
upon the total number of cysteine residues in the BK channel. 
 
Figure 3.8- BK channel S-nitrosylation scores for cysteine residues calculated by GPS-SNO predictive 
software. Figure displaying GPS-SNO 1.0 scores for cysteine residues predicted to be S-nitrosylated. 
Included is the GPS-SNO 1.0 calculated S-nitrosylation prediction threshold for each residue indicated 
by the grey section of each column. The prediction score for each of the cysteine residues indicated by 
the orange section of each column.  
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SUMOylation 
SUMOylation is the addition of SUMOs (small ubiquitin-like modifiers) to proteins via the lysine (K) 
amino acid residue, and is categorised as a post-translational modification that tags proteins for 
ubiquitin-dependent degradation (Geoffroy and Hay, 2009; Wang and Prelich, 2009; Miteva et al., 
2010). Sites of predicted SUMOylation were identified by submitting the canonical BK channel protein 
isoform amino acid sequence to the GPS-SUMO predictive software. This process identified 4 sites of 
predicted SUMOylation, K65, K480, K583 and K887. The amino acid location of the identified sites as 
well as the scores from the predictive software are detailed in Figure 3.9. Three of the predicted sites 
are found in the intracellular linker regions, with the exception of K65 which is located on the 
extracellular N-terminal region of the channel (Figure 3.11). The overall frequency of predicted 
SUMOylation is 1 per 309 total amino acid residues, and the frequency related to the total number of 
lysine residues in the BK channel is 1 in 16. SUMOylation predicted sites were not located within three 
amino acids of key structural, or functional sites, nor near other predicted post-translational 
modification sites. None of the predicted sites had been experimentally verified for BK channels.  
 
 
Figure 3.9- BK channel predicted SUMOylation scores for lysine residues calculated by GPS-SUMO 
predictive software. Bar chart displaying GPS-SUMO scores for lysine residues predicted to be 
SUMOylated; included is the GPS-SUMO calculated SUMOylation prediction threshold for each lysine 
residue indicated by the grey section of each column. The prediction score for each of the lysine 
residues indicated by the green section of each column.  
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N-Glycosylation 
N-glycosylation is the addition of a carbohydrate moiety to the amino acid residue asparagine (N) and 
is implicated in the control of ion channel folding, stability, trafficking and function (Schwarz and Aebi, 
2011; Moharir et al., 2013). Using the prediction software NetNGlyc 1.0, the predicted number of N-
glycosylated residues on the BK canonical protein isoform was identified. Three sites were predicted, 
N133, N265 and N1007, details of which are shown in Figure 3.10. N133 and N1007 are located in the 
intracellular linker regions between S0–S1 and S9–S10 respectively (Figure 3.11). N265 is located on 
the first amino acid of the S4 trans-membrane domain, which is the voltage-sensing region that spans 
the length of the domain. Also of significance is N1007, which is located within the calcium bowl, 
spanning from T1003 to E1025. The overall frequency of predicted N-glycosylation is 1 per 412 amino 
acid residues, and the frequency related to the total number of asparagine residues in the BK channel 
is 1 in 22. 
When a literature search was conducted to identify N-glycosylation sites that had been verified 
experimentally, only one site was found (N200). Interestingly, the N-glycosylation site identified and 
experimentally verified in 2000, was not predicted by NetNGlyc 1.0 software (Bravo-Zehnder et al., 
2000). The publication places the asparagine residue between transmembrane domains S3 and S4 of 
the human BK channel with the GenBank accession number U11058. In the BK channel isoform used 
in this investigation, there is no asparagine amino acid residue between transmembrane domains S3 
and S4, and given the location of N200, it is plausible that the location is the asparagine N201 found 
between S1 and S2. Alignment of the amino acid sequence of known human BK channel isoforms 
indicate that there is no asparagine amino acid at N200. In a recent review (Shipston and Tian, 2016), 
there was debate as to whether this site was truly modified by N-glycosylation, as mutation of this site 
to alanine had no effect on channel localization, but the mutation resulted in a change to activation 
voltage. Figure 3.12 summarises the number of software program predicted post-translational 
modification sites on the BK channel, and illustrating the number of experimentally verified sites 
associated with each.  
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Figure 3.10- BK channel predicted N-glycosylation scores for asparagine residues calculated by 
NetNGlyc 1.0 predictive software. Bar chart displaying N-glycosylation scores for asparagine residues 
predicted to be N-glycosylated; included is the NetNGlyc 1.0 calculated N-glycosylation prediction 
threshold for each asparagine residue indicated by the grey section of each column. The prediction 
score for each of the asparagine residues indicated by the green section of each column. 
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Figure 3.11- BK channel post-translational modifications: S-nitrosylation, SUMOylation, N-glycosylation 
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Figure 3.11- BK channel post-translational modifications: S-nitrosylation, SUMOylation, N-
glycosylation. A)-The BK channel α-subunit schematic is annotated with verified and predicted sites of 
S-nitrosylation, SUMOylation and N-glycosylation. The FASTA amino acid sequence for the BK channel 
canonical protein isoform was entered into the relevant predictive software for each PTM. Verified 
sites were identified by literature and database search. 
B) BK channel amino acid sequence annotated with predicted and verified palmitoylated amino acid 
residues, as plotted in Figure 3.11A. The figure key provides the symbols for amino acid predicted and 
verified to undergo S-nitrosylation, SUMOylation and N-glycosylation in the schematic and amino acid 
sequence. 
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Figure 3.12- Summary of post-translational modifications on the BK channel. Presented is an 
illustration of the number of phosphorylation, palmitoylation, S-nitrosylation, SUMOylation and N-
glycosylation sites on the BK channel, which were identified using predictive software tools. This is 
shown alongside those post-translational modification sites that have been verified by lab-based 
experimentation and were identified as a result of a literature and database search (filled boxes). The 
figure key provides the symbols for the amino acids predicted and verified to undergo post-
translational modifications. 
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3.2.5 Identification of DNA variations sites on the BK channel gene 
In the quest for a better understanding of the origins of disease and the most effective way to treat 
those diseases, there has been a significant shift of opinion on the best way to proceed, moving from 
treatments based on generic population characteristics, to understanding that the future lies in fully 
individualised treatment. To achieve this, new research has sought to uncover, down to the molecular 
level, what differentiates one human from another, and if there are any changes to an individual 
person’s DNA that may make them more susceptible to disease or perhaps more resistant to 
treatment. Thus far in this chapter, the investigation has focused on mapping the amino acid locations 
of structural and functional regions of importance onto the human BK channel amino acid ‘reference 
map’. In addition, the locations of post-translational modifications, that add a further layer of control 
and modulation to the BK channel, have been identified using predictive software and literature 
searches, have been added the BK channel amino acid ‘reference map’. One way to make use of this 
map is to incorporate it into an attempt to prioritise BK channel single nucleotide polymorphisms 
based upon their proximity to key domains, and thus the number, type and location of SNPs needs to 
be established. For this reason, this study attempts to determine the extent of genetic variation of the 
human BK channel using bioinformatics databases, and map the locations of the variations in relation 
to domains of structural, functional and post-translational modification.  
 
The BK Channel canonical protein isoform is subject to extensive DNA variation.  
To determine the extent of genetic variation of the BK channel, the KCNAM1 canonical protein isoform 
(ENSP00000286628) was selected from the list of isoforms on the Ensembl database. Selection of the 
'variation table' option for this isoform presented a table containing known variations associated with 
the gene as a whole. In total, there were 14,132 variations (representing 1.8% of the total gene base 
pairs), with the majority (94.7%) located in the intronic regions of the transcript, as shown in Figure 
3.13A. The 3'UTR region contained 162 variations comprising 1.1% overall, whilst the 5'UTR region was 
not associated with any variations. The 'Others' category contains promoter and enhancer regions, and 
contained 203 variations comprising 1.4% overall. 
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Non-synonymous SNP were selected for further investigation. 
There were 157 synonymous variations (sSNP) in the exonic regions, where there is a change in codon 
composition but no change to the resulting amino acid, comprising 1.1% of total variations. Missense 
or non-synonymous SNP (nsSNP) variations located in exonic regions of the KCNMA1 gene were the 
focus for the next stage of investigations as, these changes modify protein sequence and have been 
shown to impact on BK channel function (Du et al., 2005; Laumonnier et al., 2006). There were 224 
variations of this type, comprising 1.6% of the total number of SNPs. After correction for duplicates, 
167 unique nsSNP were identified and these are plotted on the BK channel schematic in Figure 3.13B, 
and highlighted on the BK channel FASTA sequence as shown in Figure 3.14. 
 
3.2.6 BK channel nsSNP were scored by damage prediction software 
The 'damaging potential' of the nsSNPs has been analysed to aid in the prioritisation of targets for 
further investigation. Illustrated in Figure 3.14 is the location of the 167 nsSNP associated with the BK 
channel, alongside the damage category allocated to each SNP by the prediction software programs 
SIFT and PolyPhen-2. SIFT places nsSNP into two different categories: tolerated; and deleterious; whilst 
PolyPhen-2 has 3 categories: benign; possibly damaging; and probably damaging. SIFT allocated 54% 
of nsSNP to the 'tolerated' category and 45% into 'deleterious', with a score for the remaining 1% of 
nsSNP unable to be calculated. PolyPhen-2 placed 39% percent of nsSNP into the most harmful 
category of 'probably damaging' and 35% in the least damaging category of 'benign'. In addition, 
PolyPhen-2 contains the category of 'possibly damaging' in which 20% of nsSNP were categorised and 
5% of nsSNPs were not scored. 
Each program uses a slightly different method or criteria of scoring the damaging potential of a DNA 
variation. Nevertheless, there was 66% agreement between SIFT and PolyPhen-2 for 'tolerated' and 
'benign', and 87% percent agreement between the programs for deleterious and probably damaging. 
The extra category used by PolyPhen-2 of 'possibly damaging' covered the approximately 20% SNPs 
that lay at the border between benign and deleterious in SIFT and can be seen in Figure 3.15. 
 
  
 118 
 
 
Figure 3.13- DNA variations on the BK channel. A) Illustration of the variations associated with the BK 
channel canonical protein DNA. The majority of variations are located in the intronic regions (94.7%). 
3’UTR, 5’UTR as well as the exonic synonymous and missense (nsSNP) variations accounted for the 
remaining 5.3%. Data was extracted from the Ensembl database. B) Schematic of the BK channel 
structure annotated with the location of nsSNPs, represented by pink bars, and the transmembrane 
domains by grey columns.  
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Figure 3.14- Assessment of the predicted damage of nsSNP on the BK channel 
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Figure 3.14- Assessment of the predicted damage of nsSNP on the BK channel. The damage prediction 
scores generated by A) SIFT and B) PolyPhen-2 for the 167 unique nsSNP associated with the BK 
channel are shown as a proportion of total in the pie chart, and with the corresponding colour code 
on the BK channel amino acid sequence. SIFT placed 54% of nsSNP into the 'tolerated' category and 
45% into 'deleterious. PolyPhen-2 predicted that 39% are 'probably damaging', 20% are ‘possibly 
damaging’ and that 35% are ‘benign’. 
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Figure 3.15- Comparison of nsSNP damage scoring between SIFT and PolyPhen-2. This figure 
illustrates the extent of agreement in BK channel nsSNP damage category between damage prediction 
software programs SIFT and PolyPhen-2.  
 
3.2.6.1 nsSNP co-localisation with BK channel structural sites 
The BK channel amino acid sequence has been annotated with channel a) structural regions, b) 
functional domains and c) nsSNP location and the damage categories allocated by SIFT and PolyPhen-
2 (Figure 3.16 and Figure 3.17). Results indicate that the frequency of genetic variation within the 
transmembrane regions S0 to S6 and hydrophobic domains S7 to S10 is approximately 13% of the total 
number of nsSNPs (Figure 3.18). The prediction software is not designed to take into account the 
structural and functional motifs of a specific protein and so may provide a predictive score that does 
not correlate with location within the BK channel. Thus, although an assumption would be that highly 
conserved regions would consistently obtain a higher score, this does not appear to be the case. Of 
the 21 nsSNP in these regions, SIFT scored 11 of them as 'tolerated' and PolyPhen-2 scored 5 as benign 
and 5 as possibly damaging. The linker with the highest incidence of nsSNP was the S7-S8 linker which 
was associated with 19% co-localisation (Figure 3.19).  
 
3.2.6.2 nsSNP co-localisation with BK channel functional sites 
BK channel nsSNP have been plotted over areas of functional importance to highlight co-localisation. 
As shown in Figure 3.18, nsSNP co-localisation with areas of functional importance was variable; 17% 
within the pore-forming domain, 14% within the entrance to the intracellular vestibule and 11% within 
the calcium bowl. There was also co-localisation at REDOX sensitive cysteine C495, hypoxia sensitive 
site S722 and G694, a haeme binding site. Transmembrane domain S4, which duals as the voltage 
sensing domain was not associated with any variation, as was the serine motif and the magnesium 
binding sites. 
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Figure 3.16- SNP location and level of predicted damage in relation to structural BK channel domains. 
The BK channel amino acid sequence was annotated with structural domains and SNP damage score 
calculated by SIFT and PolyPhen-2.  
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Figure 3.17- SNP location and predicted damage score in relation to BK channel functional domains. 
The BK channel amino acid sequence was annotated with functional domains and the nsSNP location 
and damage prediction categorisation allocated by SIFT and PolyPhen-2. Additional functional sites not 
annotated are hypoxia motif (C721-C723), REDOX sensitive cysteine (C495, C680, C1034), CO sensitive 
amino acids (H430, H459, D432).  
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Figure 3.18- Summary of SNP co-localisation with BK channel functional and structural sites. An 
illustration of co-localisation of nsSNP with A) functional sites and B) structural sites of the BK channel. 
The black bars indicate the number of amino acids within a domain that are co-localised with nsSNP, 
the colour bars indicate the number of unaltered amino acids within the site. Structural domains S0-
S10 are shown as light grey bars. In each case, the proportion of amino acids within each domain that 
are co-localised with nsSNP is expressed as a percentage. Additional functional sites not annotated: 
hypoxia motif (C721-C723) and REDOX sensitive cysteines (C495, C680, C1034) each have 1 nsSNP co-
localisation (33%), whilst there was no co-localisation with CO sensitive amino acids (H430, H459, 
D432).  
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Figure 3.19- Summary of SNP co-localisation with BK channel linker regions. An illustration of co-
localisation of nsSNP with BK channel linker regions. The black bars indicate the number of amino acids 
within a domain that are co-localised with nsSNP, the brown bars indicate the number of unaffected 
amino acids within the linker region. In each case, the proportion of amino acids within each domain 
that are co-localised with nsSNP is expressed as a percentage.  
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3.2.6.3 nsSNP co-localisation with BK channel post-translational modification sites 
The structural and functional domains of the BK channel, the location of nsSNP and the nsSNP 
predicted damage score category taken from SIFT and PolyPhen-2 have been compiled into a single 
figure to enable the prioritisation of SNPs based upon their proximity to key regions on the BK channel. 
However, as post-translational modifications play a role in further amending BK channel function, such 
as channel activity and membrane localisation it was important to assess the extent of co-localisation 
of nsSNP and post-translational modifications. Thus, sites of post-translational modification of the BK 
channel have been combined with the other key channel domains to create a comprehensive resource 
(Figure 3.20). To assess the extent of co-localisation at a glance, Figure 3.21 summarises the number 
of nsSNP per type of post-translational modification.  
There was a 1 in 18 incidence of co-localisation of nsSNP with serine phosphorylation sites that had 
been predicted but not verified (S722, S1188 and S1195), but a 1 in 3 incidence of nsSNP co-localisation 
with serine phosphorylation sites that had been predicted but also verified by experimentation (S701, 
S765 and S782). For threonine phosphorylation, for those sites predicted, there was a 1 in 11 incidence 
of co-localisation, with the site T617. However, of the two verified sites discovered by literature search, 
one of those, T970, was co-localised with a nsSNP, resulting in a 50% overlap. Tyrosine phosphorylation 
sites that were predicted co-localised with nsSNP at one site, Y359. One site that was verified but not 
predicted was Y885; this site was not associated with a nsSNP. 
There was no co-localisation of nsSNP with sites of palmitoylation, whether predicted or verified. This 
may be due to the low occurrence of predicted palmitoylation across the channel, with 8 predicted 
sites associated with the modification in comparison with 87 for phosphorylation. The same was true 
for predicted sites of S-Nitrosylation and N-Glycosylation. However, there was one site of predicted 
SUMOylation, K583, that was co-localised with an nsSNP.  
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Figure 3.20- Post-translational modification sites and nsSNP on the BK channel: SIFT and PolyPhen-
2 damage scoring. The BK channel amino acid sequence, annotated with post-translational 
modification sites (phosphorylation, palmitoylation, SUMOylation, S-nitrosylation and N-glycosylation) 
is overlaid with the location and predicted damage score for nsSNP generated by SIFT and PolyPhen-
2.
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Figure 3.21- Summary of post-translational modification sites and nsSNP on the BK channel. 
Illustration of the number of post-translational modification sites that have been i) predicted but not 
verified experimentally, ii) predicted and verified and iii) verified but not predicted by the software 
programs. Overall, the incidence of co-localisation between nsSNP and predicted sites of post-
translational modification was 1 in 15. In predicted and verified sites, this was 1 in 5, and in those 
verified but not predicted, 1 in 4. 
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3.2.7 Site-directed mutagenesis of BK channel amino acids 
Research into  BK channel function and regulation over the past three decades has included 
the application of site-directed mutagenesis as a means of investigating the role of amino acids on 
cellular processes, such as membrane translocation (Jeffries, 2010; Jeffries et al., 2010), 
phosphorylation (Tian et al., 2008, 2012) and channel activity (Schreiber and Salkoff, 1997). The 
location of these designed mutations and their relationship with sites and regions of structural 
and functional impact was investigated as a final step to complete the BK channel 
“map” (Figure 3.22). A literature search highlighted 43 sites of site directed mutagenesis on the BK 
channel; the amino acid locations of these sites are summarised in  Table 3.4, and lists the amino 
acid location, the substitution and any effect noted. The list of site-directed mutagenesis is not 
exhaustive; the table provides an indication of the location and result of mutagenesis most relevant 
to the study. There is currently no bioinformatics database or software that captures all the SDM 
associated with the BK channel.  
3.2.7.1 Co-localisation of nsSNP and AA involved in lab based mutagenesis 
After assessing the co-localisation of nsSNP and sites of lab based mutagenesis, 8 sites were 
identified; D146, G354, A381, V384, D434, C495, S722 and S765. These sites are naturally 
occurring genetic variations that have also been investigated in a wet lab setting, and accounted for 
5% of all nsSNP of the BK channel and 18% of identified site directed mutagenesis sites. The 
consequence of the lab based mutagenesis sites is already known and are detailed in  Table 3.4, 
however it was of interest to see if any information on the physiological consequence of the 
naturally occurring nsSNP co-localised existed. Information was only available for nsSNP D434; 
as described in the chapter introduction, this mutation has been found in humans and is causative of 
the disease 'Generalized Epilepsy and Paroxysmal Dyskinesia' (GEPD). This is a 'gain of function' 
mutation that causes the channel to have an increased sensitivity to calcium, proposed to be 
reduced flexibility of the AC region in the RCK1 domain (Yang et al., 2010).  
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Table 3.4-Examples of Site Directed Mutagenesis of the BK channel. This table lists the details of site-
directed mutagenesis of the BK channel, including the amino acid reference of the site in the human 
BK channel, the species of BK channel in which the mutation was made, the nature of the amino acid 
substitution and the resulting effect of the mutation on the BK channel. Also included is the reference 
for the mutagenesis publication. D146N and D1015N associated with reduced calcium sensitivity is not 
included in the table (Braun and Sy, 2001).  
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Figure 3.22- Site-directed mutagenesis sites and nsSNP on the BK channel: SIFT and PolyPhen-2 
damage scoring. Shown are nsSNP sites with SIFT and PolyPhen-2 scoring category, alongside the 
location and result of amino acid mutagenesis. Black arrows indicate the amino acid residues selected 
for further investion in the ‘deep dive’ section.   
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3.2.8 SNP Deep Dive 
One of the key aims of this work was to prioritise single nucleotide polymorphisms for further research. 
To achieve this, information on the structural, functional, post-translational modification and site-
directed mutagenesis of the BK channel has been collated and mapped onto the BK channel canonical 
amino acid sequence. In addition, the location and nature of single nucleotide polymorphisms of BK 
channel amino acids has been collated and mapped onto the channel sequence and schematic to 
create a novel BK channel ‘reference material’.  
This reference material has enabled the extent of co-localisation between single nucleotide 
polymorphisms and the key domains of the channel to be viewed at ‘at glance’, and demonstrates that 
this co-localisation occurs in areas of structural, functional, post-translational modification and site-
directed mutagenesis. However, in order to prioritise a single nucleotide polymorphism for lab-based 
research, more detailed information, such as the nsSNP effect on the local PTM environment, was 
required. Therefore, a search was undertaken for the single nucleotide polymorphisms that are most 
likely to have an effect on BK channel function. This was determined by a) co-localisation with, or being 
less than three amino acids away from a crucial functional site, such as the potassium selectivity 
domain, b) proximity to crucial sites proven by site-directed mutagenesis to have a profound effect on 
channel function, c) a SNP with a dramatic effect on the local post-translational modification 
environment, for example a SNP that results in the introduction or removal of a cysteine rich domain 
or d) proximity to another SNP shown to have physiological effects, such as D434G.  
The search identified 8 single nucleotide polymorphisms as potential candidates for this more detailed 
analysis, based upon the aforementioned criteria and diverse potential effect on channel function. The 
following nsSNP were selected; H120Q and G122A located in the S0-S1 linker region and adjacent to 
the cysteine residues mediating channel cell membrane localisation, Y359N located in the S5-S6 
intramembrane linker and three amino acids downstream of the potassium selectivity domain, and 
G694C and G694V located in the region between the RCK1 and RCK2 domains associated with haeme 
binding and REDOX sensitivity. Additionally, S722L in the hypoxia sensitivity domain, and R1222G and 
R1222M which are possible disruptors of a serine phosphorylation rich domain in the C terminus of 
the channel were selected. 
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3.2.8.1 H120Q and G122A and S0-S1 linker palmitoylation 
H120Q and G122A mutations are located in the S0-S1 linker region, flanking cysteine residues C118, 
C119 and C121 that are sites for palmitoylation and have been shown to modulate cell-membrane 
association of the channel (Jeffries, 2010; Jeffries et al., 2010; Bi, 2014; Kim et al., 2014). Mutagenesis 
of C118, C119 and C121 to alanine residues reduced the cell membrane localisation of a truncated 
channel lacking the C-terminus by over 80%, and the full-length channel by approximately 50%. In 
addition, C121 has been shown to be the cysteine residue with the greatest single effect on channel 
cell membrane localisation, reducing membrane expression to 25% of wild-type. As a result, it was of 
interest to investigate the nsSNPs (H120Q and G122A) that are located within this key region.  
H120Q (rs147098205) is the substitution of the positively charged histidine (H) amino acid for the 
neutrally charged glutamine (Q) amino acid. This mutation was detected in an unknown subject of 
European American decent, and uploaded to the Ensembl database by the NHLBI-ESP project. The 
mutation has a genotype frequency of 1 in 4299, indicating that based upon the population assessed, 
1 in 4299 people will have this mutation. As shown in Figure 3.23, this mutation causes a small increase 
in the predicted palmitoylation score for cysteines C118 and C119, (score from 16.75 to 16.84 and 5.21 
to 5.56 respectively) but is predicted to reduce predicted C121 palmitoylation below threshold. SIFT 
and PolyPhen-2 mutation damage prediction software allocated the mutation to different damage 
categories; SIFT as tolerated (0.81) and PolyPhen-2 as ‘possibly damaging’ (0.64). The H120Q mutation 
did not result in a change in the frequency, or change in predicted score for the other post-translational 
modifications assessed in this thesis, such as phosphorylation, N-glycosylation, S-nitrosylation or 
SUMOylation. 
The G122A mutation is a substitution of the hydrophilic, neutrally charged glycine (G) amino acid for 
the hydrophobic alanine (A) amino acid. This mutation was detected in a male subject of Utah-
European origin, and was submitted to Ensembl via the 1000 genomes project database. The mutation 
has a genotype count of 1:84 in Utah-Europeans and 1:378 in Europeans.  
This variation is predicted to have a differing effect on palmitoylation than H120Q; the score for C118 
was reduced from 16.75 to 15.72, whilst C119 and C121 scores are increased from 5.21 and 4.38 in the 
wild type, to 5.22 and 6.14 respectively in the mutant. There was a lack of agreement between SNP 
damage scoring software as to the damaging potential of the mutation, with SIFT scoring it as tolerated 
(0.92) and PolyPhen-2 as ‘possibly damaging’ (0.38). As with H120Q, the G122A mutation did not result 
in a change to the frequency or predicted score of other post-translational modifications on the 
channel. When comparing the H120Q and G122A mutations, the main difference is the predicted effect 
on C121 palmitoylation. 
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Figure 3.23- Investigation into nsSNPs flanking C121 residue (H120Q and G122A)  
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Figure 3.23- Investigation into nsSNPs flanking C121 residue (H120Q and G122A). This figure presents 
information held on bioinformatics databases for the A) H120Q and B) G122A mutants. Included is a 
schematic indicating the location of the mutations in the BK channel, a summary of the flanking amino 
acid sequence and an illustration of chemical structure of histidine (H), glycine (G), glutamine (Q) and 
alanine (A) amino acid residues. Also included are the background details of the mutation, such as the 
program and individual in which it was detected, and the genotype count of the mutation. The CSS-
Palm 4.0 predicted palmitoylation score for the wild-type channel and the two mutants are plotted, as 
is the damaging score allocated to each of the mutants by SIFT and PolyPhen-2. The H120Q mutation 
results in a reduction in the predicted palmitoylation score for of C121 to below threshold, while in 
contrast the G122A mutation increases the predicted palmitoylation score.  
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3.2.8.2 Y359N in the BK channel pore domain 
The Y359N mutation involves the substitution of the neutral, polar tyrosine (Y) amino acid residue with 
the neutral and polar asparagine (N) amino acid residue. The mutation was detected via exome 
screening of a tissue biopsy taken from carcinoma of the larynx of a 36-year-old smoker and drinker of 
unknown gender. Details of the mutation were submitted to the Ensembl database via the COSMIC 
database, which collates genetic variation data from those suffering from cancer. The genotype count 
for this mutation in the population studied was 1 in 74. 
The mutation is located in the pore domain of the BK channel, and is three amino acids downstream 
of the GYG motif of the potassium selectivity domain spanning from G354 to G356. In addition to the 
mutation occurring near a crucial functional motif, the tyrosine amino acid involved is also a predicted 
site of phosphorylation. The mutation resulted in the loss of the predicted tyrosine phosphorylation 
site, and also had an effect on the phosphorylation status of nearby residues (Figure 3.24). The 
predicted phosphorylation score for tyrosine amino acid residue upstream of the mutation (Y355) 
increased from 0.938 to 0.955, whilst the score for the threonine amino acid residue downstream of 
the mutation (T363) reduced from 0.656 to 0.529.  
Although this mutation adds a potential additional site for N-glycosylation as a result of asparagine 
amino acid addition, when the modified FASTA sequence containing the mutation was submitted to 
NetNGlyc 1.0 there was no difference in the number of predicted N-glycosylation sites, and there was 
no change to the scores of those N-glycosylation sites already predicted in comparison to wild type. 
There was a lack of consensus between SNP damage prediction software, as SIFT categorises the 
mutation as being tolerated and PolyPhen-2 as probably damaging (scores of 0.1 and 0.99 
respectively).  
Due to the proximity of the mutation to the potassium selectivity motif, an area where site-directed 
mutagenesis to alanine caused loss of channel function, and the alteration in predicted 
phosphorylation of amino acids in the region, it would be of interest to assess the effect of this 
mutation on channel function assessed by electrophysiology. 
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Figure 3.24- Investigation into nsSNP Y359N in the BK channel pore domain 
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Figure 3.24- Investigation into nsSNP Y359N in the BK channel pore domain. Summary of 
bioinformatics data for A) wild type Y359 and the Y359N mutant B). A schematic indicating the location 
of the mutation in the BK channel, the flanking amino acid sequence and chemical structure of tyrosine 
(Y) and asparagine (N) amino acid residues. Details of the mutation with the program and individual in 
which the mutation was detected and the genotype count of the mutation. The NetPhos 2.0 predicted 
phosphorylation scores for the wild-type channel and the Y359N mutant are plotted and the damaging 
score allocated to each of the mutants by SIFT and PolyPhen-2. The mutation results in the removal of 
a tyrosine amino acid and therefore the loss of a predicted phosphorylation site. The inclusion of an 
arginine amino acid does not create a predicted N glycosylation site.  
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3.2.8.3 G694C and G694V in the RCK1-RCK2 linker 
G694 is located in the region between the RCK1 and RCK2 domains in the C-terminus of the BK channel, 
and specifically in a region that has been identified as important for haeme binding and REDOX agent 
sensitivity (Tang et al., 2003; Zhang and Horrigan, 2005; Yi, Morgan and Ragsdale, 2010). There are two 
mutations occurring on the same glycine amino acid residue (G694). The first mutation, G694C, 
substitutes the hydrophilic, neutrally charged glycine (G) amino acid for a cysteine (C) amino acid with 
similar characteristics, and was detected as a result of an exome screen of a biopsy taken from 
carcinoma of the lung of a 61-year-old female subject. The mutation was submitted to Ensembl via the 
COSMIC project database; unfortunately, there is no information on the genotype frequency of the 
mutant. The G694C variation introduced an additional cysteine residue into a region with an already 
high density of cysteine residues (9 in 50 amino acids residues); this had a significant impact on the 
palmitoylation status of the region. Whilst C693 and C695 are not predicted to be palmitoylated in the 
wild type channel, in the G694C mutant channel all three cysteines are predicted to be palmitoylated 
with scores of 15.73, 12.20 and 6.00 for C693, C694 and C695 respectively (Figure 3.25). This mutation 
however reduces the palmitoylation score of the STREX cysteine residue C710 from 19.62 to 19.10 and 
increases the palmitoylation score for C711 from 6.39 to 6.58. The mutation did not result in a change 
to the number or score of other post-translational modifications of the channel. As has been observed 
in the other ‘deep dive’ nsSNP, there was no agreement between the nsSNP damage prediction 
software regarding the damaging potential of the mutation; SIFT categorised the mutation as 
deleterious with a score of 0.02, whilst PolyPhen-2 categorised it as ‘possibly damaging’ with a score 
of 0.73. 
The G694V mutation introduces a non-polar and hydrophobic valine (V) amino acid to the region, and 
was detected in a subject of unknown gender and of African origin. This was submitted to the Ensembl 
database by the 1000 genomes project, and the genotype frequency of this mutant is 1:660. The 
mutation had no effect on the predicted palmitoylation status of C693 and C695 which remained 
undetectable, however the mutation reduced the C710 score from 19.62 to 18.94, and increased C711 
from 6.39 to 6.60. The mutation did not result in a change to the number or score of other post-
translational modifications of the channel. SIFT and PolyPhen-2 were not in agreement that this nsSNP 
was not damaging, with categories of tolerated and possibly damaging allocated (scores of 0.09 and 
0.23 respectively). Although the damage prediction software SIFT and PolyPhen-2 do not unanimously 
predict mutation at G694 to be harmful to the protein, there is evidence to support lab based 
investigation of the mutant as it is located in a region of the channel associated with haeme binding 
and sensitivity to REDOX agents, (site-directed mutagenesis has been shown to perturb these 
processes), and the G694C mutant results in the creation of a cysteine rich domain.  
 140 
 
 
Figure 3.25-- Investigation into nsSNPs G694C and G694V in the RCK1-RCK2 linker  
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Figure 3.25- Investigation into nsSNPs G694C and G694V in the RCK1-RCK2 linker. Summary of 
bioinformatics data for the A) G694C and B) G694V nsSNPs. A schematic indicating the location of the 
mutations in the BK channel, the flanking amino acid sequence and the chemical structure of glycine 
(G), cysteine (C) and valine (V) amino acid residues. Also included are details of the program and 
individual/s that the mutation was discovered in. The CSS-Palm 4.0 predicted palmitoylation score for 
the two mutants are plotted, as well as the damaging score allocated to each of the mutants by SIFT 
and PolyPhen-2. The G694C mutation results in the creation of a cysteine rich domain, the G694V 
mutation has a limited effect on predicted palmitoylation in the region.  
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3.2.8.4 S722L in the STREX splice insert 
Serine residue S722 is located between RCK1 and RCK2 in the STREX splice insert, and is situated 
adjacent to the cysteine residues crucial to the function of the hypoxia sensitivity motif; this serine 
residue is also predicted to be phosphorylated by NetPhos 2.0. The S722L mutation (rs373620901) 
involves the substitution of the polar, uncharged, hydrophilic serine amino acid residue (S) for the non-
polar, hydrophobic amino acid residue leucine (L). The mutation was detected in an individual of 
unknown description and was submitted to Ensembl by the ESP database via the ExAc project, which 
holds large-scale sequencing data from 60,706 unrelated individuals (Figure 3.26).  
The S722L mutation results in the removal of a predicted serine phosphorylation site. Though the 
mutation did not result in any significant change the phosphorylation score of other amino acids in the 
region, nor the palmitoylation score for the cysteine residues in STREX. The mutation was classified as 
tolerated by damage prediction software SIFT, with a score of 0.3, whilst PolyPhen-2 could not assign 
a score to the mutant. 
Although the bioinformatics investigation did not detect a significant impact of the mutation on the 
local environment, due to the location of the mutation within the hypoxia motif and the fact that the 
mutation results in the removal of a predicted phosphorylation site, there is evidence to support the 
progression of this mutation forward to lab based investigation, particularly investigating the effect of 
the mutation on hypoxia sensitivity, and the effect of protein kinases on channel activity. 
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Figure 3.26- Investigation into nsSNP S722L in the STREX splice insert 
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Figure 3.26- Investigation into nsSNP S722L in the STREX splice insert. Summary of bioinformatics 
data for the wild type A) and S722L mutant B). A schematic indicating the location of the mutation in 
the BK channel, the flanking amino acid sequence and chemical structure of serine (S) and leucine (L) 
amino acid residues. Details of the mutation with the program and individual in which the mutation 
was detected and the genotype count of the mutation. The NetPhos 2.0 predicted phosphorylation 
scores and CSS-Palm 4.0 predicted palmitoylation scores for the wild-type channel and the S722L 
mutant are plotted alongside the damaging score allocated to the mutant by SIFT and PolyPhen-2. The 
mutation results in the removal of a serine amino acid and therefore the loss of a predicted 
phosphorylation site. There is no change to the palmitoylation score of cysteine residues C721 and 
C723. 
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3.2.8.5 R1222G and R1222M in the C-terminus of the BK channel 
R1222 is a charged arginine amino acid residue located in the extreme C-terminus of the channel, 
downstream from the S10 hydrophobic domain. This region is one of dense phosphorylation with 19 
predicted sites in the 100 amino acids making up the intracellular C-terminal tail. There are two 
mutations identified to occur at the same amino acid location: R1222G and R1222M (Figure 3.27).  
The R1222G mutation involves the substitution of arginine for a glycine residue; this moves the local 
environment from being positively charged and polar to being hydrophobic and neutral. This mutation 
was detected in an unknown subject and was uploaded to Ensembl via the dbSNP database. Whilst the 
mutation appears to have a minimal effect on neighbouring phosphorylation, causing only a small 
reduction in predicted phosphorylation of S1224 from 0.997 to 0.982, both SIFT and PolyPhen-2 
databases are in agreement that the mutation is highly damaging, scoring the nsSNP as deleterious 
and probably damaging (0.03 and 0.99 respectively). There appears to be no effect on other post-
translational modifications in the area.  
A similar pattern is presented for the R1222M mutation, where the arginine amino acid residue is 
substituted with the non-polar and hydrophobic methionine (M) amino acid. The mutation was 
detected as a result of an exome screen of the biopsy from a 65-year-old male suffering from 
carcinoma of the prostate. The mutation was submitted to the Ensembl database by the COSMIC 
project. Damage prediction software also categorised this mutation as being harmful with SIFT and 
PolyPhen-2 calculating scores of 0.01 (deleterious) and 0.99 (probably damaging).  
In this case, there is a reduction in the predicted phosphorylation score for S1224, from 0.997 to 0.96, 
however no other difference in post-translational modification of the channel was observed. 
Methionine residues are sensitive to redox agents, and it is possible that the R1222M mutation 
introduces redox sensitivity to the region, thus a lab based investigation into REDOX agent sensitivity 
in this region would of interest.  
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Figure 3.27- Investigation into nsSNP: R1222G and R1222M 
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Figure 3.27- Investigation into nsSNP: R1222G and R1222M. Summary of bioinformatics data for the 
A) R1222G and B) R1222M nsSNPs. A schematic indicating the location of the mutations in the BK 
channel, the flanking amino acid sequence and the chemical structure of arginine (R), glycine (G) and 
methionine (M) amino acid residues. Also included are details of the program and individual/s that the 
mutation was discovered in. The NetPhos 2.0 predicted phosphorylation score for the wild-type 
channel and the two mutants are plotted, as well as the damaging score allocated to each of the 
mutants by SIFT and PolyPhen-2. Damage scoring software SIFT and PolyPhen-2 predicted this 
mutation to be damaging.  
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3.3 Discussion 
The aim of the work in bioinformatics chapter was firstly to capture key aspects of data relating to the 
BK channel contained within databases and to compile this information into a BK channel ‘map’, a 
resource in which the key structural and functional information, plus post-translational modification 
and site-directed mutagenesis sites on the BK channel could be assessed ‘at a glance’. Subsequently, 
the aim was to use this resource to prioritise potentially damaging single-nucleotide polymorphisms 
for lab-based experimentation by investigating the location of SNPs in relation to the key features of 
the channel.  
 
3.3.1 Creation of an ‘at a glance’ resource for the BK channel  
The primary aim was achieved, as it was possible to create an ‘at a glance’ resource for the BK channel 
containing key domains of importance, which is the first of its kind. This resource contains information 
analysed and synthesised from a variety of databases and incorporates information from a range of 
software tools. The ‘map’ is based on the amino acid sequence of the BK channel canonical transcript 
and incorporates: the location of channel structural domains, the 167 unique nsSNP on the channel; 
and the location of 83 predicted sites of phosphorylation. The bioinformatics approach has also lead 
to the production of a list of the location and impact of site-directed mutagenesis on the BK channel, 
data that exists partially in databases and in publications, but has yet to be collated into a single 
resource.  
The mining of the data has led to the creation of new insights into the BK channel such as, a) the 
relative proportions of predicted and experimentally verified post-translational modification sites, b) 
the extent of agreement between the damage score categories calculated by SIFT and PolyPhen-2 for 
BK channel nsSNP, and c) and the extent of co-localisation between nsSNP and structural, functional, 
post-translational modification and site-directed mutagenesis sites. These figures were constructed in 
collaboration with a graphic designer to ensure that the results were presented in a simple, aesthetic 
and informative way, with the aim that the key features and themes were easier to identify and 
appraise. Evidence of the aesthetic method of data presentation is displayed throughout the chapter 
and particularly in the figures displaying co-localisation of nsSNP with structural and functional sites, 
and the figures illustrating the results of a detailed nsSNP bioinformatics investigation. Previous studies 
have successfully assessed the occurrence and damaging potential of nsSNP in a gene using an 
algorithmic approach (Teng et al., 2012; Ghaedi et al., 2015; Liu et al., 2015; Alipoor et al., 2016), 
however there is no evidence of studies using a graphical and schematic approach such as used in this 
thesis to present results. Uniprot and Ensembl databases do provide basic gene and protein 
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schematics, as shown in the (general methods chapter) which do provide a good basis for 
understanding the positions of key sites on the gene/protein. Assessment of the effectiveness of a 
graphical data presentation method in comparison to an algorithmic method was not within the scope 
of this thesis; however, recent publications have discussed the importance of drawing compelling 
figures to aid scientific communication and ensure that data ‘doesn’t go unnoticed’; the use of a 
specialist graphic designer is also advocated (Rolandi, Cheng and Pérez-Kriz, 2011; Riccomini, 2013; 
Cheng and Rolandi, 2015; Rodríguez Estrada and Davis, 2015). 
 
3.3.2 Prioritised BK channel genetic variations may affect channel function via altered post-
translational modification. 
This study demonstrated that it is possible to prioritise single nucleotide polymorphisms using the BK 
channel resource created in this research project, and this achieves the second main aim of the study. 
Cross-referencing of information within the resource highlighted the existence of nsSNP with the 
potential to affect BK channel function; 8 single nucleotide polymorphisms where prioritised for 
further bioinformatics investigation (H120Q, G122A, Y359N, G694C, G694V, S722L, R1222G and 
R1222M). Three of the mutations resulted in significant changes to the predicted palmitoylation status 
of neighbouring cysteine residues.  
Firstly, predicted palmitoylation of the C121 residue in the S0-S1 loop, a residue proven to be 
important to the membrane translocation of the channel (Jeffries, 2010; Jeffries et al., 2010), was 
abolished upon the introduction of the nsSNP H120Q, identified by the ESP project in the exome of an 
unidentified individual. On the other hand, nsSNP G122A, identified in the exome screen of a Utah 
European subject by the 1000 genomes project, resulted in an increase in the predicted palmitoylation 
score of C121. Introduction of the G694C mutant to the amino acid sequence coding for the haeme 
binding domain and REDOX sensitivity motif introduced a new cysteine rich domain. As palmitoylation 
modulates BK channel function (Tian et al., 2008; Jeffries, 2010; Zhou et al., 2012), the abolition or 
introduction of palmitoylation sites has the potential to affect the proper functioning of the channel. 
Due to the locations of the mutations, this may manifest as altered membrane translocation (H120Q 
and G122A) and changes to haeme binding affinity and sensitivity to REDOX agents (G694C).  
Altered palmitoylation status of cysteine residues, as a result of endogenous genetic mutation, has 
previously been shown to affect ion channel function. Mutation C981F (rs199473591), was identified 
in cardiac voltage-gated sodium channels (Nav1.5) as a result of an exome screening project in those 
suffering from Long QT Syndrome (LQTS) (Kapplinger et al., 2009). Cysteine residue C981 was predicted 
to be palmitoylated by CSS-Palm 3.0, and site directed mutagenesis of this site from cysteine to 
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phenylalanine resulted in slowed inactivation of the channel, paradoxically accompanied by 
enhancement of closed-state inactivation leading to multiple openings of the channel during a single 
action potential. These factors combined to result in the increased duration of high intracellular 
sodium concentration, leading to extended depolarisation and LQTS. This demonstrates another 
potential link between mutations causing palmitoylation status alterations and disease. An Ensembl 
review of SIFT and PolyPhen-2 revealed that the databases were not in agreement; damaging category 
of the C981F mutation was of 0.36 (tolerated) and 0.99 (probably damaging) respectively.  
Cysteine binding at the highly reactive sulfhydryl groups creates a dimer containing a disulphide bridge 
between two cysteines; as a result the effect of cysteine residues on protein structure and stability has 
been the focus of investigations (Tatara, Yoshida and Ichishima, 2005; Linder and Deschenes, 2007; 
Qiu et al., 2015; Tao Liu et al., 2016). This once again provides support for the prioritisation of nsSNPs 
that change the local cysteine environment.  
Another nsSNP with an effect on the surrounding post-translational environment is Y359N, which was 
identified via exome screening of a 36-year-old by the COSMIC project, and resulted in the removal of 
a tyrosine residue predicted to be phosphorylated by NetPhos 2.0. This mutation is of importance due 
to its proximity to the pore forming domain containing the potassium selectivity domain, which sits 
immediately upstream of the mutation. Whilst this mutation introduced a potential N-glycosylation 
site, this was not predicted by the NetNGlyc software. Site directed mutagenesis of amino acids within 
and in the proximity of the pore-forming region and selectivity filter were associated with gain and loss 
of function changes. Examples such as the GYG354-356AAA mutation which resulted in loss of function 
of the channel (Quirk and Reinhart, 2001) and T352S which resulted in a channel activated at more 
negative voltages and with a slower rate of inactivation (Gordon et al., 2010). There is no published 
experimental data verifying Y359 as a site of phosphorylation, and therefore the consequence of its 
removal from the sequence cannot be determined. However, as Y359 is situated within the membrane, 
it is unlikely the kinase or phosphatase enzymes would be able to gain access to the site and thus Y359 
is not thought to be phosphorylated. Mutation of tyrosine in this highly-conserved domain may 
however result in a change of ion selectivity or conductance as was shown when residues 354, 355 and 
356 were mutated; this potential effect could be tested using electrophysiology.  
However, as the site-directed mutagenesis results suggest that mutations proximal to the pore forming 
and selectivity domains perturb channel function, the mutation was an ideal candidate for 
prioritisation.  
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3.3.3 Additional Findings 
Despite differences in the number of predicted sites, the frequency of predicted phosphorylation 
and palmitoylation on the BK channel is similar. 
Analysis of the data uncovered that although the number and frequency of predicted palmitoylation 
and phosphorylation sites on the BK channel were considerably different (8 vs 83 sites respectively, 
and frequency of 1 in 14 vs 1 in 155 respectively), when the frequency assessment was adjusted from 
incorporating all amino acid residues, to including only those amino acids that could participate in the 
post-translational modification, the rates of the two modification were similar (1 in 3 and 1 in 4 
respectively). This was not the case for the other post-translational modifications investigated; S-
nitrosylation had a frequency of 1 in 7 cysteine residues, SUMOylation 1 in 16 lysine residues and N-
glycosylation 1 in 22 asparagine residues. This finding suggests that phosphorylation and 
palmitoylation are the most common post-translational modifications on the BK channel. Given the 
extensive research proving the effects of phosphorylation and palmitoylation on BK channel function 
as reviewed by (Nishi, Hashimoto and Panchenko, 2011; Contet, 2016), nsSNP affecting these 
processes would be of high priority for future investigation. As there is no known publication detailing 
the comparative occurrence of post-translational modifications per amino acid for the BK channel, the 
results obtained here cannot be compared. However, whilst the rate of respective PTMs have not been 
compared, publications exist that compile evidence of verified PTMs for proteins (Levitan, 1994; 
Dephoure et al., 2013; Voolstra and Huber, 2014; Shipston and Tian, 2016). 
 
BK channel linker regions are subject to greater nsSNP co-localisation than transmembrane domains 
Linker regions have been associated with flexibility, variation and modulation of protein function 
across proteins via a range of protein-protein interactions and PTMs (as reviewed by Ma et al., 2011), 
whilst TMDs are considered to be more conserved. One of the objectives of the work in this chapter 
was to determine the extent of co-localisation between nsSNP and key regions of the channel, such as 
structural domains. Compilation of the BK channel resource highlighted a small imbalance between 
nsSNP occurring in the transmembrane domains and in the linker regions, with a rate of 1 nsSNP per 
11 amino acids and 1 nsSNP per 8 amino acids respectively. In support of this finding, a 2014 masters 
study investigating the occurrence of variations in exonic regions of DNA found that nsSNP occurrence 
in the transmembrane domains was significantly less than in linker regions (Petty, 2014). Therefore, 
the higher rate of nsSNP in BK channel linker regions is in line with existing evidence.  
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S0-S1 linker region is one of frequent and varied post-translational modification 
The S0-S1 linker has been established as a region associated with channel translocation to the cell 
membrane via palmitoylation of cysteine residues (Jeffries, 2010; Jeffries et al., 2010), and thus a link 
with this region and post-translational modification has already been established. However, the 
assessment highlighted that it is not only palmitoylation that is predicted to occur in this region; as 
well as the 3 palmitoylated cysteine residues, there were 6 sites of predicted phosphorylation and 1 
site of predicted N-glycosylation. The predicted post-translational modification frequency of 
phosphorylation, palmitoylation and N-glycosylation is greater in the S0-S1 loop than in the rest of the 
linker regions; the frequency was 1 in 2, 1 in 1 and 1 in 2 respectively, in comparison to 1 in 3 and 1 in 
4 and 1 in 19 respectively in the linker regions as a whole. Processes other than membrane 
translocation are associated with the S0-S1 linker, such as calcium sensitivity (Braun and Sy, 2001) and 
ethanol response (Jianxi Liu et al., 2006); thus the high level of post-translational modification in the 
region may relate to the mechanisms for these processes, or may be an indicator of function that has 
yet to be determined. For this reason, the S0-S1 loop would make an ideal target for future 
investigation.  
 
3.3.4 Study Challenges  
A number of challenges arose in using a bioinformatics methodology as a tool in the creation of the BK 
channel resource and in the process of prioritisation of nsSNP for further research.   
 
Bioinformatics prediction software outputs should be treated as hypothesis generating due to 
inherent limitations  
Whilst the use of nsSNP damage prediction software is a useful tool to facilitate the prioritisation 
nsSNPs, findings should be treated as hypothesis generating, due to issues of accuracy of prediction. 
For example, SNPs that have been shown by site-directed mutagenesis to perturb BK channel function 
were classified by the damage prediction software as ‘tolerated’ or ‘benign’. An example of this is single 
nucleotide polymorphism S722L, which occurs in the hypoxia sensing motif spanning from C721 to 
C723 in the STREX splice insert, and is also a predicted to be a phosphorylation site by NetPhos 2.0 
software. Inclusion of this mutation into the BK channel amino acid sequence did not result in a change 
in the local predicted post-translational modification environment; however, site-directed 
mutagenesis experimentation showed that S722A mutation results in loss of hypoxia sensitivity 
(McCartney et al., 2005), proving that mutation at that site had an effect on BK channel function. 
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However, this mutation was not predicted to be damaging to channel function by nsSNP damage 
software. This discrepancy between validated experimental results and the predictions of 
bioinformatics tools was also highlighted in instances of disagreement in the damage score allocated 
by SIFT and PolyPhen-2. The most notable example of this is D434G (the mutation associated with 
Generalized Epilepsy and Paroxysmal Dyskinesia) which was categorised as tolerated by SIFT, and 
probably damaging by PolyPhen-2.  
The appraisal of nsSNP damage prediction software is challenging as the algorithms used to assign a 
damaging score to mutations are extremely complex, however the inconsistency between the lab 
based results and software programs may be due to a number of factors. Firstly, it could be related to 
the method of algorithm improvement and development; PolyPhen-2 predictive software is ‘trained’ 
with the location and consequences of nsSNP from previous lab based experimentation, whilst SIFT is 
not (Adzhubei, Jordan and Sunyaev, 2013). This may be the cause behind the PolyPhen-2 damage 
category allocation of ‘probably damaging’ for D434G, whilst SIFT having not being trained with this 
mutation has no information in the algorithm to indicate a change in BK channel function. Whilst 
training of prediction algorithms with verified results can be advantageous, the fact still remains that 
site directed mutagenesis investigations often can only assess for effect of the mutant on one or two 
variables. Thus, it is unlikely that the software has the complexity to accurately predict damage on a 
multifactorial basis; for example, the software may have difficulty accurately classifying a mutation 
that effects channel translocation to the membrane, but does not have an effect on channel kinetics 
once in the membrane. 
Another explanation for the inconsistency between lab based results and software programs is the 
limitation of sequence-based characterisation and multiple sequence alignment used by the programs 
as methods of nsSNP damage estimation (Sim et al., 2012; Adzhubei, Jordan and Sunyaev, 2013). This 
method aligns proteins with a similar amino acid sequence over the region of interest, and allocates a 
nsSNP damage score based upon information on structural and functional information (such as 
annotation of the region as a transmembrane domain or a functional site) from hundreds of proteins. 
This may mean that in areas crucial for effect in many proteins of the same type (such as voltage 
sensing domain and ion selectivity motif in voltage gated channels), mutations in these regions will be 
consistently classified as damaging, but in other regions such as the S6-RCK1 linker, where a functional 
relationship has not been widely established, these methods are not capable of predicting harm 
without the ability to incorporate experimentally verified data into the scoring system.  
There also are challenges with the accuracy of post-translational modification prediction software; for 
example, there are instances where post-translational modification is predicted to occur in the 
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transmembrane domains (S248, N265, T617, C845 and S1041). There is limited experimental data to 
support this (Kordyukova et al., 2008, 2010); therefore, it raises the question of whether the sites were 
predicted as a result of sequence alignment with other proteins which the sites are not within the 
transmembrane domain. Whilst it is known that PTM prediction software use a variety of methods and 
information types to determine the likelihood of PTM at a site, it is not possible as a tool user to 
ascertain the specific information used in the calculation of the score for a specific residue.  
In the process of data gathering using bioinformatics resources another challenge arose with PTM 
identification. Phosphorylation can occur on histidine residues (Besant, Tan and Attwood, 2003; Zu, 
Besant and Attwood, 2008; Wieland et al., 2010; Wieland and Attwood, 2015), however, the NetPhos 
2.0 software has not been updated to reflect this evidence. This is another example to highlight that 
bioinformatics tools are reliant on algorithm updates to produce accurate results.  
The bioinformatics tools discussed above have been developed to be generic to permit the assessment 
of any genome or protein; this has enabled the successful collation and examination of key areas on 
the BK channel without the need for experimental analysis. However, this ‘wide net’ approach means 
that when looking in detail at a specific gene or protein, discrepancies may come to light; this is likely 
because many of the algorithms (such as SIFT) do not incorporate BK specific experimental results 
comprehensively. As a result, the intention is not to rely solely on predictions but to prioritise nsSNP 
using a combination of bioinformatics tools and experimental evidence, and to verify experimentally 
the predicted effect of the selected nsSNP on BK channel function. Whilst a number of examples of 
bioinformatics tools and experimental result mismatch have been discussed, the tools provide a useful 
guide for further experimentation.  
 
The reliability of bioinformatics investigation results may be limited by the quality of data input and 
the method of data validation 
The accuracy and quality of the data included in bioinformatics database and software determines 
reliability of any assessment using a bioinformatics methodology. This begins with the accuracy of the 
protein or base sequence of a protein uploaded into the database. It is difficult to determine if the data 
entered is consistent and has it been verified against more than one source, however the advantage 
in using the canonical version of the BK channel is that it is part of the CCDS and thus sequence 
information associated with that transcript has been validated and is consistent across databases.  
The level of certainty decreases when looking at the verification of post-translational modifications, 
which can be undertaken using several different methods, and are not included in a consensus project 
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to ensure quality and accuracy of results. For example, 5 post-translational modification sites on the 
BK channel, all of phosphorylation, were identified using mass spectroscopy (S778, S782, S978, S982 
and T970); this method has advantages and disadvantages. Mass spectroscopy enables the analysis of 
complex mixtures of proteins in a high throughput fashion (Aebersold and Mann, 2003) and has been 
quoted as a ‘hypothesis generating engine’ for the identification of hundreds of different PTM types 
at multiple amino acid locations (Cravatt, Simon and Yates, 2007; Parker et al., 2010; Doll and 
Burlingame, 2015). Over and above the high diversity of modifications that can be detected and high 
speed of analysis, the use of mass spectroscopy is advantageous because isolation of the specific region 
of analysis is not required, as is the case with site directed mutagenesis experimentation. In addition, 
the ability to quickly determine the nature and quantity of relative changes in PTM occupancy at 
specific amino acid sites is advantageous (Larsen et al., 2006), as it increases the number of 
experiments that can be run in a set time, in comparison to techniques such as site-directed 
mutagenesis. 
However, the technique is not without flaws; in a 2016 review article, the common errors associated 
with the detection of PTMs using mass spectroscopy are discussed (Kim, Zhong and Pandey, 2016). 
One of the errors addressed in the study is that the incorrect PTM can be associated with a protein 
because the of mass of two separate moieties being very similar; for example, phosphorylation 
(79.96633 Da) and O-sulfonation (79.95682 Da) are extremely similar in mass and occur on the same 
amino acid residues (i.e. serine, threonine and tyrosine) and thus the modifications can be 
inappropriately allocated. Another error that can occur using mass spectroscopy is that the PTM can 
be allocated to the incorrect amino acid residue, particularly when there are multiple residues of the 
same type neighbouring each other, such as in the serine rich domains in the N and C termini. 
Therefore, sites of interest identified using this method should ideally be verified using another 
method in addition. Phosphorylation site T763 is an example where this process was undertaken. The 
PTM site was initially identified in BK channels located in rat brain using mass spectroscopy (Yan et al., 
2008), but was then verified using SDM of the site in the BK channels of chicken cochlea (Bai et al., 
2012). Site directed mutagenesis was used to verify the majority of post-translational modification 
sites documented in this chapter, likely due to the ability to test the effect of the removal of a predicted 
site on factors such as channel activity.  
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BK channel post-translational modification and site-directed mutagenesis lists in bioinformatics 
databases are not comprehensive 
Whilst bioinformatics databases such as UniProt contain information on the location and result of site-
directed mutagenesis and experimentally verified sites of post-translational modification on the BK 
channel, there is currently no database which list the sites comprehensively. Consequently, the 
compilation of verified sites of post-translational modification and location of site-directed 
mutagenesis listed in this chapter was extremely challenging and time-consuming to produce. This is 
partly due to difficulty in gaining access to the publications themselves, and secondly, in locating the 
amino acid residue mutated in the publication. This was due to differences in the transcript used 
(species or transcript length) and the detail to which the location of the amino acid was described.  
Experiments have taken place using BK channels constructs of differing amino acid composition or in 
species other than human. Consequently, time was spent determining the equivalent amino acid 
location on the human BK canonical transcript to produce the list of verified post-translational 
modification and site-directed mutagenesis sites. As a result, the sites compiled in this resource may 
not be comprehensive, but the lists serve as a current best estimate of the research conducted on the 
BK channel, and a basis for future study to compile a comprehensive list.  
 
Bioinformatics rapidly evolves 
The field of bioinformatics is a rapidly growing and evolving one, with tens of terabytes of new data 
uploaded to databases daily (Baker et al., 2000; Marx, 2013). Projects such as ExAC and the 100,000 
genomes progress knowledge by increasing the number of accurately sequenced exomes and genomes 
uploaded into the public domain via free to access databases. This constant upload of information, and 
the development and improvement of the methodologies means that information rarely remains static 
in the major bioinformatics databases. The work conducted in this thesis serves to provide a snapshot 
of BK channel information across several different bioinformatics databases and software, whilst 
compiling this with data in journal articles, still to be integrated into the databases.   
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3.3.5 Implications and practical application 
The need for specialised BK channel biocuration 
To create a resource containing the key domains associated with the BK channel, and achieve one of 
the primary aims of the chapter, information on the channel was taken from a number of sources such 
as bioinformatics databases, predictive software programs and published literature; this information 
was cross-referenced. This process required access to data from multiple disparate fields, ranging from 
basic genetics to mass spectroscopy and predictive algorithms and integration of this information with 
an understanding of BK channel structure and function. The cross-referencing and validation of 
biological information from multiple sources, with consideration for the functional properties of the 
protein, is also referred to as biocuration.  
Examples of biocuration performed in this chapter were a) the removal of duplication from the 224 
nsSNP initially associated with the BK channel by the Ensembl database down to 167 unique nsSNP, b) 
extracting the amino acid location of BK channel mutagenesis and PTM validation experiments from 
publications and locating the equivalent amino acid residue in the canonical human BK channel 
construct and c) compiling information on the amino acid locations of BK channel nsSNPs, structural 
and functional domains and creating a figure illustrating the extent of co-localisation.   
Bioinformatics requires biocuration to increase the reliability and accuracy of the data held within the 
databases (Howe and Yon, 2008); however as described, this is a complex process which is time 
consuming and labour intensive. An example specific to this thesis was the collation of the location 
and consequence of sites of site-directed mutagenesis, which was extremely challenging. It has been 
quoted to take a minimum of five times longer to do the basic analysis of data than to upload it into 
databases (Mangubat 2016). Furthermore, the work of biocuration is rarely given recognition equal to 
projects that add to the amount of data in the databases (such as the ExAC, 1000 genomes and ESP 
studies) (Howe and Yon, 2008; Burge et al., 2012; Mitchell et al., 2015). Biocuration at this stage is 
unable to be fully automated due to the complexity of the task, as it requires knowledge of multiple 
areas of bioinformatics, such as PTM, SNP damage prediction software, and molecular science such as 
SDM and physical science such as mass spectroscopy. Thus, analysis and sorting of the data must be 
tailored and adjusted specifically to answer the specific question at hand. As a result of the complexity, 
high workload, restricted timelines and low funding in comparison to data generation projects, 
biocuration has been typically restricted to expert and PhD level analysis as a minimum level of 
qualification (Hirschman et al., 2012; Mitchell et al., 2015; Reiser et al., 2016).  
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The creation of a dedicated BK channel bioinformatics database 
The work in this chapter was successful in creating a paper-based resource (a thesis) for the BK channel 
and its key sites. The next step would be to process and map the steps taken to collate and curate the 
information, to enable the identification of the drivers and barriers and to minimise some of the 
challenges with a view to create an online BK channel specific database or software tool. One of the 
desired outcomes of a BK channel specific online resource would be to enable specialists in BK channel 
research, and a wider scientific audience, to access experimental data from a range of labs effectively 
and efficiently. This would be possible as the data would be collated at one site (likely a website or 
database) with instant access to the results rather than the delays associated drawing information 
from a range of sources such as peer review publication and other data resources. Another desired 
outcome would be the rapid and comprehensive validation of BK channel information contained within 
the database; this would be achieved by specialist ion channel researchers reviewing and assessing 
data uploaded into the system regularly. It is hoped that the time spent undertaking biocuration could 
be reduced, as the data within the database would be more comprehensive and constructs used in site 
directed mutagenesis or post-translational modification site verification could be instantly aligned, 
pinpointing the location of each mutation or PTM site for each isoform of the BK channel.  
A BK channel specific resource does not currently exist, though dedicated bioinformatics resources 
have been developed for other ion channels. For example, KvSNP (available at 
http://www.bioinformatics.leeds.ac.uk/KvDB/KvSNP.html); is a database dedicated to predicting the 
damaging potential of genetic mutations occurring on voltage-gated potassium (Kv) channel genes 
(Stead et al., 2011). ‘VKCDB’ (available at http://vkcdb.biology.ualberta.ca/index.php); is a multi-
organism sequence database of Kv channels (Gallin and Boutet, 2010) and ‘Channelpedia’ an ion 
channel specific database (available at http://channelpedia.epfl.ch/), attempts to create an 
information management framework to collectively build ion channel knowledge base by 
accommodating both structured and unstructured data (Ranjan et al., 2011). Whilst this latter 
database did have a sub-section for calcium gated potassium channels, it did not contain sufficient 
information on the BK channel and therefore could not be used as a reference source for data 
collection in this chapter.  
Creation of specific bioinformatics databases and software programs has been extended to other 
proteins such as protein kinases (Torkamani and Schork, 2007; Lahiry et al., 2010) available at 
http://sequoia.ucsf.edu/ksd/, where the prediction accuracy for damaging nsSNP was increased from 
74% to 83% in comparison to whole genome prediction methods. A database has been created to store 
information on G protein-coupled receptors (GPCRs) (Elefsinioti et al., 2004) available at 
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http://bioinformatics.biol.uoa.gr/gpDB/. These are a small number of examples where the need for 
protein specific resource was identified, and databases and tools were built to address this need. 
To create a specific database software program for the BK channel a number of steps would need to 
take place; the publications listed above provide an example of what information and processes would 
be required. Examples include the collation of the most up-to-date structural information for the BK 
channel, available from databases as well as recent BK channel publications (Tao, Hite and MacKinnon, 
2016), collation of SNP information from a number of sources both bioinformatics and literature and 
the selection of a machine learning model for the BK channel (Lin and Chen, 2015). Availability of open 
access databases and the formation of a consortium of researchers who specialise in the BK channel 
would likely be necessary to achieve this goal. Whilst challenges such as intellectual property, financial 
support for the project and the recruitment of a bioinformatician with a specialty in BK channels must 
be overcome. A pilot study was launched to evaluate whether a subscription-based membership model 
would provide a sustainable funding source for a Arabidopsis thaliana specific biocuration database 
and avoid reliance on short term grants (Reiser et al., 2016).  
 
3.3.6 Future Work 
Selection of S0-S1 mutants for lab based experimentation 
One of the aims of the work conducted in this chapter was to prioritise BK channel nsSNPs for lab-
based investigation. This aim was achieved and 8 nsSNPs were prioritised and investigated in detail 
using information contained in the literature, in bioinformatics databases and through the use of 
bioinformatics software tools. Whilst all 8 mutations would be valid for future investigation, the 
mutants that will be taken forward for lab-based investigation in the next chapter will be H120Q and 
G122A located in the S0-S1 linker. As adjacent cysteine residue C121 is associated with modulating cell 
membrane translocation of the channel, lab-based investigations will focus on the effect of H120Q and 
G122A mutations on BK channel cellular distribution. Localisation to the cell membrane is required for 
BK channel function.  
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3.3.7 In summary 
The aim of this chapter was to organise specified aspects of BK channel information already contained 
within bioinformatics databases and convert them into an accessible form that is easy to understand, 
so that others looking to conduct research on the BK channel have access to a resource of collated 
information. Secondary to this, the aim was to use this information to prioritise nsSNP with the 
potential to perturb channel function, and forward them for lab based experimentation. To achieve 
this, a process of biocuration, which involves the manual cross-referencing of biological information 
held in databases and lab-based research, was utilised. These aims were successfully achieved and 
whilst 8 nsSNP were put forward for detailed bioinformatics assessment, mutations H120Q and G122A, 
located in the S0-S1 linker, were prioritised and selected for lab-based investigation due to their 
varying effect on the CSS-Palm 4.0 predicted palmitoylation status of C121, a cysteine residue proven 
to modulate cell membrane expression of the channel. H120Q and G122A were selected also because 
there is existing detailed information relating to the flanking cysteine residues (C118, C119 and C121) 
and palmitoylation of the S0-S1 linker. There was also the availability of existing tools to study SNP 
effects- such as BK channels incorporating cysteine residue mutations and the facilities to conduct 
confocal microscopy. These factors made H120Q and G122A the “best” targets for further 
investigation. A summary of the thesis workflow is included in Figure 3.28.  
 
There is no known published BK channel resource akin to the work produced in this chapter, making 
the resource a novel addition to the field. There is pressure to increase the speed of biocuration of 
bioinformatics data to ensure its usability and ability to positively influence lab based research. 
Therefore, future advancement avenues for this research would be to increase the extent of 
biocuration for the BK channel, and the creation of a dedicated online BK channel database software 
tool.  
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Figure 3.28- Schematic of thesis workflow: Summary of chapter 3. Described are the steps to be 
undertaken in this thesis work to identify new potential genetic targets for personalised medicine. 
Steps 1-6 have been successfully achieved in this chapter by the selection of the BK channel gene 
KCNMA1, the canonical BK channel transcript, the collation of available information, the biocuration 
of this work into a ‘BK channel resource’ and the prioritisation of nsSNP. Step 7 will be addressed in 
Chapter 4.  
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4 Lab-Based Chapter 
 
4.1 Introduction  
4.1.1 Amino acid residues of the BK channel S0-S1 linker and modulation of channel cell-
membrane expression 
In chapter 3, two endogenous single nucleotide polymorphisms (SNPs) in the S0-S1 loop of the BK 
channel (H120Q and G122A) were identified using a bioinformatics methodology and were prioritised 
for lab-based investigation. The decision was based on their proximity to, and predicted impact on 
palmitoylation of C121; a cysteine residue important for the cell membrane translocation of the BK 
channel. Introduction of the H120Q mutation into the canonical wild type BK channel sequence was 
predicted to result in the loss of C121 palmitoylation. On the other hand, the G122A mutation was 
predicted to increase the likelihood of C121 palmitoylation in comparison to wild type. The double 
mutant has a predicted palmitoylation score driven predominantly by G122A and thus has an increased 
likelihood of C121 palmitoylation in comparison to the wild type channel.  
Previously, investigations on S0-S1 loop cysteine mutations were conducted using the murine version 
of the BK channel (mSlo) (Jeffries, 2010; Jeffries et al., 2010). As the current lab-based investigation 
was carried out in a murine BK channel, the numbering of the human SNPs has been aligned with the 
murine channel sequence and numbering. Therefore, in this chapter the human SNPs H120Q and 
G122A will be referred to as the murine equivalents H55Q and G57A, and the potentially palmitoylated 
cysteine residues C118, C119 and C121, will be referred to as murine residues C53, C54 and C56 (Table 
4.1). An illustration of the amino acid changes resulting from the DNA mutations is included in the 
general methods chapter (chapter 2). As the mutants H55Q, G57A and H55Q:G57A were designed to 
mimic the human SNPs, they will now be referred to at the SNP-mimetic mutants.  
 
hSlo 
amino-acid 
numbering 
C118 C119 H120 C121 G122 
mSlo 
amino-acid 
numbering 
C53 C54 H55 C56 G57 
 
Table 4.1- Conversion of hSlo amino acid numbering to mSlo equivalent over residues of 
investigation in the S0-S1 linker   
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Palmitoylation of BK channel N-terminal cysteine residues C53, C54 and C56 located in the S0-S1 loop 
have been shown to modulate channel trafficking and surface expression in the HEK293 cell line 
(Jeffries, 2010; Jeffries et al., 2010; Bi, 2014; Kim et al., 2014). Mutation of these cysteine residues to 
alanine residues resulted in an almost complete cessation of channel palmitoylation and a two-fold 
reduction in membrane expression of the C53:54:56A mutant compared to the wild-type channel 
(ZERO) (Jeffries, 2010; Jeffries et al., 2010). Palmitoylation of the S0-S1 C53:54A mutant channel was 
reduced by 50% and membrane expression of the C53:C54A-YFP fusion protein was reduced by 70% 
in comparison to the wild type S0-S1 ZERO construct (Jeffries 2010).  
Of the three individual S0-S1 cysteine residues investigated, C56 had the greatest impact on channel 
membrane expression; with the S0-S1 C56A-YFP construct reducing cell membrane expression to 25% 
of control, in comparison to reductions to 31% and 64% for C53A-YFP and C54A-YFP respectively. The 
triple mutant (C53:54:56A-YFP) reduced expression to 13% of control, whilst expression of the triple 
mutation in the full-length channel reduced cell-membrane expression to 45% of wild-type (Jeffries, 
2010; Jeffries et al., 2010). A 50% reduction in BK channel membrane expression occurred when the 
C53:54:56A mutation was incorporated into rat BK channels (rSlo) transiently expressed in COS-7 cells 
(Kim et al., 2014). 
The SNP-mimetic mutants H55Q, G57A and H55Q:G57A have not previously been investigated for their 
impact on channel function or channel cellular distribution. However, incorporation of naturally 
occurring mutations into the BK channel and the subsequent expression of the channel in a mammalian 
cell model system has been successfully undertaken previously, as in the case of the D434 (Du et al., 
2005; Wang, Rothberg and Brenner, 2009; Yang et al., 2010) and A138V (Plante, 2016) mutations. 
These studies showed mutation-dependent effects on channel activity identified using patch-clamp 
electrophysiology. The effects on the cell-membrane expression of the channel were not investigated, 
therefore SNP-mimetic mutant channels could be interesting constructs to investigate the mechanisms 
involved in BK channel trafficking to the cell membrane.  
 
4.1.2 The potential for metabolic substrates to modulate the cell membrane expression of BK 
channel constructs.  
A range of factors, in addition to channel amino acid sequence, such as the exposure to changes in 
composition and concentration of key signalling and metabolic agents has been shown to influence 
the function of BK channels. Examples include oxygen concentration (Liu, Moczydlowski and Haddad, 
1999; Williams et al., 2004; McCartney et al., 2005; Cheng et al., 2008), pH levels (Avdonin, Tang and 
Hoshi, 2003) and exposure to alcohol (Dopico, Lemos and Treistman, 1996; Jakab, Weiger and 
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Hermann, 1997). Studies on the impact of metabolic status on BK channel function and distribution 
have examined rapid reversible changes (10 to 30 minutes), longer acute changes (24-48 hours), and 
chronic changes (3 days or longer) in cell culture conditions. However, these studies have not 
specifically examined the impact of metabolic status through the prism of the BK channel’s S0-S1 loop, 
nor investigated the influence of S0-S1 SNP–mimetic amino acid mutations in isolation nor in 
combination with alterations in metabolic status. Although an array of metabolic agents exists with 
the potential to alter cellular status, the decision was made to focus on three metabolic substrates: a) 
glucose, b) the C16 saturated fatty acid palmitate, and c) the C18:1 unsaturated fatty acid oleate. 
 
Rationale for glucose as a metabolic agent for investigation  
Glucose is a major substrate required for metabolic homeostasis and plays a role in a wide variety of 
cellular processes, enabled by activation of complex signalling cascades that link glucose with key 
processes, often via ‘the master metabolic regulator’ AMP-activated protein kinase (AMPK) (as 
reviewed by Hardie, Ross and Hawley, 2012) which is sensitive to the AMP-ADP-ATP ratio. 
Mitochondrial function and signalling is another major player in actioning the downstream effects of 
glucose concentration on metabolic homeostasis (Liesa and Shirihai, 2013; Pekkurnaz et al., 2014; 
Mishra and Chan, 2016). 
Glucose effects on cell metabolic status vary depending on the type and role of the cell. For example, 
research has shown that glucose concentration has modulatory and regulatory effects on signalling in 
the glucose sensitive pancreatic cells (Heimberg et al., 1993; Schuit et al., 1997; Jichun Yang et al., 
2005; Bagge et al., 2012; Broca et al., 2014), in insulin sensitive tissues such as skeletal muscle and  
adipocytes (Moore et al., 2012; Bijland, Mancini and Salt, 2013; Koutny, 2013; Stanford et al., 2013; 
Sakagami et al., 2014; Tunduguru et al., 2014; Yang, 2014; Sylow et al., 2015) as well as endothelial 
cells (Wang et al., 2012; Peiró et al., 2016). 
Some of the effects of glucose in mammalian cells are mediated by the BK channel; as it has been 
shown that high glucose concentrations can inhibit BK channels causing a significant reduction in cell 
apoptosis and increasing cell proliferation in HEK293 cells (Chang et al., 2011). The reduction in 
apoptosis is thought to be mediated by a reduction in potassium loss; loss of intracellular potassium 
has been shown to cause apoptotic cell shrinkage (Dallaporta et al., 1998), and activation of apoptotic 
pathways involving protease enzyme caspases family and members of the apoptosis regulator Bcl-2 
family amongst others (Elmore, 2007). 
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There is evidence that both acute and chronic changes in glucose concentration can impact on BK 
channel expression and translocation to the cell membrane. For, example, mouse renal podocytes 
endogenously expressing BK channels were cultured in 11.1mM and 36.1mM glucose for 24 or 72 
hours; western-blot assay revealed no significant difference in total BK channel expression with 
glucose concentration, though exposure to the higher glucose concentration resulted in a significant 
70% decrease in BK channel cell membrane expression in the 24 and 72-hour exposure groups (Kim 
and Dryer, 2011). In the same publication, 25mM mannitol used in combination with 11.1mM glucose 
revealed that the changes were not due to alterations in osmotic pressure. 
Investigation of BK channel cellular distribution in response to a reduction in glucose concentration 
may have implications for our understanding of the regulation of processes such as vascular tone, 
neuronal function and hormone release in the pancreas; dysregulation of these processes is implicated 
in the development and progression of diabetes and its associated co-morbidities. BK channels are 
required to be located in the cell membrane in order to function as modulators of membrane potential 
or calcium signals and integrators of phosphorylation and lipid signalling; thus, investigating if glucose 
concentration alters channel distribution would be a step closer to understanding the processes 
involved in the growing link between the BK channel and metabolic dysregulation. The specific culture 
medium adjustment chosen was a reduction in extracellular glucose from 25mM to 5mM; this choice 
was driven by; a) 5mM being within the normal blood glucose range for humans (4mM to 6mM), and 
b) the fact that a considerable number of studies have used this concentration to test the effect glucose 
on different processes (Nutt and O’Neil, 2000; Moritz et al., 2001; Lin et al., 2005; Smith et al., 2006; 
Daoyan Liu et al., 2008; Chang et al., 2011; Sun et al., 2013; Viskupicova et al., 2015), thus making the 
data outputs from this study comparable. 
 
Rationale for palmitate as a metabolic agent for investigation  
The saturated fatty acid, palmitate (C16:0), is the principal product of the fatty acid synthase system 
in mammalian cells and is the precursor of other long-chain fatty acids such as stearate (C18:0) and 
arachidonate (C20:4). Palmitate is one of the most common fatty acids found in human serum and 
tissues, with large peaks in concentration observed in the post-prandial phase (Kingsbury et al., 1961; 
Miles et al., 2003; Sabin et al., 2007; Abdelmagid et al., 2015).  
Several studies have shown that an increased extracellular concentration of palmitate elicits a change 
in cellular processes. Examples include altered autophagy regulation in human aortic endothelial cells 
mediated by diminished AMPK activity, and increased phosphorylation of previously inactive kinase 
enzymes (Weikel et al., 2014), induction of apoptosis in hepatocytes via activation of protein kinase C 
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(Cai et al., 2014), increased expression of interleukin-6, a cytokine with an inflammation modulating 
role, in human myotubules (Staiger et al., 2004; Weigert et al., 2004) and to increase the protein 
expression of the pseudo-kinase Tribbles homolog 3 (TRB3) (Morse et al., 2010; Yan et al., 2014).  
Palmitate has also been shown to affect the cell membrane expression of proteins; when human 
monocytic (THP-1) cells were exposed to palmitate at 0.3mM, the cell membrane expression of the 
integrins CD11b and CD36 was increased by over 60% (Pararasa, 2013). While exposure to 0.4mM 
palmitate for 8 hours increased by more than 2-fold tumour necrosis factor-related apoptosis-inducing 
ligand (TRAIL) death receptor 5 (DR5) cell surface expression in Huh-7 cells (Cazanave et al., 2011).  
Furthermore, high concentrations of extracellular palmitate (0.2-0.6mM) can impair stimulus-induced 
insulin secretion and induce beta cell apoptosis (Hagman et al., 2005; Watson et al., 2011; Broca et al., 
2014). 
High glucose and palmitate concentrations are hypothesised to have a cumulative effect on a range of 
cellular processes including: increased autophagy in endothelial cells cultured in 40mM glucose and 
0.5mM palmitate (Jiaqi Liu et al., 2016) and in HUVEC cells cultured in 25mM glucose and 0.4mM 
palmitate (Yanxia Liu et al., 2016); increased bone morphogenic protein (BMP4) expression in HUVEC 
cells cultured in 27.8mM glucose and 0.5mM palmitate for 24 hours (Hong et al., 2016); and increased 
P2X7 and P2X4 expression in HUVEC cells cultured in 30mM glucose and 0.15mM palmitate for 24 
hours (Sathanoori et al., 2015).  
There is also evidence to indicate that the combination of glucose and palmitate at high concentrations 
has a pronounced effect in pancreatic β-cells (Remizov et al., 2003; Poitout and Robertson, 2008; Maris 
et al., 2013), with some studies attributing this to a drastic increase in the formation of ceramide and 
associated increase in nitrous oxide (NO) production (Paumen et al., 1997; Shimabukuro et al., 1998; 
Maedler et al., 2003), others attributing the effect to oxidative stress (Okuyama, Fujiwara and Ohsumi, 
2003; Elsner, Gehrmann and Lenzen, 2011) or more specifically ER stress induced by calcium depletion 
in the ER (Cunha et al., 2008; Cnop et al., 2010). The nature of the more significant effect of 
‘glucolipotoxicity’ on beta cell behaviour and the handling of cellular components is likely due to the 
acute sensitivity required for their role as energy sensor and regulator of energy homeostasis (Parker 
et al., 2003; Remizov et al., 2003; Thorn, 2010; Watson et al., 2011; Martino et al., 2012; Maris et al., 
2013). 
The effects of palmitate toxicity have been shown to be mediated via ion channels; with apoptosis of 
HUVEC cells resulting from exposure to high concentrations of palmitate (0.25-8mM) linked to 
increased expression of the voltage activated potassium channel subtype Kv1.5 (Du et al., 2017). Kv1.5 
channel augmentation has been shown with palmitate addition to adult mouse ventricular myocytes 
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resulting in increased Kv1.5 peak outward current amplitude and is theorised to cause impairment of 
excitation-contraction coupling (Haim et al., 2010). A literature search did not identify research papers 
describing the effects of palmitate, or palmitate in conjunction with high glucose, on BK channel 
function, protein expression or cell membrane expression, thus identifying a gap in knowledge. The 
concentration of palmitate to be used in the investigation was 0.4mM as it is within the range found 
endogenously in human plasma (0.3mM to 4.1mM) (Abdelmagid et al., 2015), and within the range 
commonly used in research publications (0.2mM to 0.5mM) (Luiken et al., 1997; Staiger et al., 2004; 
Weigert et al., 2004; Bunn et al., 2010; Oberbach et al., 2012; Schilling et al., 2013; Weikel et al., 2014). 
 
Rationale for oleate as a metabolic agent for investigation  
The monounsaturated fatty acid, oleate (C18:1), alongside palmitate (C16:0) and stearate (C18:0) is 
one of the most common fatty acids found in humans, and is the second most abundant fatty acid in 
human tissues, behind palmitate (Kingsbury et al., 1961; Havel, Naimark and Borchgrevink, 1963; Miles 
et al., 2003; Sabin et al., 2007; Bergouignan et al., 2009). Oleate has been linked with physiological 
effects, such as reductions in blood pressure, in the frequency of cardiovascular events, and in certain 
forms of cancer in humans who consume a diet rich in oleate containing foods such as olive oil (Martin-
Moreno et al., 1994; Perona et al., 2004; Psaltopoulou et al., 2004; Terés et al., 2008).  
Oleate is commonly used in laboratory experiments as a fatty acid control for saturated lipids such as 
palmitate. Experiments have compared and contrasted the effects of this lipid on mitochondrial 
function, markers of ER stress, apoptosis, insulin signalling, insulin resistance and inflammation 
(Gaster, Rustan and Beck-Nielsen, 2005; Coll et al., 2008; Yuzefovych, Wilson and Rachek, 2010; Kwon, 
Lee and Querfurth, 2014; Hetherington et al., 2016). The majority of studies demonstrate that oleate 
has no significant effect on study endpoints in comparison to control, normally culture medium 
supplemented with bovine serum albumin (BSA). However, a small number of studies have shown that 
raised oleate can influence cellular processes. For example, incubation of the neural cell culture line 
N2a with 0.3mM oleate decreases mitochondrial superoxide levels, which are associated with 
oxidative damage and inflammation (Kwon, Lee and Querfurth, 2014), exposure to oleate at 1mM for 
48 hours resulted in cell death of hepatic stellate cells (Hetherington et al., 2016) and oleate exposure 
at 0.1mM increased the phosphorylation of Akt protein kinase (Hardy et al., 2005). 
As this current study focussed on the potential effects of oleate on cell membrane expression of a 
channel protein, a literature search was conducted to determine if oleate had any effect on protein 
cellular distribution. No consistent pattern seems obvious; exposure of neutrophils to 0.08mM oleate 
for 5 minutes resulted in a 2.5 fold increase in CD11b cell membrane expression (Mastrangelo, Jeitner 
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and Eaton, 1998), whilst HEK293 exposure to oleate at 0.1mM for 16 hours reduced membrane 
expression of sterol regulatory element-binding proteins (SREBPs) to 40% of control (Hannah et al., 
2001). In another study oleate had no significant impact on protein cell membrane localization (Benoit 
et al., 2009) but in others regulates the activity of adrenoceptor and G-protein activities, this effect has 
been theorised to be due to incorporation of oleate into the cell membrane, altering membrane 
structure (Funari, Barceló and Escribá, 2003; Prades et al., 2003; Q. Yang et al., 2005). 
There is no data readily available in the literature describing the effect of oleate on BK channel or ion 
channel cellular distribution. However there are publications describing the effects of oleate on BK 
channel activity; oleate has been show to increase BK channel activity in rabbit pulmonary arteries 
(Clarke et al., 2002), the rat pituitary tumour cell line (GH3) (Denson et al., 2000) and in Xenopus 
oocytes (Sun et al., 2007). In line with these studies, and results showing that the endogenous human 
plasma concentration of oleate can range between 0.03mM and 3.2mM (Abdelmagid et al., 2015), it 
was decided that a concentration of 0.4mM oleate would be used to investigate the impact of an 
unsaturated fatty acid on BK channel construct cellular distribution. 
 
Chapter Aims 
1. To investigate the impact of SNP-mimetic changes in BK channel sequence, by determining the 
cellular distribution of S0-S1 loop SNP-mimetic BK channel constructs in HEK293 cells and 
comparing the distribution to the wild-type channel (ZERO).  
2. To investigate the relationship between BK channel cellular distribution and the predicted 
linker,  1S-0palmitoylation scores of specific cysteine residues in the S by analysing the 
distribution of the wild-type BK channel, the SNP-mimetic and cysteine mutant BK channels in 
comparison with predicted palmitoylation software scoring.  
 
To date, there is no known published data describing the effects of glucose, or fatty acid concentration 
on the cell membrane expression of BK channels containing endogenous SNPs of the S0-S1 loop. Thus, 
the next aim of the experiments conducted in this chapter is: 
3. hour) in metabolic substrates on BK  48-24To investigate the impact of short term changes (
of channel cellular distribution associated with changes in  channels through analysis
type and -mimetic, wild-extracellular glucose, palmitate and oleate concentrations on SNP
cysteine mutant BK channels.   
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4.2 Results 
4.2.1 Assessment of the cellular distribution of the full-length wild-type BK channel construct 
(ZERO) in HEK293 cells cultured in 25mM glucose. 
One of the main aims of this research was to determine the impact of the SNP-mimetic mutants H55Q, 
G57A and H55Q:G57A on BK channel cellular distribution. In order to achieve this, it was necessary to 
first establish the baseline distribution of the wild-type ‘control’ isoform of the BK channel in the 
HEK293 cell line. The ZERO isoform of the BK channel was used as it forms functional units, and 
contains the S0-S1 loop, -the location of the SNP-mimetic mutations- as well as the key structural and 
functional regions used in the bioinformatics screen. The main difference between ZERO and the 
canonical form being the lack of the STREX splice insert in the intracellular linker between the RCK 
domains. Use of the BK channel isoform without the STREX insert was crucial, as the STREX variant 
contains cysteine residues (C12 and C13 in STREX amino acid numbering) shown to be palmitoylated 
and that contribute to the translocation of the channel to the cell membrane (Jeffries, 2010). These 
STREX located cysteine residues would complicate the interpretation of the impact of S0-S1 loop SNP-
mimetic induced changes to cellular distribution. and for this reason, the ZERO form without STREX 
was utilised for all imaging experiments. The control condition for the baseline experiments was 25mM 
glucose culture medium; this culture environment has been utilised in other studies investigating the 
effect of BK channel amino acid mutation on cell membrane expression (Jeffries, 2010; Bi, 2014) and 
serves to facilitate comparison. 
To estimate the proportion of BK channels in the cell membrane of HEK293 cells, the raw ratio was 
calculated as the total of red fluorescence – the amount of BK channel protein at the surface 
membrane- over the sum of red and green fluorescence -total BK channel protein in the HEK293 cells 
- with the green fluorescence capturing the intracellular distribution of channels). This proportion was 
calculated from analysis of field of view (FOV) images captured using confocal microscopy (Figure 4.1). 
The cell membrane-bound ratio of the ZERO channel (Figure 4.2A) was obtained from z-stacked ‘fields 
of view’ (FOV area 146µm2) of cells from three separate transfections. The numbers of HEK293 cells in 
each stack varied from three to fifteen (average 9 cells per FOV) and the number of optical slices (slice 
thickness 0.34-0.5μm) within each stack varied from nine to nineteen depending on the distribution 
and structure of the cells within the FOV. Figure 4.2A shows the raw ratio values and normalised values 
for the six separate stacks as well as the mean and standard deviation (SD) for the group, which are 
plotted in Figure 4.2B.  
Raw ratio values in this experiment set ranged from a minimum of 0.53 to a maximum of 0.68 for the 
stacks, with the average percentage of BK channels in the cell membrane of this group at the time of 
staining being 63 %, so a mean ratio of 0.63±0.05. This data is the product of a single experiment and 
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transfection (N=1) made up of six separate stacked fields of view (n=6); this nomenclature will be used 
throughout the rest of the manuscript. Figure 4.2C shows a plot of the raw ratio values from three 
separate experiments (N=1, n=6 for each), the results of which were combined to create the overall 
mean of the ZERO channel raw ratio in HEK293 cells cultured in 25mM glucose, which was 0.51 ± 0.11 
(Figure 4.2D). This approach indicated that it was possible to calculate the cellular distribution of the 
BK channel ZERO construct based on the double FLAG tag (red/green) methodology.  
When using red and green fluorescent markers to differentiate between membrane and intracellular 
distribution of the channel constructs, it was clear in the majority of slices and stacks that the two 
populations were clearly separate. However, when the red and green are adjacent or co-localised then 
there is the appearance of ‘orange’ as seen in slices 2 and 17 in Figure 4.1. These were taken from close 
to the top and bottom of the FOV stack comprised of 19 slices. To address the potential issue of 
membrane-bound and intracellular BK channel co-localisation, a co-localisation assessment of the 
image was undertaken using the image processing software Image J. The Pearson's correlation 
coefficient (PCC) value was 0.29 for the stack of cells; with the range from -1 to 1, with 1 indicating a 
total positive correlation (as red increases, green increases), 0 indicating no correlation and -1 
indicating total negative correlation (as red increases, green decreases). The results thus imply a low 
level of co-localization between red and green fluorescence in the cells overall.  
The double FLAG approach was therefore successful in determining that the membrane expression of 
ZERO in 25mM glucose was 51%. The next stage was to investigate the distribution of the SNP-mimetic 
mutants H55Q, G57A and H55Q:G57A, to determine their impact on the cellular distribution of BK 
channels.  
 
4.2.2 Assessment of the distribution of the SNP-mimetic BK channels constructs H55Q, G57A and 
H55Q:G57A in HEK293 cells cultured in 25mM glucose. 
The BK channel SNPs H55Q and G57A are of interest due to their potential effect on the probability of 
C56 cysteine residue palmitoylation in the intracellular S0-S1 region, as this cysteine residue has a 
modulatory role in channel cell membrane translocation. The naturally occurring H55Q and G57A 
mutations, and the synthetically produced combination of the two mutations, H55Q:G57A, were 
independently incorporated into the murine BK ZERO channel construct DNA and successfully 
transiently expressed in HEK293 cells. Exemplar confocal FOV images of the transfected cells with 
fluorescent channels labelling are shown in Figure 4.3.  
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Figure 4.1- The cellular distribution of ZERO channels expressed in HEK293 cells cultured in 25mM 
glucose. A series of exemplar confocal images of HEK293 cells cultured in 25mM glucose and 
transfected with the BK channel construct ZERO. Each row shows three field of view (FOV) images 
taken from towards the bottom, middle and top (slices 2, 11 and 17) of a Z-stack comprised of 19 slices. 
The top row shows the Red (Alexa® 546) labelling that shows FLAG-tagged BK channels located at the 
cell membrane, with antibody and fluorophore labelling taken place prior to cell permeabilisation. The 
middle row contains Green (Alexa® 488) labelled intracellular FLAG-tagged BK channels. This labelling 
having taken place after cell permeabilisation. The red and green channel images were then merged 
as shown in the bottom row. Images show HEK293 cells from the control group, cultured in 25mM 
glucose. Orange arrows indicate areas of ‘orange’ in the FOV that are discussed in the chapter text. 
Image intensity settings were adjusted for illustrative purposes; intensity settings were not altered in 
images used for quantitative analysis. FOV area 146µm2. 
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Figure 4.2- Analysis of the distribution of ZERO channels expressed in HEK293 cells cultured in 25mM 
glucose: Raw ratio and normalised values. A) The numerical values for the average raw ratio 
calculated for each of six individual stacked fields of view (n=6) from a single transfection/experiment 
(N=1), with the normalised value for each stack, which is a product of the individual raw ratio divided 
by the average for all six stacks (N=1, n=6). B) Scatter plot of the raw ratio values for the same 6 z-stack 
fields of view from a single transfection. Filled black circles indicate raw ratio values for each of the 
individual field of view stacks. The longer thinner horizontal line indicating the mean (0.63) for this 
group, and the thicker horizontal bars joined by a thin vertical line intersected by the mean indicates 
the range of a single standard deviation (SD): 0.05 in this case. C) Scatter plots of the raw ratio values 
for three separate experiments/transfections with the ZERO BK channel construct. The individual 
values of raw ratio for each stack, and the resulting means and SDs are shown (N=1, n=6 for each). D) 
Bar graph showing the mean raw ratio 0.51 ± 0.11 (N=3, n=18) that was calculated using the mean 
values from each FOV (n=18), rather than the average FOV value per experiment/transfection (N=3). 
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The raw ratio values for the SNP-mimetic mutant channels were determined, and ranged from 0.32 to 
0.53 in H55Q transfected cells, 0.41 to 0.67 in G57A transfected cells and 0.44 to 0.60 in H55Q:G57A 
transfected cells with the mean raw ratio value of the H55Q mutant significantly lower than that of the 
G57A (p<0.001) and H55Q:G57A (p<0.05) mutants; though all three SNP mimetic mutants were not 
significantly different in mean raw ratio from ZERO (Figure 4.4). The H55Q mutant had a smaller 
proportion of total channels located in the membrane at 44% vs 51% and 57% for ZERO and 
H55Q:G57A respectively. This data may reflect a trend whereby the SNP-mimetics have an effect on 
membrane distribution but do not support the hypothesis that they significantly alter the baseline 
cellular distribution in comparison to the wild-type channel ZERO in 25mM glucose.  
 
4.2.2.1 Relationship between cysteine residue predicted palmitoylation score and BK channel 
distribution 
Nonetheless, the data may indicate that there is a relationship between palmitoylation of the S0-S1 
loop cysteines and BK channel cell membrane insertion. If this is the case, then plotting the channel 
raw ratio against predicted palmitoylation score for the three cysteines should show a correlation. The 
first step was to plot the predicted palmitoylation scores for the three S0-S1 loop cysteines at C53, C54 
and C56 for the wildtype ZERO and three SNP-mimetic mutants. One challenge was that when using a 
high threshold setting for the CSS Palm prediction software, the H55Q mutant returned a score for C56 
of 0. This was overcome by setting a medium threshold in the CSS-Palm 4.0 software – that allowed 
the predicted score for the mutant to be calculated and did not alter the predicted scores returned for 
the other SNP mimetics.  
Figure 4.5A shows the predicted palmitoylation scores of the cysteines C53, C54 and C56 for ZERO and 
each of the SNP-mimetic mutants, expressed as a normalised ratio of the palmitoylation score and the 
palmitoylation threshold value calculated by CSS-Palm 4.0 software (see methods). The normalised 
predicted palmitoylation score is similar across the mutants for C53 and C54 (0.9 to 1.0; and 1.0 to 
1.1). In contrast, there are larger inter-mutant differences for C56 of 0.88 to 1.39 (Figure 4.5B), which 
has a similar in order/pattern to the normalised raw ratio values for the SNP-mimetics (Figure 4.4).  
An assessment of the relationship between the predicted palmitoylation score of cysteine resides and 
the cell membrane expression of ZERO and SNP-mimetic mutant BK channels (Figure 4.6) showed no 
correlation between predicted palmitoylation score and SNP-mimetic raw ratio for C53 and C54.  
Pearson’s correlation coefficient (PCC) value of +0.95 was obtained for C56, indicating a strong positive 
correlation between C56 predicted palmitoylation score and SNP-mimetic cell membrane expression.   
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Figure 4.3- Confocal images of BK channel SNP mimetic mutants H55Q, G57A and H55Q:G57A: 
channel cellular distribution in HEK293 cells cultured in 25mM glucose. Exemplar single field of view, 
mid-stack, confocal images of HEK cells cultured in 25mM glucose and transfected with H55Q (top 
row), G57A (middle row) or H55Q:G57A (bottom row). The left column shows the Red (Alexa® 546) 
labelling that indicates BK channels located at the cell membrane, as the labelling had taken place prior 
to permeabilization. The middle column contains Green (Alexa® 488) labelled intracellular BK channels, 
as this labelling took place after cell permeabilisation. The red and green channel images were then 
merged in the right-hand column. Images show HEK293 cells cultured in 25mM glucose. Image 
intensity settings were adjusted to allow channel labelling to be clear for illustrative purposes; intensity 
settings were not altered in images used for quantitative analysis. FOV area 146µm2. 
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Figure 4.4- ZERO and SNP mimetic BK channels H55Q, G57A and H55Q:G57A distribution in HEK293 
cells cultured in 25mM glucose. Normalised raw ratio values in 25mM glucose; the proportion of total 
H55Q channels at the membrane was significantly lower in comparison to G57A and H55Q:G57A. ZERO 
raw ratio= 0.51± 0.11, H55Q raw ratio= 0.44 ± 0.05, G57A= 0.57 ± 0.08 and H55Q:G57A= 0.54 ± 0.09. 
Normalised values are ZERO= 1, H55Q= 0.88, G57A= 1.13, H55Q:G57A= 1.07. Data expressed as mean 
± SD. N=3, n=17-18 *=p<0.05 ***=p<0.001 one-way ANOVA with post hoc Tukey test analysis.  
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This supports the hypothesis that the proportion of BK channels in the cell membrane follows the CSS-
Palm 4.0 calculated pattern of C56 palmitoylation probability, with H55Q mutant having the lowest 
cell membrane expression and G57A the highest. 
As a result of this close relationship in the pattern of C56 predicted palmitoylation and cellular 
distribution of the SNP-mimetic mutants, it was of interest to investigate the cysteine mutant 
constructs, and establish if the same relationship and pattern was evident in their cellular distribution. 
In other studies, the C53:54:56A mutant had a reduced membrane expression in comparison to ZERO, 
and this was linked to a reduction in palmitoylation due to the removal of cysteines C53, C54 and C56. 
There is less information available for the C53:54A mutant in comparison to C53:54:56A mutant. 
 
Assessment of the distribution of cysteine mutants C53:54A and C53:54:56A in HEK293 cells cultured 
in 25mM glucose. 
The mean raw ratio values obtained from the ZERO BK channel construct were then compared with 
those containing double cysteine mutations (C53:54A) and triple cysteine mutations (C53:54:56A). 
Exemplar confocal field of view images are shown in Figure 4.7A and raw ratio values indicate that the 
double cysteine mutant had a significantly increased proportion of total BK channels in the cell 
membrane, with a 23% increase in comparison to ZERO; while the triple cysteine mutant showed no 
significant difference from ZERO but had 21% less channel in the membrane than the double mutant 
(Figure 4.7B). 
The C56 predicted palmitoylation score for the cysteine triple mutant is null because the cysteine 
residue has been mutated out. Interestingly the C56 score for the cysteine double mutant is also null 
at all detection thresholds even though the cysteine residue is present in the amino acid sequence, 
and has been shown to be palmitoylated by experimentation with radiolabelled palmitate (Jeffries, 
2010). The consequence of this is that there is no predicted palmitoylation pattern for C56 for the 
cysteine mutants. Nevertheless, the higher cell membrane expression of the C53:54A mutant in 
comparison with that of the triple mutant C53:54:56A, may support a role for the C56 residue as it is 
present in the double mutant and thus available for palmitoylation- despite the lack of predicted score 
from the software. The increase in the membrane expression of the double cysteine mutant in 
comparison with ZERO may reflect the balance between the role for C56 with the potentially negative 
correlation with membrane expression seen with C53 and C54 (Figure 4.6). 
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Figure 4.5- Normalised predicted palmitoylation scores for the S0-S1 loop cysteines for ZERO and the 
SNP-mimetic mutants H55Q, G57A and H55A:G57A. A) The predicted palmitoylation scores generated 
by the CSS-Palm 4.0 software have been normalised to ZERO with a score of 1.0 (100%); the deviation 
from ZERO is then shown for cysteines C53, C54 and C56. Mutation of the BK channel amino acid 
sequence to that of the SNP-mimetics H55Q, G57A and H55Q:G57A has little impact on predicted 
palmitoylation of C53 or C54, with greater inter-mutant differences present for C56. B) C56 normalised 
predicted palmitoylation scores show the raised G57A and H55Q:G57A palmitoylation scores in 
comparison to ZERO and the lower value for H55Q. CSS-Palm 4.0 scores are detailed in chapter 3.  
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Figure 4.6- Correlation between predicted palmitoylation score and normalised raw ratio for BK 
channel constructs. The normalised predicted palmitoylation scores for cysteine residues C53, C54 and 
C56 for each of the SNP-mimetic mutants were plotted against the normalised raw ratio values for the 
SNP-mimetic mutants. A Pearson’s correlation coefficient (PCC) value of +0.95 was obtained for C56, 
indicating a strong positive correlation between predicted palmitoylation score and cell membrane 
expression. Weaker negative correlation was observed for C53 and C54 with PCC values of -0.80 and -
0.66. 
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Comparison of the cellular distribution of the cysteine mutants C53:54A and C53:54:56A and the SNP-
mimetic mutants revealed a significant difference between H55Q and C53:54A (mean raw ratio 0.44 ± 
0.05 vs 0.62 ± 0.10). The lack of predicted palmitoylation score for the C56 residue in the C53:54A 
mutant means that this difference with the lowest scoring SNP-mimetic mutant H55Q cannot currently 
be fitted to the C56 model and once again raises issues with the completeness of the algorithm and 
model used to calculate predicted palmitoylation and is discussed in more detail elsewhere.  
 
4.2.3 Assessment of the effect of glucose on the cellular distribution of the SNP mimetic and 
cysteine mutant BK channels in HEK293 cells 
Glucose is an important, tightly regulated, metabolic substrate with a vital, yet complex role in 
mammalian cellular systems and has an influence on ion channel distribution through a range of 
mechanisms including potential alterations in the balance of PTMs via phosphorylation and lipid 
metabolism. The simplest approach was to investigate the effect that a change in glucose 
concentration would have on the cellular distribution of the BK channel, and whether there were any 
patterns in this cellular distribution associated with S0-S1 linker mutations. This was achieved by 
seeding and culturing HEK293 cells in 25mM glucose for 48 hours prior to transfection with ZERO or 
the SNP mimetic mutants H55Q, G57A and H55Q:G57A. then maintaining the cells in a lower 
concentration of glucose (5mM) for 24 hours before the cells were fixed and imaged.  
The 5mM glucose treatment resulted in an increase in membrane-bound ratio for both ZERO and H55Q 
channels in comparison to their distribution in 25mM glucose, and a decrease for both G57A and 
H55Q:G57A mutants (Figure 4.8) though only the H55Q mutant displayed a statistically significant 
change in membrane-bound ratio in comparison to its 25mM glucose equivalent (P<0.05). In addition, 
there was a significant inter-group difference between the SNP-mimetic mutants. The mean raw ratio 
for H55Q:G57A was 19% lower than that of the H55Q mutant (p<0.05). Furthermore, the pattern of 
inter-SNP-mimetic relationship based upon C56 predicted palmitoylation highlighted earlier in 25mM 
glucose was inverted. In 5mM glucose the mutant channel with the lowest C56 predicted 
palmitoylation (H55Q) has the highest cell membrane expression, and one of the channels with a C56 
score higher than ZERO (H55Q:G57A) has the lowest cell membrane expression. This may indicate that 
the inter-SNP-mimetic cellular distribution pattern can modified by the glucose concentration of the 
cell culture medium.  
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Figure 4.7- ZERO, C53:54A and C53:54:56A cysteine mutant channel distribution in HEK293 cells 
cultured in 25mM glucose. A) Exemplar confocal field of view images of HEK cells cultured in 25mM 
glucose and transfected with ZERO, C53:54A or C53:54:56A BK channel constructs. The left column 
shows the Red (Alexa® 546) labelling that indicates BK channels located at the cell membrane. The 
middle column contains Green (Alexa® 488) labelled intracellular BK channels. The red and green 
channel images were then merged in the right-hand column B) Comparison of BK channel construct 
mean raw ratio values; the proportion of C53:54A (raw ratio= 0.62 ± 0.10) channels at the membrane 
was significantly higher than ZERO (0.51 ± 0.11) and C53:54:56A (0.51 ± 0.13). Data expressed as mean 
± SD. N=3 n=18. *=p<0.05 **=p<0.01, one-way ANOVA with post hoc Tukey test, FOV area 146µm2  
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In 5mM glucose, there was no significant difference in cellular distribution between the C53:54A and 
C53:54:56A mutants (mean raw ratio value of 0.56 for both). There was also no difference found 
between ZERO (mean 0.56) and the cysteine mutants. The pattern of raised C53:54A mean raw ratio 
observed in 25mM glucose was absent in the 5mM glucose, and there was no also significant difference 
between the mean cellular distribution values of H55Q, C53:54A and C53:54:56A. 
 
4.2.4 Assessment of the effect of palmitate on the cellular distribution of the SNP mimetic BK 
channels in HEK293 cells 
Given the impact that a change in glucose concentration can have on BK channel distribution, the next 
step was to investigate the influence of palmitate concentration as it is also a metabolic substrate, and 
plays a role in several cellular signalling mechanisms and a link has been identified between the 
predicted palmitoylation score of the BK channel C56 cysteine residue and the membrane expression 
of the channel. 
The impact of an increased concentration of palmitate in HEK293 cell growth medium on the 
proportion of total BK channels located in the cell membrane was undertaken by transiently expressing 
the BK channel ZERO or SNP mimetic mutants in HEK293 cells in 25mM glucose media containing 
0.4mM palmitate. Exemplar confocal field of view images for H55Q and H55Q:G57A expressing cells 
cultured in 25mM glucose and 0.4mM palmitate are shown in Figure 4.9A. There was no statistically 
significant difference between the cell membrane expression of ZERO and the SNP mimetic mutants. 
However, when the individual SNP-mimetic mutants were assessed for variation, H55Q displayed a 
significant, 21% reduction in comparison with H55Q:G57A (Figure 4.9B). The ‘C56 palmitoylation 
pattern’ seen in 25mM glucose was maintained in 25mM glucose and raised palmitate concentration. 
In addition, culturing cells in 0.4mM palmitate resulted in a significantly increased mean cell membrane 
expression of ZERO to 64% (range 52% to 0.79%) from 51% (range 31% to 0.68%) in 25mM glucose 
control (Figure 4.9C). Palmitate addition lead to increased cell membrane expression across all the 
SNP-mimetic mutants in 25mM glucose, with significant increases for H55Q (from 44% to 56%) and 
H55Q:G57A (from 54% to 68%).  
Earlier in the chapter, the concentration of glucose in the culture media was shown to affect the 
cellular distribution of BK channels. Therefore, to assess if glucose concentration changes the nature 
of the palmitate effects, an assessment of the cell membrane expression of BK channel constructs 
expressed in HEK293 cells cultured in 0.4mM palmitate was repeated, but this time with the lower 
glucose concentration of 5mM in the cell culture medium.   
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Figure 4.8- ZERO and SNP mimetic BK channels H55Q, G57A and H55Q:G57A cell membrane 
expression in HEK293 cells cultured in 5mM glucose. A) Comparison of BK channel construct raw ratio 
values in 5mM glucose, normalised to the ZERO mean raw ratio; the reduced raw ratio value of 
H55Q:G57A indicates that the proportion of total H55Q:G57A channels at the cell membrane was 
significantly reduced in comparison to H55Q alone. B) The raw ratio values for ZERO and the SNP-
mimetic mutants in 5mM glucose are shown in comparison to the corresponding 25mM group; H55Q 
raw ratio is significantly reduced in 25mM glucose. Normalised values in 5mM glucose are ZERO= 1.0, 
H55Q= 1.01, G57A= 0.94, H55Q:G57A= 0.82. Mean raw ratio values in 5mM glucose are ZERO= 0.56, 
H55Q= 0.57 ± 0.10, G57A= 0.53 ± 0.07, H55Q:G57A= 0.46 ± 0.12. Data expressed as mean ± SD. N=3 
n=18 *=p<0.05. One-way ANOVA with post hoc Tukey test.  
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Figure 4.9- ZERO and BK channel SNP mimetic mutants channel distribution in HEK293 cells cultured 
in 25mM glucose and 0.4mM Palmitate. A) Exemplar FOV image of H55Q and H55Q:G57A transfected 
cells with non-permeabilized and permeabilized BK channel fluorescent tagging. The left column shows 
the Red (Alexa® 546) labelling that indicates BK channels located at the cell membrane, as the labelling 
had taken place prior to permeabilization. The middle column contains Green (Alexa® 488) labelled 
intracellular BK channels, as this labelling took place after cell permeabilisation. The red and green 
channel images were then merged in the right-hand column. Images show Image intensity settings 
were adjusted to allow channel labelling to be clear for illustrative purposes; intensity settings were 
not altered in images used for quantitative analysis. FOV area 146µm2. B) The proportion of 
H55Q:G57A channels at the membrane was significantly greater than in the H55Q mutant. C) 
Comparison of BK membrane expression of cells cultured in 25mM glucose with and without palmitate. 
Palmitate significantly increased the membrane expression of ZERO, H55Q and H55Q:G57A. Raw ratio 
H55Q= 0.56 ± 0.09, G57A= 0.61 ± 0.06, H55Q:G57A= 0.68 ± 0.13. Data expressed as mean ± SD. N=3 
n=12-18 **=p<0.01. One-way ANOVA with post hoc Tukey test. 
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Figure 4.10- ZERO and BK channel SNP mimetic mutants channel distribution in HEK293 cells cultured 
in 5mM glucose and 0.4mM Palmitate. A) Reduced H55Q and increased G57A cell membrane 
expression results in multiple significant differences between BK channel mutants. G57A membrane 
expression alone was significantly different from ZERO; whilst the H55Q mutant was significantly 
different to G57A and H55Q:G57A. B) Comparison of BK membrane expression of cells cultured in 5mM 
glucose with and without palmitate. Palmitate significantly increased the membrane expression of 
G57A and H55Q:G57A, whilst reducing H55Q membrane expression. Raw ratio H55Q= 0.44 ± 0.06, 
G57A= 0.70 ± 0.08, H55Q:G57A= 0.61 ± 0.13. Data expressed as mean ± SD. N=3 n=16-18 **=p<0.01, 
***=p<0.001, ****=p<0.0001. One-way ANOVA with post hoc Tukey test. 
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In 5mM glucose and 0.4mM palmitate the G57A mutant was the only SNP-mimetic mutant with a cell 
membrane expression that was statistically different to ZERO.  As before there were significant 
differences in the cell membrane expressions of H55Q and G57A and H55Q:G57A (47% and 31% 
respectively). The ‘C56 palmitoylation pattern’ is apparent again under these condition in the cell 
membrane expression values of the SNP-mimetic mutants. 
Palmitate addition did not significantly alter the cell membrane expression of ZERO in 5mM glucose 
(Figure 4.10B), though the cell membrane expression of H55Q was significantly lower (23%) than the 
corresponding 5mM control group. For mutants G57A and H55Q:G57A, palmitate addition significantly 
increased cell membrane distribution by 32% and 33% respectively. Thus, the addition of palmitate to 
the 5mM glucose media appears to result in the return of cellular distribution of the SNP-mimetic 
channels to fit with the C56 predicted palmitoylation scoring pattern seen initially with 25mM glucose 
alone.  
 
4.2.5 Assessment of the effect of palmitate on the cellular distribution of the cysteine mutant BK 
channels in HEK293 cells 
The effect of 0.4mM palmitate addition on BK channel cysteine mutants, C53:54A and C53:54:56A was 
also investigated. Results showed that there was no significant difference in mean raw ratio between 
the cysteine mutant channels, with variation from ZERO of 0% and 8% for C53:54A and C53:54:56A 
respectively. The membrane expression range was between 52% to 79% for ZERO; the double and 
triple cysteine mutants had a range from 52% to 80% and 43% to 72% respectively. The mean raw ratio 
of C53:54A and C53:54:56A was not significantly increased in cells cultured in 25mM glucose and 
0.4mM palmitate when compared to equivalent cells cultured in the same glucose concentration in 
the absence of palmitate. 
In the lower glucose concentration, C53:54A mean raw ratio was 21% higher than that of ZERO (Figure 
4.11). There was no significant difference between 5mM glucose control and 5mM glucose and 0.4mM 
palmitate groups or 25mM glucose plus 0.4mM palmitate groups for ZERO, C53:54A or C53:54:56A. 
There was no significant difference in the mean raw ratio values of ZERO, the SNP-mimetic mutants 
and the cysteine mutants in 25mM glucose and 0.4mM palmitate. 
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Figure 4.11- ZERO, C53:54A and C53:54:56A cysteine mutant channel distribution in HEK293 cells 
cultured in 5mM glucose and 0.4mM palmitate. A) Table detailing the raw ratio values, standard 
deviation, number of fields of view, and percentage difference in raw ratio between the equivalent 
5mM glucose control and equivalent 25mM glucose plus 0.4mM palmitate group, for ZERO, C53:54A 
and C53:54:56A mutants. Raw ratio values were not significantly different between the control group 
and palmitate groups, as well as in comparison to the equivalent 25mM glucose + 0.4mM palmitate 
groups. B) C53:54A raw ratio was significantly increased in comparison to Zero when the 5mM glucose 
plus 0.4mM palmitate values were analysed and compared against each other using Tukeys post hoc 
analysis. One-way ANOVA for statistical analysis. 
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The results were more varied in 5mM glucose and 0.4mM palmitate, with the previously described 
high mean raw ratio of the G57A mutant that is significantly raised compared to ZERO and H55Q. H55Q 
is also significantly lower than C53:54A and C53:54:56A. When comparing the synthetic mutants that 
remove predicted C56 palmitoylation to the endogenous SNP, there is no significant difference 
between H55Q, G57A and C53:54:56A in 25 or 5mM glucose. 
 
4.2.6 Assessment of the effect of oleate on the cellular distribution of the SNP mimetic BK 
channels in HEK293 cells 
In a final series of experiments the influence of oleate on BK channel distribution was investigated. 
Oleate has been shown to compensate for the perturbing effects of excess palmitate and its effect on 
BK channel distribution has not previously been described. 
Exemplar confocal field of view images of HEK293 cells cultured in 25mM glucose with and without 
addition of 0.4mM oleate are shown in Figure 4.12A. In 25mM glucose with 0.4mM oleate, there was 
no significant difference between the cell membrane expression of ZERO and the SNP-mimetic 
mutants. The membrane expression of the H55Q channel construct was significantly increased by 18% 
in comparison to H55Q:G57A. As H55Q was once again significantly different from a mutant with a 
higher predicted palmitoylation score than ZERO, it indicates that the cellular distribution of BK 
channels may still be influenced by palmitoylation in the presence of oleate (Figure 4.12B).  
Furthermore, there was no significant difference in the cell membrane expression of ZERO as a result 
of oleate addition (Figure 4.12C). Unlike palmitate, which increased the proportion of all channels in 
the membrane oleate only increased the proportion of the H55Q mutant, which was 48% higher than 
the control equivalent. H55Q was the only SNP-mimetic mutant to have a mean raw ratio in the oleate 
group that was significantly different from that of the equivalent in the control group. 
To determine if the effects of oleate addition were conditional on the baseline glucose concentration 
of the cell culture medium, the experiments were repeated in 5mM glucose where the H55Q mean 
raw ratio was again significantly higher than H55Q:G57A, with a difference of 15% between the groups 
(Figure 4.13A). There was also a significant difference in the cell membrane expression of H55Q and 
H55Q:G57A of 18%.  
In 5mM glucose, there was no significant difference between the cell membrane expression of ZERO 
in control or oleate treated groups (Figure 4.13B). In these low glucose conditions, the G57A mutant 
alone was the only SNP-mimetic mutant to have a significantly different raw ratio as a result of oleate 
addition, with a mean change of 17% in cell membrane expression between oleate and control groups. 
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4.2.7 Assessment of the effect of oleate on the cellular distribution of the cysteine mutants BK 
channels in HEK293 cells 
The C53:54A and C53:54:56A mutants exposed to 25mM glucose and 0.4mM oleate showed no 
significant difference in the cell membrane expression at 57% and 54% respectively. There was also no 
significant difference in the cellular distribution of ZERO and the cysteine mutant channels under these 
conditions nor was there any significant difference between control and oleate treated groups in 
25mM, with differences in cell membrane expression of 9% and 6% respectively. Finally, the mean raw 
ratio of the C53:54A and C53:54:56A mutants exposed to 5mM glucose and 0.4mM oleate were 
analysed and there was no significant difference in the cell membrane expression between the groups 
(56% and 60% respectively). 
To get a better understanding of the relationship between the SNP-mimetic and the cysteine mutant 
channels in conditions of raised oleate, the cell membrane expression values of the two groups were 
compared. There was a significant 22% difference in the mean raw ratio of H55Q in comparison to 
C53:54:56A in 25mM glucose but there was no significant difference in the mean raw ratio values of 
the SNP-mimetic and the cysteine mutants in 5mM glucose and 0.4mM oleate.  
 
4.2.8 Assessment of the differential effect of fatty acids on the membrane expression of ZERO and 
the BK channel mutants. 
The addition of 0.4mM extracellular oleate resulted in an inverted SNP-mimetic palmitoylation pattern 
in comparison to cells treated with 0.4mM palmitate, therefore it was of interest to compare the effect 
of oleate and palmitate addition on the cellular distribution of BK channel constructs individually. In 
25mM glucose, palmitate addition resulted in a significantly increased cell membrane expression in 
ZERO and H55Q:G57A (increases of 18% and 22% respectively) in comparison to oleate; whilst on the 
other hand the cell membrane expression of H55Q was significantly reduced by 16% (Figure 4.14A). 
The cellular distribution of the G57A mutant was not affected. In low glucose, the pattern was similar; 
although the type of fatty acid added did not significantly affect the cell membrane expression of ZERO 
with a difference of 5%, palmitate significantly increased that of H55Q:G57A and G57A by 16% and 
11% respectively, however reduced H55Q membrane expression by 36% in comparison to the oleate 
groups (Figure 4.14B). As was the case in 5mM glucose plus palmitate in comparison to the same 25mM 
group, inter-SNP-mimetic differences are most clear in low glucose; here there is a clear pattern that 
reduced C56 palmitoylation status makes the channel more likely to be affected by oleate 
concentration, whilst increased likelihood of C56 palmitoylation results in channels that are more likely 
to go to the membrane in the presence of palmitate.  
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There was no significant difference between the cellular distribution of the cysteine mutant channels 
in 25mM glucose; for C53:54A and C53:54:56A there was an 11% and 8% difference between palmitate 
and oleate groups respectively. However, under low glucose conditions, there was a significant 
difference in C53:54A, where exposure to palmitate increased cell membrane expression by 15% in 
comparison to the oleate group. Once again, there was no difference in C53:54:56A membrane 
expression in palmitate in comparison to oleate. 
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Figure 4.12- ZERO and BK channel SNP mimetic mutants channel distribution in HEK293 cells cultured 
in 25mM glucose with and without 0.4mM oleate. A) Exemplar FOV image of H55Q transfected cells 
in 25mM glucose with non-permeabilized and permeabilized BK channel fluorescent tagging. Red 
(Alexa® 546) labelling indicates BK channels located at the cell membrane; the middle column contains 
Green (Alexa® 488) labelled intracellular BK channels and red and green channel images were then 
merged in the right-hand column. Image intensity settings were adjusted to allow channel labelling to 
be clear for illustrative purposes; intensity settings were not altered in images used for quantitative 
analysis. FOV area 146µm2. B) Bar graph showing significantly different membrane expression 
between H55Q and H55Q:G57A. Raw ratio: 25mM glucose and 0.4mM oleate ZERO 0.54 ±0.16, H55Q 
0.65 ±0.06, G57A 0.61 ± 0.05, H55Q:G57A 0.53 ±0.06. C) Comparison of BK membrane expression of 
cells cultured in 25mM glucose with and without oleate. Oleate significantly increased the membrane 
expression of H55Q. Data expressed as mean ± SD. N=3 n=13-18, **=p<0.01, ****=p<0.0001. One-way 
ANOVA with post hoc Tukey test. 
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Figure 4.13- ZERO and BK channel SNP mimetic mutants channel distribution in HEK293 cells cultured 
in 5mM glucose with and without 0.4mM oleate. A) There was a significant difference in the raw ratio 
values between H55Q and H55Q:G57A in HEK293 cells cultured in 5mM glucose and 0.4mM oleate. 
5mM glucose Zero 0.52 ±0.04, H55Q 0.60 ± 0.08, G57A 0.62 ±0.09, H55Q:G57A 0.51 ± 0.10. N=3 n=14-
18. B) Comparison of BK membrane expression of cells cultured in 5mM glucose with and without 
oleate. Oleate significantly increased the membrane expression of G57A.Data expressed as mean ± SD. 
N=3 n=18. *=p<0.05, **=p<0.01, one-way ANOVA with post hoc Tukey test. 
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Figure 4.14- The effect of fatty acid on the cell membrane expression of ZERO and SNP-mimetic 
channels cultured in 25mM or 5mM glucose. The raw ratio of ZERO and the SNP-mimetic mutants in 
HEK293 cells cultured in either A) 25mM glucose or B) 5mM glucose and treated with either 0.4mM 
palmitate or 0.4mM oleate for 24 hours. In 25mM glucose, there were significant differences in fatty 
acid treatments for ZERO, H55Q and H55Q:G57A constructs, whilst in 5mM glucose H55Q, G57A and 
H55Q:G57A had fatty acid mediated differences in cell membrane expression Data expressed as mean 
± SD. N=3 n=13-18, *=p<0.05, **=p<0.01, ****=p<0.0001. One-way ANOVA with post hoc Tukey test. 
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4.3 Discussion 
This is the first study to investigate the relationship between the cellular distribution of the SNP-
mimetic BK channels (H55Q, G57A and H55Q:G57A), the cysteine mutant channels (C53:54A and 
C53:54:56A), and the predicted palmitoylation score of cysteine residues within the S0-S1 linker region 
of the channel. In addition, there is novel data on the effects of differing concentrations of glucose, 
with the addition of palmitate or oleate, on the membrane-bound ratio of BK channel SNP-mimetics. 
 
4.3.1 The cell membrane expression of the BK ‘wild-type’ ZERO channel  
The first step of the investigation focused on assessing the cellular distribution of the ZERO isoform of 
the BK channel in 25mM glucose as utilised in previous BK channel studies with the  HEK293 cell line 
(Shipston et al., 1999; Shipston, 2001; McCartney et al., 2005; Tong et al., 2006; Tian et al., 2008; 
Saleem, Rowe and Shipston, 2009; Chang et al., 2011).  
The aim was to quantify, via ratio, the distribution of the ZERO channel variant in the cell membrane 
using double-FLAG antigen tag labelling of the BK channel in stacked sections across a field of view that 
contained several cells rather than the single cell or single stack approach that had been utilised in a 
previous study (Chen et al., 2005). Many studies do not state the confocal imaging protocol in detail 
(Barden et al., 2003; Ishiwata et al., 2004; Sheng and Acquaah-Mensah, 2011; Wu et al., 2013) and 
thus it can be difficult to make direct comparisons. 
Nevertheless, the FLAG-FLAG immunocytochemistry method provided data from which the 
percentage of BK channels in the membrane could be calculated and indicating that between 31% and 
68% of total BK channels were located at the cell membrane at the time of staining, with a mean value 
of 51%. The FLAG-FLAG method had been used in one other study of BK channel membrane 
distribution. Unfortunately, the results do not include a breakdown of the relative proportion of total 
BK channels located in the cell membrane and thus results could not be compared (Chen et al., 2013). 
In other research investigating the surface expression of BK channels, it was not possible to extract the 
membrane-bound BK channel percentage as the method of calculation did not allow for a comparison 
of membrane-bound fraction against the total number of BK channels (Kim, Alvarez-Baron and Dryer, 
2009; Jeffries et al., 2010; Kim and Dryer, 2011; Föller et al., 2012; Tian et al., 2012). These studies only 
allowed for the assessment of treatment or mutant channel deviation from the control group. This 
deviation is expressed as an arbitrary ratio or normalised value without reference to the total amount 
of selected protein in isolation. 
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One study that used biotinylation to label surface BK channels, in combination with western blotting 
using an anti-BK antibody for an assessment of the total number of channels, calculated the BK channel 
cell membrane-bound proportion to be approximately 80% of total in 25mM glucose (Kim et al., 2014). 
The difference in cell membrane expression of the BK channel between the studies may arise for 
several reasons. For example, the species of BK channel used differs; the current study used the murine 
ZERO (mSlo), whilst Kim et al (2014) was rat Slo1 (rSlo). When directly compared, there is a small 
difference (89% identity) between the amino acid sequences of the two channels, though the S0-S1 
loop domain was completely conserved and neither channel possessed the STREX insert. In addition, 
this current study was conducted using the HEK293 cell line, whilst Kim et al used COS-7 cells. Despite 
being derived from different species (human for HEK293, monkey for COS), both cell types are 
mammalian and renal in origin with no documented evidence that the cell types would have differing 
impacts on ion channel overexpression, and neither cell type express the BK channel endogenously. 
Both the fluorescent tagging of the channel in this study, and biotinylation and western blotting used 
by Kim et al require the use of antibodies for protein identification, however with that exception, the 
two methodologies vary in many aspects (confocal microscopy vs gel separation) and are thus difficult 
to directly compare.  
In other research investigating the surface expression of BK channels, it was not possible to extract the 
membrane-bound BK channel percentage as the method of calculation did not allow for a comparison 
of membrane-bound fraction against the total number of BK channels (Kim, Alvarez-Baron and Dryer, 
2009; Jeffries et al., 2010; Kim and Dryer, 2011; Föller et al., 2012; Tian et al., 2012). These studies only 
allowed for the assessment of treatment or mutant channel deviation from the control group. This 
deviation is expressed as an arbitrary ratio or normalised value without reference to the total amount 
of selected protein in isolation. 
A publication addressed the mean membrane-bound ratio of another ion channel; in a study of Kir2.1 
channels expressed in Opossum kidney (OK) cells, the cell membrane-bound percentage was 15% of 
total, a value obtained by using HA antigen tagging for surface and immunoblot for total (Stockklausner 
and Klocker, 2003). Additional studies investigated the effect of endogenous and exogenous factors 
on the surface/cell membrane expression of a number of ion channels, but normalised the results of 
the control and details of the ratio of cell membrane-bound channels to total are not provided (Zhang 
et al., 2005; Frindt and Palmer, 2010). In conclusion, the difference in absolute values obtained for 
percentage of membrane bound BK channel is probably a product of the different techniques used- 
for example, the specificity of the primary and secondary antibodies. The absolute value of channel 
expressed in an overexpression assay may also depend on the size of the protein product and the 
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efficiency of the vector, but the main finding is that the percentage and/or ratio was consistent for BK 
channels in HEK293 cells under normal culture conditions (25mM) with a normal distribution and 
standard deviation of ~10%- in line with the variance seen in previous studies (Jeffries, 2010; Jeffries 
et al., 2010; Bi, 2014; Kim et al., 2014). Therefore the double FLAG approach can be used to investigate 
BK channel membrane distribution.  
 
4.3.2 The cellular distribution of BK 'SNP-mimetic channels' and the predicted palmitoylation 
status of the C56 cysteine residue of the S0-S1 linker. 
Key aims were to investigate whether the BK channel SNP-mimetic mutants H55Q, G57A and 
H55Q:G57A would alter the cellular distribution of the channels and whether there was a relationship 
with the CSS-Palm 4.0 determined pattern of predicted C56 palmitoylation. The confocal imaging 
screen revealed no significant difference in the distribution of the SNP-mimetics and the ZERO wild-
type channel. Although there were statistically significant differences in distribution between the SNP-
mimetics channels themselves, and a trend emerged where the proportion of channel in the 
membrane rose from 44% for H55Q to 51% for ZERO onto 54% for H55Q:G57A to peak at 57% for 
G57A.  
This pattern of membrane expression of the SNP-mimetic mutants appeared to correlate with the CSS-
Palm 4.0 generated predicted palmitoylation scores. SNP-mimetic mutants that decreased the 
predicted palmitoylation score for C56 in comparison to ZERO had a lower membrane expression 
(H55Q membrane expression was 88% that of ZERO), and those that increased C56 palmitoylation 
score lead to a greater membrane expression of BK (G57A 113% of ZERO and H55Q:G57A 107% of 
ZERO). The strong positive correlation between predicted C56 palmitoylation score and SNP-mimetic 
cell membrane expression (PCC of +0.95) suggests that palmitoylation plays an important role in the 
targeting of BK channels to the cell membrane.  
The current theory is that the BK channel is: a) palmitoylated (Tian et al., 2008); and b) that this 
palmitoylation modulates cell membrane translocation (Jeffries, 2010; Jeffries et al., 2010). This 
relationship has been based on investigation of those palmitoylated cysteine residues in the amino 
acid sequence alone.  The implication of the current study is that naturally occurring mutations to 
amino acid residues flanking the cysteine residues, but not just mutations to the cysteine residues 
themselves, 1) have an impact on the palmitoylation status of that residue and, 2) results in a 
predictable effect on the cellular distribution of that construct.  
Despite evidence linking C56 palmitoylation to the inter-mutant differences, other factors may also 
determine the cellular distribution of the channel. In the case of the H55Q mutant, the histidine to 
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glutamine substitution itself is significant because mutations of this type have been shown to reduce 
zinc-binding affinity in proteins such as calbindin D28k, a calcium-binding protein (Bauer et al., 2008). 
Zinc binding in proteins can participate directly in chemical catalysis and help to maintain protein 
structure, which stabilises and may induce folding of protein subdomains (Coleman, 1992). A study 
investigating the effects of histidine to glutamine mutation concluded that the structure of the 
surrounding hydrogen bond network is crucial for metal ion affinity of the zinc-binding site (McCall, 
Huang and Fierke, 2000). Alteration of this network caused by the increased hydrogen-bonding 
capability of glutamine may be the basis of the reduced zinc affinity and possible local loss of proper 
folding structure. Mutation of histidine residues in the C-terminus of EEA1, an auto-antigen, reduced 
zinc binding and importantly, as a result, reduced protein membrane association (Stenmark et al., 
1996). Although zinc binding has been shown to increase BK channel activity, and histidine residues 
were found to be crucial to this modulation (Hou et al., 2010), there is no current evidence that zinc 
affects BK channel membrane expression. Further investigation to determine if this impacts channel 
membrane translocation, in addition to C56 palmitoylation, may be worthwhile. 
Similarly, the glycine to alanine mutation (as seen with G57A) could affect BK cellular distribution as it 
affects the stability of proteins depending on the location of the amino acid position in the α-helix 
structure of the protein (Serrano et al., 1992). Alanine is the most powerful α-helix stabiliser with 
glycine associated with α-helix destabilization (López-Llano, Campos and Sancho, 2006; Scott et al., 
2007). The mechanics of this are complex; however, it is possible that increased stability of the protein 
structure enables more efficient palmitoylation enzyme binding to the C56 site, thus greater ease of 
palmitoylation and increased cell membrane expression. This information may shed some light as to 
why the predicted palmitoylation of C56 is raised when the DNA includes the G57A mutation.  
The location of the amino acid substitutions in the SNP-mimetic channels, therefore have the potential 
for causing a conformational change to the region where the protein is palmitoylated. As stated, this 
could be due to a change in zinc association near a PAT-binding site, a change to the local environment 
of a binding site, or possibly as a direct result of the different mass, shape and binding potential 
associated with the substituted amino acid residue, as was discussed in the bioinformatics chapter.  
 
4.3.3 The cellular distribution of the cysteine mutant channels C53:54A and C53:54:56A  
In contrast with the SNP-mimetic mutants that had not been previously described, the double and 
triple cysteine mutants have been investigated before in BK channels; these results form the basis of 
the C56 model as the C53:54:56A mutant and the C53:54A mutants significantly reduce membrane 
expression (Jeffries, 2010; Jeffries et al., 2010; Bi, 2014; Kim et al., 2014). The data presented here is 
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not identical to that produced in previous studies as C53:54A was associated with an increase in 
membrane insertion in comparison with ZERO and though C53:54:56A has reduced membrane 
expression from the double mutant it was not significantly lower than ZERO. There are a number of 
possible explanations, based on the difference in tagging, that may contribute to the disparity.  
Whilst there is information available about each of the antigen tags (Zhao, Li and Liang, 2013), no 
specific measure of sensitivity/selectivity is given, and there is no publication with comparison of the 
sensitivity and specificity of FLAG and HA antibodies and further information could not be sourced 
from the manufacturers. The dilution of primary antibody used in permeabilised tagging was the same 
for non-permeabilised tagging at 1:100, which was considerably higher than the 1:500 dilution used 
by Jeffries et al 2010 and Chen et al 2013. The 1:100 dilution was used to reduce the number of 
variables in the protocol and to ensure equity in the measurement of total channel by adding red and 
green fluorescence and using a higher concentration of primary antibody is a consistent change and 
should not affect the magnitude of change between groups. Antibody controls, conducted on non-
transfected HEK293 cells, did not show any significant non-specific fluorescence, indicating this was 
unlikely to be the cause of the disparity.  
For FLAG-FLAG and FLAG-HA tagging methods to be comparable, both antigens must be equally 
accessible. As FLAG and HA antigens are positioned on opposite terminus of the channel (N- and C- 
respectively), the orientation of the channel in the organelle membranes or transport vesicles may be 
important as this may render sites more or less accessible. If all membranes are fully permeabilised to 
allow for antibody access there should be no restriction of access. At the concentration used in this 
study, Triton-X is predicted to permeabilise all cell membranes and thus incomplete permeabilisation 
is an unlikely explanation for the difference in cell membrane expression (Willingham, 2010). Whilst 
surface expression of C53:54:56A channels was reduced by 2-fold in COS-7 cells when compared with 
a ZERO control (Kim et al., 2014), the final membrane-bound ratio of approximately 35% for the triple 
mutant is in agreement with the results obtained in this study.  
 
4.3.4 The cellular distribution of the cysteine mutant channels C53:54A and C53:54:56A and the 
predicted palmitoylation status of C56 
The data obtained also raised issues with the potential relationship between the cellular distribution 
of the cysteine mutant channels and the SNP-mimetic channels, based upon the palmitoylation status 
of the C56 cysteine residue. Firstly, because the triple mutant does not contain C56 and secondly 
because the predictive score for the double cysteine mutant was 0, even though the C56 residue in the 
double mutant has been shown to be significantly palmitoylated in a previous study utilising 
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radiolabelled palmitate  (Jeffries, 2010). This highlights a limitation in the predictive software program 
CSS-Palm 4.0, as the palmitoylation results extracted to compile training data for the software is only 
taken from results published in peer reviewed journal articles, rather than PhD theses. In this case, an 
important piece of information for software accuracy at an amino acid has been omitted.   
One interpretation of the cysteine mutant data produced in this current study is that a higher predicted 
palmitoylation score at C56 is indeed associated with raised membrane insertion of the BK channel, 
but this is counterbalanced by the weaker negative correlations between C53 and C54 palmitoylation 
and membrane insertion (Figure 4.6). Thus the removal of C53 and C54 would result in loss of the 
“negative” drive- so the removal of these residues that would normally reduce insertion would in real 
terms enhance BK membrane expression. Thus, providing an explanation as to why C53:54A had a 
higher raw ratio than ZERO. Equally, in the triple mutant the loss of the stronger positive influence of 
C56 is balanced by the loss of the two weaker negative drivers at C53 and C54, resulting in an almost 
neutral impact. 
 
4.3.5 Low glucose concentration affected BK channel membrane expression in a manner related 
to C56 palmitoylation status 
Changes in extracellular glucose concentration have previously been shown to have variable effects on 
ion channel expression and membrane translocation; raised glucose resulted in a 2-fold increase in 
TRPM7 and a significant  increase in TRPC6 protein expression (Sun et al., 2013).(Daoyan Liu et al., 
2008). While a reduction in glucose concentration resulted in increased KATP ion channel expression 
by 50% in 30 minutes and by 270% within 10 hours (Smith et al., 2006). Liu et al 2008 also showed that 
glucose concentration may have no effect; the expression of TRPC1, TRPC3, TRPC4, or TRPC5 were 
unchanged when cells expressing the channels were exposed to high glucose.  
An aim of this investigation was to uncover the effects of reducing the glucose concentration from 
25mM to 5mM. The data could be split into two patterns with ZERO, H55Q and C53:C54:C56A cell 
membrane ratio increased in 5mM glucose (by 10%, 30% and 10% respectively), whilst G57A, 
H55Q:G57A and C53:54A membrane-bound ratio decreased in 5mM glucose (by 8%, 17% and 10% 
respectively) relative to levels seen in the control conditions of 25mM glucose. Within the context of 
the current model, the channel constructs with potentially lower C56 palmitoylation – the H55Q and 
the triple cysteine mutant plus ZERO, have an increased membrane insertion in lowered (5mM) 
glucose. While those channels with higher predicted C56 palmitoylation scores: G57A; H55Q:G57A; 
and the double cysteine mutant whose predicted score appears inaccurate; all show reduced 
membrane insertion with lowered glucose. 
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Thus, the channels in 5mM glucose display a reversed ‘C56 palmitoylation status pattern’ in 
comparison to the 25mM results; with the H55Q mean raw ratio was now significantly raised in 
comparison to H55Q:G57A.  
As far as other BK channel data is concerned, experiments by Kim & Dryer (2011) with endogenously 
BK channel expressing mouse podocytes found that cell exposure to high glucose led to a 70% 
reduction in the proportion of BK channels at the cell membrane. As the BK channels used by Kim & 
Dryer (2011) did not contain any of the SNP-mimetic mutations, the most appropriate comparator 
channel was ZERO. In this case, whilst a cell membrane expression reduction of that magnitude was 
not seen, there was nonetheless a reduction in ZERO in 25mM glucose.  
In mouse podocytes, the high glucose effect was proposed to be mediated by a reduction in cell 
membrane expression of the adhesion and scaffolding protein nephrin; a protein that binds almost 
exclusively to BK channels containing the extreme C-terminal amino acid sequence VEDEC, which 
increases its cell surface expression by 800% (Kim, Choi & Dryer 2008). The nephrin theory is not 
directly applicable to this current study as HEK293 cells do not endogenously express nephrin despite 
their distant renal cell lineage (Khoshnoodi et al., 2003), and the protein was not co-transfected 
alongside the BK channel. However, as the BK channel constructs used in this study do contain the 
VEDEC amino acid sequence in the C-terminus, it is possible that other proteins affect BK channel 
surface expression in a glucose dependent manner and could be targets for future investigation.  
The novel findings in 5mM glucose indicate that a) BK channel cellular distribution can indeed be 
affected by glucose concentration and suggests that b) the extent of the channel distribution change 
is influenced by the nature of the amino acid mutation in the S0-S1 linker region. 
 
4.3.6 The addition of extracellular palmitate, but not oleate, increases the cell membrane 
expression of BK channels in HEK293 cells 
Raising extracellular palmitate by 0.4mM significantly increased the mean cell membrane expression 
of the constructs, with ZERO rising from 51% to 64% in 25mM glucose with 0.4mM palmitate and  echo 
data published in the literature, where the addition of palmitate can increase cell membrane 
expression of proteins by 60% and 100% (Cazanave et al., 2011; Pararasa, 2013). The magnitude of cell 
membrane expression change observed in the current experiments is lower, but with a common trend 
with glucose and palmitate concentrations having an additive effect to increase protein expression 
(Sathanoori et al., 2015; Hong et al., 2016). 
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Oleate, an unsaturated fatty acid, has been shown to have a variable effect on protein membrane 
expression (Mastrangelo, Jeitner and Eaton, 1998; Hannah et al., 2001; Benoit et al., 2009), and in this 
study the addition of 0.4mM oleate did not result in a change in ZERO cellular distribution nor the 
cysteine mutants but significantly increased the cell membrane expression of the H55Q mutant by 48% 
in 25mM glucose.  
 
4.3.7 The effect of palmitate and oleate, in combination with changes in glucose concentration, 
on BK channel distribution 
The data acquired from experiments where alterations in glucose concentration (5mM vs 25mM) were 
combined with the addition of palmitate or oleate produced a range of changes in the membrane 
expression of BK channels. One key observation was that the inversion of C56-dependent distribution 
pattern produced by exposure of ZERO and the SNP-mimetic channels to 5mM glucose was reversed 
by 0.4mM palmitate but not by 0.4mM oleate. Furthermore, the specific order and any significant 
difference in BK channel membrane distribution associated with the change in metabolic substrates 
was dependent on the specific constructs. Thus, the pattern displayed by H55Q was different from 
G57A and H55Q:G57A and in most occasions showed reversed trends. Thus where 0.4mM palmitate 
would be associated with raised levels of membrane expression over 0.4mM oleate for the G57A and 
H55Q:G57A constructs, the opposite was observed for H55Q in both 25mM and 5mM glucose.   
In the literature, there is evidence to suggest that palmitate and oleate have either a) opposing actions, 
or that b) oleate can compensate for the perturbing effects of excess palmitate. For example oleate, 
in comparison to palmitate, did not cause mitochondrial DNA damage in skeletal muscle cells 
(Yuzefovych, Wilson and Rachek, 2010). Potentially, the differences in the effect of oleate and 
palmitate are due to a shift in metabolic status of the HEK293 cells. In a 2014 study, oleate increased 
cellular triglyceride (TG) levels and thus mitochondrial β-oxidation, whilst palmitate increased the 
protein kinase C activator, diacylglycerol (DAG) levels associated with PKC/NF-κB activations (Coll et 
al., 2008; Kwon, Lee and Querfurth, 2014). Thus it may be that there is competition between palmitate 
and oleate to bind the cysteines in the BK channel S0-S1 loop, or that the binding and resulting efficacy 
of modulation is dependent on the palmitoylation profile of the cysteines and thus the different 
predicted score for the separate constructs informs the likely outcomes (Greaves et al., 2017).  
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4.3.8 The metabolic substrates glucose, palmitate and oleate may be moderating BK channel 
membrane expression in HEK293 cells via multiple mechanisms 
Are the effects of glucose and fatty acids on BK channel membrane expression mediated by AMPK?  
Glucose, as the main metabolic substrate in humans, plays a role in many physiological processes; 
therefore, there are a number of routes by which a reduction in glucose concentration may alter the 
cellular distribution of the BK channel in HEK293 cells. As introduced earlier, many of the downstream 
effects of glucose (such as fatty acid synthesis, glyconeogenesis and protein synthesis) are regulated 
by a powerful kinase enzyme called AMPK (Figure 4.15). AMPK is strongly activated by the low energy 
status of a cell where the supply of ATP cannot match demand, increasing the ratio of AMP/ADP to 
ATP; this occurs in times of limited glucose, lipid or oxygen availability (Kudo et al., 1995; Salt et al., 
1998; Marsin et al., 2000; da Silva Xavier et al., 2003; Minokoshi et al., 2004; Evans et al., 2005), and 
during exercise (Hutber, Hardie and Winder, 1997; Wojtaszewski et al., 2000; Chen et al., 2003).  
As part of the cell treatment protocol, the glucose concentration of the HEK293 cell growth medium 
was reduced from 25mM to 5mM; this may have been sensed by the cells as a relative hypoglycaemia, 
activating AMPK and inhibiting protein synthesis. This has been shown to occur via a) inhibition of 
eukaryotic elongation factor 2 (EF2) required for protein elongation by the ribosomes (Horman et al., 
2002; Yan et al., 2003) and b) via inhibition of the mammalian target of rapamycin (mTOR), a 
serine/threonine kinase and a key regulator of protein translation/synthesis (Bolster et al., 2002; 
Kimura et al., 2003; Cheng et al., 2004). Based upon the results, a reduction in glucose concentration 
did not result in a reduction in BK channel synthesis, as there was no significant reduction in raw ratio 
in the 5mM glucose groups. However, it is important to note that the aim of the immunofluorescent 
tagging method in combination with confocal microscopy was to assess differences in the proportion 
of total BK channel situated in the cell membrane, rather than the absolute quantity of BK channel 
protein translated. Therefore, in future experiments to more accurately quantify changes in protein 
synthesis, a protein quantification technique such as Western blotting, could be undertaken. Western 
blotting could also support investigation into the production of other proteins involved in BK channel 
translocation such as the PAT and APT/PPT enzymes involved in palmitoylation and de-palmitoylation.  
AMPK activation also results in the inhibition of fatty acid synthesis and an increase in fatty acid 
oxidation via inhibition of acetyl-CoA carboxylase (ACC) isoforms 1 and 2, which are responsible for the 
formation of malonyl-CoA, an essential component in the pathway for fatty acid synthesis (Saddiksj et 
al., 1993; O’Neill et al., 2014). This may have implications for the amount of palmitate available, as 
AMPK activation would reduce palmitate production and increase its breakdown. Reduced palmitate 
availability may contribute to the differential effects of glucose on the cell-membrane expression of 
the SNP-mimetic mutants, as expression is closely linked to C56 palmitoylation status. 
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It has been hypothesised that regulation of AMPK by glucose may normally be restricted to specialised 
energy sensitive cells, such as pancreatic beta cells, skeletal muscle cells, adipocytes and hepatocytes 
(Hardie, Hawley and Scott, 2006); however significant glucose mediated changes were observed in this 
study. Interestingly, a publication investigating AMPK mediated changes in BK channel protein 
abundance in Xenopus oocytes using confocal immuno-microscopy (Föller et al., 2012) showed that 
AMPK increased BK channel abundance in the cell membrane. This result ties in with the increased BK 
channel cell membrane expression seen with the H55Q construct. However, the effect of AMPK on BK 
channels may be splice variant specific (Ross et al., 2011). In this chapter, results indicate that glucose 
concentration can affect the cellular distribution of BK channels expressing SNP-mimetic mutations, 
however, the precise mechanisms behind this have not been determined and further investigation is 
required. 
As fatty acids are metabolic substrates it would be logical that the addition of excess palmitate or 
oleate to the cell environment would inhibit AMPK activation in the same manner as glucose; however, 
results in the literature do not consistently support this logic. For example, when cultured bovine aortic 
endothelial cells (BAECs) were exposed to 0.4mM palmitate for 40 hours, there was a 72% reduction 
in AMPK activation (Wu et al., 2007), which supports the hypothesis. Similar effects on AMPK inhibition 
have been shown in vitro, and in vivo in rodents fed a diet high in fatty acids (Yi Liu et al., 2006; Fujii et 
al., 2008; Kwon and Querfurth, 2015). 
On the other hand, L6 rat skeletal muscle cells were exposed to a range of palmitate concentrations 
from 0.01mM to 0.8mM for 1 hour, which resulted in up to a 4-fold increase in AMPK activation 
(Fediuc, Gaidhu and Ceddia, 2006). This effect has been reported in other publications (Clark, Carling 
and Saggerson, 2004; Watt et al., 2006).  
Results of the experiments conducted in this chapter highlight that fatty acids of different length and 
saturation may not have the same downstream effects; addition of palmitate and not oleate resulted 
in an increase in BK wild-type channel cell membrane expression. Differences have been shown in the 
literature; oleate increased cellular triglyceride (TG) levels and thus mitochondrial β-oxidation, whilst 
palmitate increased the protein kinase C activator, diacylglycerol (DAG) levels associated with PKC/NF-
κB activations (Coll et al., 2008; Kwon, Lee and Querfurth, 2014). In addition, fatty acids can have 
opposing effects on AMPK activation; monounsaturated oleate has been shown to activate AMPK 
whilst saturated palmitate inhibits (Hickson-Bick, Buja and McMillin, 2000; Wu et al., 2007; Yuzefovych, 
Wilson and Rachek, 2010; Kwon and Querfurth, 2015). 
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Are the BK channel membrane expression changes mediated by lipid raft formation and composition? 
The increased cell membrane expression of proteins associated with palmitate addition extracellularly 
has been attributed to an increase in protein association with lipid rafts (Cazanave et al., 2011). Lipid 
rafts are a membrane sub-compartmentalisation, composed of sphingolipid, cholesterol and proteins, 
that play a role in lipid–lipid, protein–lipid, and protein–protein interactions (as reviewed by Calder 
and Yaqoob, 2007). The percentage of the cell membrane occupied by lipid rafts appears to be variable 
depending on the cell type (Pike, 2003), with estimates ranging from approximately 50% (Mayor and 
Maxfield, 1995; Hao, Mukherjee and Maxfield, 2001), to below 15% (Koutny, 2013). 
However, there are challenges with accurately determining lipid raft composition and quantity due to 
limitations in the methods available to isolate and to study rafts (Lai, 2003; Calder and Yaqoob, 2007).  
BK channels have been shown to localise in lipid rafts (Bravo-Zehnder et al., 2000; Lam, Shaw and 
Duszyk, 2004; Weaver et al., 2007), and as palmitate is a component of lipid rafts (Laethem et al., 2003; 
Schumann et al., 2011), it is possible that the increased palmitate concentration in the cell culture 
medium resulted in an increase in the number and or size of lipid rafts in the cell membrane, allowing 
for increased BK channel – cell membrane association.  
Association of proteins to lipid rafts has been shown to increase when the protein has been 
palmitoylated; palmitoylation of DR4 is essential for the redistribution of this receptor into lipid rafts 
(Rossin et al., 2009). This brings into question whether an increase in the availability of palmitate not 
only affects the cellular structure of the cell allowing for increased BK channels in the cell membrane, 
or if the effects can be attributed to an increase in the extent of protein palmitoylation. Association of 
BK channels with cell membrane lipid rafts has been linked with palmitoylation; the SNP-mimetic 
mutants increase or decrease the palmitoylation status of C56, this may be the link between the amino 
acid mutations and their differing cell membrane expression. Further research is required to uncover 
the specific mechanisms involved in palmitate mediated cell membrane expression regulation.   
If the palmitate and lipid raft theory is correct, then it is possible that the extra cellular energy source, 
in the form of high glucose concentration, is necessary to complete the processes required to transport 
excess palmitate into the cell membrane (Bizzozero, Sanchez and Tetzloff, 2002) and may explain why 
there is an additive effect seen in cell-membrane expression in 25mM glucose and 0.4mM palmitate.   
It is plausible that differences between the cell membrane expression values of BK channels in 
palmitate and oleate treated cells could be related to the varying properties of the lipids. 
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Figure 4.15- AMPK activation as a mechanism of glucose control of BK channel cell-membrane 
expression. Illustrated is a simplified schematic showing a small number of the potential mechanisms 
by which AMPK regulates lipid, protein and glucose homeostasis. Activation of AMPK promotes fatty 
acid oxidation and glucose utilisation, but inhibits protein, fatty acid and glycogen synthesis. Shown 
are pathways of activation (indicated by arrows) or pathways of inhibition (indicated by perpendicular 
lines) of agents by AMPK in downstream pathways. Figure adapted from (Wang, Song and Zou, 2012). 
(GLUT4) glucose transporter type 4; (GS) glycogen synthase; (PFK2) phosphofructokinase 2; (TSC2) 
tuberous sclerosis complex 2; (mTOR) mammalian target of rapamycin; (EF2) eukaryotic elongation 
factor 2; (ACC1, ACC2) acetyl-CoA carboxylase 1 and 2; (HSL) hormone-sensitive lipase; (HMGR) HMG-
CoA reductase. 
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In a 2005 study, extracellular oleate was found mainly as free oleic acid in phospholipids, whereas 
palmitate was incorporated into phospholipids and to a lesser extent found as cellular free palmitic 
acid (Gaster, Rustan and Beck-Nielsen, 2005). This may impact the fluidity or viscosity of the lipid rafts 
(with oleate being in a liquid state at cell culture temperature, whilst palmitate favours a solid state), 
and affect the dynamics of BK incorporation into the cell membrane. 
 
4.4 Limitations and Further Work 
Limitations 
The experiments conducted in this chapter have a number of possible limitations. The investigations 
assess changes during a treatment period of 24 hours, a time period used in a number of other studies 
(Liu et al., 2001; Peiró et al., 2001; Hovsepyan, Sargsyan and Bergsten, 2010; Chang et al., 2011; Kim 
and Dryer, 2011; Su et al., 2013). However, for a better understanding of the changes, it would be of 
value to determine responses over a range of timepoints, as has been conducted in other studies 
(Samikkannu et al., 2006; Cho et al., 2013). The results obtained in the 24-hour period in this study are 
still valid and show significant responses over a moderate timeframe. Confocal microscopy was utilised 
as a method to assess trends in the proportion of total BK channels that were at the cell membrane at 
the time of fixing, a method that has been utilised to assess surface expression in many other studies 
(Barden et al., 2003; Jeffries, 2010; Jeffries et al., 2010; Sun et al., 2010; Bi, 2014). However, as this 
study did not use live cell imaging, it is not possible to determine the real-time change in BK channel 
cell membrane distribution.  
 
Future Work 
To gain further clarity of the mechanisms behind the C56 palmitoylation pattern and the variations in 
pattern depending on cell culture medium composition, further investigation is required in several 
areas. Firstly, to more accurately quantify the effect of SNP-mimetic mutation on C56 palmitoylation 
status, it would be of great interest to determine the level of C56 palmitoylation of each of the mutants 
via 3H-palmitate incorporation. This method has been used in many studies to establish the extent of 
amino acid palmitoylation (Pouliot and Béliveau, 1995; Luiken et al., 1997; Ducker et al., 2004; Liang 
et al., 2004; Jeffries, 2010; Dasgupta et al., 2011).  
Another aim of future interest would be to test adherence to the C56 palmitoylation pattern using 
different amino acid mutations; as for example, H55G mutation, in place of H55Q, leads to increased 
predicted palmitoylation of C56. This was not the case for C53 or C54, as mutation to C53:54G still 
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resulted in removed C56 predicted palmitoylation. This may indicate a complexity to the pattern that 
would be of interest to investigate in the future. Another complicating factor is that amino acid 
substitutions can have effects other than the augmentation of palmitoylation, such as potential 
changes in zinc binding and protein structure stabilisation in the case of H55Q and G57A. These may 
impact BK channel cell membrane expression and cause other mutated BK channels to deviate from 
the C56 palmitoylation pattern.  
As the function of BK channels in this thesis was interpreted as the ability of the channel to insert into 
the cell membrane, confocal imaging was used in order to best establish the location of the BK channel 
as either at the cell membrane, or within the cell. However, the effect of the interplay between BK 
channel amino acid mutations and metabolic substrates has not yet been tested using 
electrophysiology; however, the effect of fatty acids on BK channel function (Denson et al., 2000; 
Clarke et al., 2002; Sun et al., 2007) and S0-S1 cysteine mutations on BK channel function have been 
assessed (Jeffries, 2010; Jeffries et al., 2010). Knowledge of the effects of SNP-mimetic mutation in the 
presence of excess lipids on BK channel activity would contribute considerably to the understanding 
of the mechanisms behind the changes observed in this thesis. Also, quantification of the amount of 
BK channel protein expression in each of the conditions would be of great value, as it would place 
results amongst those already published (Grunnet, Hay-Schmidt and Klaerke, 2005; Sakai, Harvey and 
Sokolowski, 2011), and for example indicate whether palmitate is associated with increased 
membrane expression of mutated BK channels.   
Using a wider scope, an alternative way of interpreting the results of metabolic substrates on BK 
channel cellular distribution would be to think of the direct effects of the compounds themselves on 
the cell. As such, an area of future work would be to investigate the effect of fatty acid addition on the 
composition of the cell membrane and lipid rafts. There is evidence that BK channels localize in lipid 
rafts (Weaver et al., 2007) and changes in their composition may either encourage or inhibit BK channel 
insertion. As palmitoylation is implicated in the translocation of the BK channel to the cell membrane, 
it would be of value to investigate the role of palmitoylation in translocation of BK channels to lipid 
rafts of varying compositions of palmitate and oleate. The specificity of palmitoylation enzymes for 
addition of particular fatty acids may also play a role in the BK channel cellular distribution differences 
between palmitate and oleate. As S-acylation has been associated with a number of fatty acids (such 
as stearate), and there is emerging evidence of differing fatty acid selectivity in the PAT family of 
enzymes (Greaves et al., 2017). Therefore, it is of interest to investigate if the substrate of S-acylation 
can shift from palmitate to when oleate is in excess.  
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As a change in metabolic substrate concentration in the cell growth medium could result in altered 
protein and fatty acid synthesis via AMPK -increasing or decreasing BK channel synthesis or the 
availability of palmitate for palmitoylation- (Saddiksj et al., 1993; Clark, Carling and Saggerson, 2004; 
Fediuc, Gaidhu and Ceddia, 2006; Watt et al., 2006; O’Neill et al., 2014), assessment of AMPK activation 
in low glucose, and in the presence of the fatty acids palmitate and oleate would be of value.  
There is a trend towards the investigation of a combination of fatty acids (Karaskov et al., 2006; Coll et 
al., 2008; Das, Mondal and Elbein, 2010; Yuzefovych, Wilson and Rachek, 2010; Kwon, Lee and 
Querfurth, 2014), as well as the different effects of glucose and fructose (Meissen et al., 2015; Diaz-
Aguirre, Velez-Pardo and Jimenez-Del-Rio, 2016; Windemuller et al., 2016; Phoomak et al., 2017). 
Therefore, in a future expansion of this research, the effect of combinations of glucose and fatty acids 
on BK channel cellular distribution could be investigated.   
 
Conclusion 
The verification of BK channel nsSNP undertaken in this chapter completes step 7 of the thesis 
workflow (Figure 4.16). The results reinforce the link between the cell membrane expression of the BK 
channel and palmitoylation, and indicates that alteration of palmitoylation status by amino acid 
mutation need not be of the cysteine residue itself, but flanking amino acids may also have an effect. 
This encourages the expansion of current research practice, to investigate not only the amino acids 
directly involved in post-translational modification of BK channels, but also those amino acids flanking 
the residue of interest. This is the first study to demonstrate the effect of differing concentrations of 
glucose, palmitate and oleate on the membrane-bound ratio of BK channel constructs that have been 
mutated to mimic endogenously occurring human SNPs. The findings also suggest that this approach 
would be beneficial in the investigation of other ion channels and proteins.   
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Figure 4.16- Schematic of thesis workflow: Summary of chapter 4. Described are the steps to be 
undertaken in this thesis work to identify new potential genetic targets for personalised medicine. 
Steps 1-6 have been successfully achieved in chapter 3 by the selection of the BK channel gene 
KCNMA1, the canonical BK channel transcript, the collation of available information, the biocuration 
of this work into a ‘BK channel resource’ and the prioritisation of nsSNP. Step 7 was achieved as a result 
of the experimental verification of H55Q and G57A (H120A and G122Q in human) this chapter.  
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5 General discussion and Further Work 
 
5.1 Thesis aims 
In this thesis, the aims were initially to; a) capture the key aspects of data relating to the human BK 
channel held on bioinformatics databases and b) create a novel ‘at a glance’ resource for the BK 
channel with the synthesised information, then to c) use this resource to prioritise single-nucleotide 
polymorphisms (SNPs) predicted to be damaging to BK channel function, and then d) forward the 
mutations for lab-based investigation. These aims were successfully achieved and naturally occurring 
mutations H120Q and G122A (H55Q and G57A in the murine form of the channel), located in the S0-
S1 linker, were prioritised and selected for lab-based investigation due to their varying effect on the 
CSS-Palm 4.0 predicted palmitoylation status of C121.  
As C121 is proven to modulate cell membrane expression of the channel, the next series of 
investigations in the thesis aimed to; 1) determine whether incorporation of the SNP-mimetic mutants 
H55Q, G57A and H55Q:G57A would alter the baseline cellular distribution of the channels in 
comparison to ZERO, the wild type channel and 2) ascertain if the cellular distribution pattern of the 
SNP-mimetic mutants is related to the CSS-Palm 4.0 determined pattern of predicted C56 
palmitoylation of the SNP-mimetics mutants. This was achieved, and it was confirmed that the SNP 
mimetic mutants alter the cell membrane expression of BK channels in a pattern related to the 
predicted palmitoylation status of C56. There is evidence linking changes in the concentration of 
metabolic substrates to BK channel dysregulation, therefore the final aim of the thesis was to establish 
whether the concentration of the metabolic substrates glucose, palmitate and oleate in the cell culture 
medium affects the cellular distribution of the BK channel. This aim was also achieved and it was 
established that metabolic substrate concentration in the extracellular environment does affect the 
cell membrane distribution of BK channel constructs. In this chapter, the main themes that arose from 
the experimental chapters (chapters 3 and 4) will be discussed, in addition to suggestions of areas of 
future work. 
 
5.2 Main Themes 
5.2.1 Bioinformatics outputs require lab-based verification  
Journal articles, online publications and opinion pieces have discussed the inter-dependency of 
bioinformatics and lab based experimentation (Haoudi and Bensmail, 2006; Penders, Horstman and 
Vos, 2008; Tachibana, 2010; Eddy, 2014). The term ‘moist zone’ was coined in reference to this, and is 
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a wordplay on the collaboration based upon lab-based experimentation being nicknamed ‘wet lab’ and 
‘in silico’ experimentation ‘dry lab’. An example of ‘moist zone’ collaboration is the development of a 
comprehensive algorithm training data set for post-translational modification prediction software by 
those in the ‘wet lab’, by conducting lab-based verification experiments of potential modification sites 
using mass spectroscopy and site-directed mutagenesis. The interdependency of the two 
methodologies is illustrated as, once the algorithm has been trained in the ‘dry lab’, the software will 
produce predictions for additional sites of post-translational modification, which will then be put 
forward for lab based verification in the ‘wet lab’. Another similar example of this interdependency is 
the verification of SNP damage consequences, which can be undertaken using site directed 
mutagenesis. The results of this experimentation can then be included in the training data of SNP 
damage prediction software such as PolyPhen-2, to improve the accuracy of the scores for future 
predictions (Adzhubei, Jordan and Sunyaev, 2013).  
An exemplar advantage of this ‘moist zone’ collaboration is that the feedback between site prediction 
and validation facilitates machine learning and increases the accuracy of predictions; research can then 
be guided towards those sites that have the highest likelihood of affecting protein function. A potential 
disadvantage of this inter-dependency is the potential over reliance on bioinformatics outputs to form 
conclusions and to guide future lab-based investigations. This over reliance may result in errors or 
miscalculations in bioinformatics outputs misdirecting lab-based investigation, and lead to false results 
if outputs are not validated. An example of this occurred in 2001; the structures of multidrug resistance 
transporters EmrE and MsbA were modelled using bespoke computational biology algorithms, which 
resulted in 5 publications based upon the software output and further work based upon this (Chang 
and Roth, 2001; Chang, 2003; Ma and Chang, 2004; Pornillos et al., 2005; Reyes and Chang, 2005). 
However, lab-based experimentation results did not agree with the findings of the publications, and a 
paper in 2006 was released which directly contradicted the computational biology results (Dawson 
and Locher, 2006). Soon after, a glitch in the software was identified which caused an inversion of parts 
of the protein structure; the previously published structure based upon the software output was 
incorrect. In this scenario, prompt verification of the protein structure by lab based experimentation 
may have highlighted a potential issue more quickly. 
A bioinformatics methodology has been used successfully in previous studies to prioritise single 
nucleotide polymorphisms for further investigation (Teng et al., 2012; Ghaedi et al., 2015; Alipoor et 
al., 2016), however there are no known studies in which this has been achieved for the BK channel. 
Therefore, the aim of the thesis was to create a BK channel resource and prioritise nsSNP using a 
bioinformatics methodology. This was achieved, however, the previously discussed disadvantages of a 
bioinformatics method manifested themselves in the thesis results in a number of ways. The Ensembl 
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database contained a list of nsSNP of the BK channel canonical transcript that were uploaded by a 
number of projects such as 1000 genomes, COSMIC and ESP; these mutations were then assigned a 
damaging score by damage prediction software. However, discrepancies between the validated 
experimental results and the predictions of bioinformatics tools for these mutants became apparent, 
as in the case of D434 and S722 detailed in Chapter 3. In these examples, lab-based experimentation 
at both sites via site-directed mutagenesis confirmed that the mutations altered channel function by 
increased calcium sensitivity, and decreased hypoxia sensitivity respectively. However, nsSNP damage 
prediction software SIFT classified both mutations as tolerated. Without knowledge of the site-
directed mutagenesis results, a researcher may erroneously bypass the nsSNP occurring at these 
locations as they appear to be unimportant for channel function. This again highlights that lab based 
verification of bioinformatics outputs, and feedback of the results to the software is crucial to increase 
the accuracy of predictions.   
Another finding from the thesis hints at the consequences of the interdependency of lab-based 
experimentation and bioinformatics. Site-directed mutagenesis and palmitoylation assessment of the 
S0-S1 linker cysteine residues C53, C54 and C56 in mSlo (C118, C118 and C121 in hSlo) (Jeffries, 2010), 
lead to the inclusion of the verified sites in the training dataset for CSS Palm 4.0 software (Xue, 2017). 
In turn, the software correctly predicted the sites as being palmitoylated on the murine BK channel 
and other orthologs, such as hSlo. The C56 predicted palmitoylation scores for each of the SNPmimetic 
mutant channels was calculated, and in chapter 4 it is shown that membrane distribution of these 
channels in HEK293 cells displayed a pattern similar to that of the predicted score. However, this 
relationship between predicted palmitoylation score and cell membrane expression results was not 
observed in the BK channels mutated to contain mutated cysteine residues. CSS Palm 4.0 predicted 
that C56 would not be palmitoylated in either cysteine mutant channel; this result was expected for 
the cysteine triple mutant (C53:54:56A), however as C56 is present in the cysteine double mutant, a 
palmitoylation score was expected. Interestingly, results from chapter 4 highlighted significant 
differences between the cell membrane expression of the double and triple cysteine mutant channels, 
indicating differences between the channels that may be related to C56. It is possible that these results 
were driven by the inclusion of Jeffries 2010 data into the CSS-Palm 4.0 training dataset, which may 
have unintentionally over weighted the lab-based validation results showing that C53 and C54 integral 
for palmitoylation of the cysteine rich domain. It is also plausible that when palmitoylation of the S0-
S1 cysteine residues is not possible that other mechanisms modulate cell membrane expression; 
however, this is not predicted to be via palmitoylation as the CSS-Palm 4.0 score for the remaining 
cysteine residues was not altered, and no additional sites were predicted.   
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As discussed in chapter 3, there is a case for more extensive biocuration of BK channel data, which 
could potentially increase the speed of crosstalk between bioinformatics and lab based 
experimentation, and ensure that lab based and software outputs ‘make sense’ in relation to each 
other. In this thesis, biocuration of the data has flagged the S0-S1 cysteine residues for further 
investigation, and highlighted that whilst the SNP mimetic mutants were shown to affect BK channel 
membrane translocation, the mutations were not predicted to have an effect on channel, therefore 
data of this result could be added to PolyPhen-2 training to increase its accuracy. On the same theme, 
there is an argument for the development of a BK channel specific database or a set of BK channel 
specialised software tools. As discussed in chapter 3, specific databases and tools have been developed 
for other proteins (Elefsinioti et al., 2004; Torkamani and Schork, 2007; Gallin and Boutet, 2010; Lahiry 
et al., 2010; Ranjan et al., 2011), which resulted in increased accuracy of site predictions and an 
increase in the density of information for that specific protein. To enable such a resource to be created 
for the BK channel, issues relating to intellectual property, project funding, the mechanism of granting 
access to data before publication, the formation of a collaboration between different research groups, 
and agreement of the type of resource to be developed need to be addressed. There are publications 
providing initial generic guidance on how to overcome a number of the aforementioned barriers 
(Toronto International Data Release Workshop Authors, 2009; Singh, 2014; Lin and Chen, 2015), 
however a comprehensive protocol for the creation of a protein specific database or tool does not yet 
exist. 
An underlying factor that determines the accuracy of the output from bioinformatics resources is the 
quality and richness of the raw data included. The background information listed for the SNPs is often 
incomplete, likely due to the ethical issues of data disclosure (Ormond, 2008; Ross et al., 2013; Clarke, 
2014; Niemiec and Howard, 2016). The nsSNP included in the ‘deep dive’ section in chapter 3 of the 
thesis are examples of this as many had missing information on the gender, age and ethnicity of the 
subject in which the mutation was identified. Single gene and genome screening has moved from an 
individual basis, to screening populations (such as 100,000 genomes project); this increased the 
volume of SNP data included in the database and ‘cast a wide net’, however it may present challenges 
when attempting to compile detailed information on each of the subjects. 
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5.2.2 The S0-S1 linker cysteine residues as cell membrane expression modulators  
In addition to cysteine residues located in the STREX splice insert at the C-terminus (Jeffries, 2010), 
other regions of the BK channel have been linked with altered cell membrane localisation. Examples 
include the acidic ER trafficking motif upstream of the STREX splice insert site (Chen et al., 2010), BK 
channel splice variant mk44 in the S0-S1 linker of the channel that results in N-terminal 
endoproteolytic cleaving (Korovkina et al., 2001). Examples also include splice variants that cause ER 
trapping of the channel, such as SV1 found in the S0-S1 linker (Zarei et al., 2004), and Δe23 in the C-
terminus (Chen et al., 2005). The cysteine residues of the S0-S1 loop (C53, C56 and C56) have been 
linked with modulation of channel localisation in the cell membrane; this relationship has been 
demonstrated in work published in 2010 (Jeffries, 2010; Jeffries et al., 2010), and in 2014 (Bi, 2014; 
Kim et al., 2014). The relationship between the cysteine residues and membrane translocation is not 
clear cut however, as in 2016 a publication indicated that BK channels containing the S0-S1 linker 
cysteine residues did not reach the cell membrane (Suzuki et al., 2016). One of the aims of the work 
undertaken in chapter 4 of this thesis was to establish if the changes in the palmitoylation status of 
C56 caused by mutation neighbouring amino acid residues H55 and G57 would affect cell membrane 
expression of the BK channel. Results indicated that this was the case, as cell membrane expression 
was linked to the palmitoylation status of C56, providing further evidence that the S0-S1 linker cysteine 
residues are implicated in cell membrane expression.  
 
5.2.3 The potential physiological effects of H120Q and G122A mutation in humans 
The impact of genetic mutation on BK channel cellular distribution was examined in chapter 4 of this 
thesis, where naturally occurring mutations discovered using a bioinformatics methodology were 
tested for differences in cell membrane expression in HEK293 cells. Results demonstrated the 
significant difference in the membrane expression of BK channels containing the mutations H55Q, 
G57A and H55Q:G57A (H120Q, G122A or H120Q:G122A in hSlo). Within the results a broad pattern 
emerged; high glucose concentration alone (25mM), and conditions of high palmitate concentration 
combined with both high or low glucose concentration (25mM or 5mM) resulted in the statistically 
significant reduction of H55Q membrane expression in comparison to either G57A or H55Q:G57A. This 
trend was reversed in conditions of low glucose concentration, and conditions of high oleate 
concentration combined with both high and low glucose concentration; in these scenarios H55Q cell 
membrane expression was significantly higher than either G57A or H55Q:G57A. These results indicate 
that individuals with the H55Q mutation may have an altered response to metabolic imbalances in 
comparison to those with a G57A or H55Q:G57A mutation. In order to pre-empt the potential 
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consequences of the mutations, it is important to understand the role that the BK channel plays in 
human physiology. 
BK channels are ubiquitously expressed in the body and are implicated in a wide range of processes, 
such as the physiological regulation of vascular tone and blood pressure (Aldrich et al., 2000; Sausbier 
et al., 2005), neuronal cell function and neurotransmitter release (Raffaelli et al., 2004; Sausbier et al., 
2004; Du et al., 2005), bladder control (Meredith et al., 2004), uterine function reviewed by (Khan et 
al., 2001) and hearing (Rüttiger et al., 2004; Föller et al., 2012). The cell membrane expression of the 
BK channel is required for proper function, and it is plausible that individuals carrying the H55Q, or 
G57A / H55Q:G57A mutations may have differing ‘regulation’ of the aforementioned processes, as the 
membrane expression of the mutants is significantly different. Normal changes in BK channel 
membrane expression are demonstrated in pregnancy where reduced BK channel expression in 
myometrium smooth muscle cells facilitates progression to labour (Song et al., 1999) and in aging 
coronary arteries (Marijic et al., 2001) where a reduction in BK channel expression in the elderly 
increases the risk of vasospasm.  
The inversion of the cell membrane expression pattern of the SNP mimetic mutants in different 
combinations of metabolic substrate is noteworthy. The cellular responses to excess palmitate and 
excess oleate differ, with palmitate commonly resulting in mitochondrial stress and cell apoptosis 
(Okuyama, Fujiwara and Ohsumi, 2003; Staiger et al., 2004; Cnop et al., 2010; Morse et al., 2010; 
Elsner, Gehrmann and Lenzen, 2011; Cai et al., 2014; Yan et al., 2014; Jiaqi Liu et al., 2016); whilst 
oleate commonly results in no change in cellular processes in comparison to control, or serves to 
reverse or limit the damaging effect of palmitate (Gaster, Rustan and Beck-Nielsen, 2005; Coll et al., 
2008; Kwon, Lee and Querfurth, 2014; Hetherington et al., 2016). This raises the question of whether 
the cell membrane expression pattern observed in high glucose and high palmitate is indicative of 
‘unhealthy’ metabolic substrate combinations.  
Individuals who suffer from diabetes mellitus have dysregulation of glucose and lipid homeostasis, and 
commonly results in high glucose and palmitate concentrations. The results of this thesis may suggest 
that mutations of the BK channel can result in a differing response to the excess concentrations of 
metabolic substrates associated with diabetes, as the cell membrane expression of H55Q and 
G57A/H55Q:G57A change inversely to one another. In the case of BK channel control of vascular tone, 
the significantly reduced BK channel membrane expression observed in mSlo H55Q mutant channels 
may suggest that individuals with the hSlo H120Q mutation will have a higher incidence of 
hypertension, as reduced BK channel activity is associated with increased vessel construction (Marijic 
et al., 2001).  
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5.3 Future Work  
5.3.1 Further investigation of the effects of H120Q and G122A mutation on the BK channel  
Investigation in chapter 4 established that mutations H55Q, G57A and H55Q:G57A affect cell 
membrane translocation, and results suggest this is actioned via altered C56 palmitoylation. Jeffries et 
al 2010 investigated the effect of cysteine mutations C56 on channel activity, and found significant 
differences in channel activation by calcium influx between the mutants. Therefore, to gain more 
information on the potential similarities between the cysteine mutants and SNP mimetic mutants, and 
to investigate whether the significant differences in SNP mimetic cell membrane expression translate 
into differences in activity, patch clamp electrophysiology of the channels could be conducted.  
It would also be of interest to conduct gene sequencing in individuals suffering from diabetes mellitus 
to establish whether there is an increased incidence of the H120Q, G122A or H120Q:G122A mutation 
in that population in comparison to those without diabetes. In addition, the incidence of hypertension 
in those with one or both of the mutations could be assessed to determine if there is a relationship 
between genetic mutations and a differential response to deranged glucose and oleate conditions.  
 
5.3.2 The effect of a combination of fatty acids on BK channel cellular distribution  
Oleate is often added to cultures containing excess palmitate to assess whether an unsaturated fatty 
acid can reverse the perturbing effects of the saturated fatty acid. Co-incubation of skeletal muscle 
cells with palmitate and oleate reversed both inflammation and impairment of insulin signalling 
created by palmitate (Coll et al. 2008), and oleate addition to palmitate prevented palmitate-induced 
mitochondrial DNA damage, increased cell ATP levels and cell viability (Yuzefovych, Wilson and Rachek, 
2010). As single fatty acids, such as palmitate and oleate are not present alone in normal physiology 
and are found in combination with other fatty acids (Havel, Naimark and Borchgrevink, 1963), it would 
be of interest to examine the effect of varied combinations of fatty acids on the cell membrane 
distribution of BK channels. 
 
5.3.3 Additional sites for potential lab based research 
An additional site for lab-based experimentation would be G694C, a nsSNP prioritised in chapter 3. 
This mutation was predicted to create a new cysteine rich domain at the heme binding domain in the 
C-terminus of the channel. Thus, assessment of the mutant channel’s affinity for haeme, and potential 
changes in cell membrane translocation would be of interest to investigate.  
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Exonic SNP are commonly the target of lab based research due to their potential impact on BK channel 
function; however, sites of post-translational modification, which add functional diversity to the 
channel are also worthy of investigation. The results of the H120Q and G122A experiments in chapter 
4 suggest that mutations flanking key amino acids that undergo post-translational modification can 
affect those processes. When comparing the locations of predicted phosphorylation and the previously 
identified structural and functional domains, 3 sites of interest came to light (Figure 5.1). The predicted 
tyrosine phosphorylation site Y355 comprises the final amino acid of the potassium selectivity domain, 
which spans from T352 to Y355. Predicted phosphorylation site Y359 immediately flanks the pore 
forming domain, which spans from A336 to V358, whilst Y1027 is located only two amino acids 
downstream from the calcium bowl, located in the C-terminus, spanning from T1003 to E1025.  
 
Figure 5.1- Sites of tyrosine phosphorylation of interest for future investigation  
 
Figure 5.1- Sites of tyrosine phosphorylation of interest for future investigation. Included in the figure 
are predicted tyrosine phosphorylation sites Y354 within the potassium selectivity motif, Y359 
adjacent to the pore forming domain and Y1027, located two amino acid residues downstream of the 
calcium bowl.  
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5.4 Conclusion 
The creation of a novel BK channel resource in this thesis highlighted the limitations, and inter-
dependency of bioinformatics and lab based experimentation, whilst SNP verification experiments 
solidified the link between S0-S1 cysteine residues and BK cellular distribution. Results also provided 
evidence that naturally occurring mutations and metabolic substrates affect the cell membrane 
expression of BK channels, and that metabolic substrates have differing effects. Figure 5.2 illustrates 
the steps undertaken in this thesis and summarises areas of future work. The BK channel is expressed 
ubiquitously in the body and plays an extensive and varied role in human physiology. Therefore, 
investigations that provide insight into channel regulation and the effects of naturally occurring genetic 
alterations will increase understanding of function and associations with disease. The potential clinical 
consequences of the SNPs prioritised in this thesis requires further research, but may be a target for 
future population stratification and personalised medicine.   
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Figure 5.2- Schematic of thesis workflow: Thesis summary and future work. 
 
 
 
 
 
Figure 5.2- Schematic of thesis workflow: Thesis summary and future work. Described are the steps 
undertaken in this thesis work to identify new potential genetic targets for personalised medicine. 
Steps 1-6 were successfully achieved in chapter 3 by the selection of the BK channel gene KCNMA1, 
the canonical BK channel transcript, the collation of available information, the biocuration of this work 
into a ‘BK channel resource’ and the prioritisation of nsSNP. Step 7 was achieved as a result of the 
experimental verification of H55Q and G57A (H120A and G122Q in human) in chapter 4. Potential 
future avenues for the work would be to a) input the results into existing databases or predictive 
software training datasets, b) to input the data into a newly created BK channel database, c) conduct 
a GWAS or gene sequencing individuals to determine the incidence and linkage of H120A and G122A 
with disease traits.    
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